Methods for producing fermentation products

By using a thermostable xylanase resistant to metal ion inhibition to liquefy starch-containing materials at high temperatures, combined with α-amylase and fermentation organisms, the problem of incomplete conversion of residual starch was solved, thereby improving the yield of fermentation products and liquefaction efficiency.

CN114867860BActive Publication Date: 2026-11-17NOVOZYMES AS
View PDF 84 Cites 0 Cited by

Patent Information

Application Number
CN202080086740.5
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Priority Date
2019-12-16
Filing Date
2020-12-16
Publication Date
2026-11-17
Estimated Expiration
2040-12-16

AI Technical Summary

Technical Problem

Existing technologies for producing fermentation products such as ethanol from starch-containing materials suffer from the problem that residual starch is not fully converted, and the yield of fermentation products using traditional methods is low.

Method used

A thermostable xylanase resistant to metal ion inhibition is used to liquefy starch-containing materials at high temperatures. It is combined with α-amylase, endoglucanase and fermentation organisms for saccharification and fermentation, thereby improving liquefaction efficiency.

Benefits of technology

It significantly reduced the amount of residual starch at the end of liquefaction, increased the generation of short-chain oligosaccharides, and improved the yield of fermentation products.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN114867860B_ABST
    Figure CN114867860B_ABST
Patent Text Reader

Abstract

The present invention relates to a method for producing fermentation products from starch-containing materials, wherein a thermostable xylanase is present and / or added during liquefaction, the thermostable xylanase being resistant to inhibition by metal ions during the liquefaction of the starch-containing material.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to a method for producing fermentation products (especially ethanol) from starch-containing materials, wherein the starch-containing materials are liquefied in the presence of a xylanase that is resistant to inhibition by metal ions present during the liquefaction of the starch-containing materials.

[0002] References to sequence lists

[0003] This application contains a sequence list in a computer-readable form, which is incorporated herein by reference. Background Technology

[0004] The production of fermentation products (such as ethanol) from starch-containing materials is well known in the art. Currently, two different types of methods are used industrially. The most commonly used method is often referred to as the "conventional method," which involves liquefying gelatinized starch, typically at high temperatures, using bacterial α-amylases, followed by simultaneous saccharification and fermentation in the presence of glucosylamylases and fermenting organisms. Another well-known method is often referred to as the "raw starch hydrolysis" method (RSH method), which typically involves the simultaneous saccharification and fermentation of granular starch at temperatures below the initial gelatinization temperature in the presence of at least one glucosylamylase.

[0005] Despite significant improvements in fermentation product production processes over the past few decades, a substantial amount of residual starch material remains unconverted into desired fermentation products, such as ethanol.

[0006] Therefore, there remains a desire and demand for methods to produce fermentation products (such as ethanol) from starch-containing materials, which can provide higher yields of fermentation products or other advantages compared to conventional methods. Summary of the Invention

[0007] This invention relates to a method for producing fermentation products (especially ethanol) from starch-containing materials using fermentation organisms, wherein the starch-containing material is liquefied in the presence of a xylanase resistant to inhibition by metal ions present during liquefaction. The invention also relates to compositions used in the method of the invention. Compared to non-metal-resistant xylanases, the metal-resistant xylanase of the present invention exhibits improved activity in hydrolyzing corn fiber and releasing more fiber-bound starch. Compared to non-metal-resistant xylanases, the metal-resistant xylanase of the present invention also produces a greater amount of short-chain oligosaccharides, such as DP1 to DP6 oligosaccharides, after liquefaction is complete.

[0008] In a first aspect, the present invention relates to a method for producing fermentation products (preferably such as ethanol) from starch-containing materials, the method comprising the following steps:

[0009] i) Use the following liquefied starch-containing materials at a temperature above the initial gelatinization temperature (preferably between 80°C and 90°C):

[0010] -α-amylase, such as bacterial α-amylase;

[0011] - Xylanase, which is resistant to the inhibition of metal ions when liquefying starch-containing materials, and also has a melting point (DSC) greater than 80°C;

[0012] -Optionally, an endoglucanase having a melting point (DSC) greater than 70°C;

[0013] ii) Saccharification is performed using enzymes that produce carbohydrates;

[0014] iii) Fermentation using fermenting organisms.

[0015] In a preferred embodiment, the xylanase (especially xylanase from the genus Thermophyton) preferably has a melting point (DSC) greater than 82°C, such as greater than 84°C, such as greater than 86°C, such as greater than 88°C, such as greater than 88°C, such as greater than 90°C, such as greater than 92°C, such as greater than 94°C, such as greater than 96°C, such as greater than 98°C, such as greater than 100°C, such as between 80°C and 110°C, such as between 82°C and 110°C, such as between 84°C and 110°C.

[0016] Examples of suitable thermostable xylanases, particularly those from the genus *Thermotoga*, include the xylanase shown in SEQ ID NO:2, for example, from strains of *Thermotoga maritima*; the xylanase shown in SEQ ID NO:3, for example, from strains of *Thermotoganeapolitana*; the xylanase shown in SEQ ID NO:4, for example, from strains of *Thermotoga naphthophila*; or those described in relation to SEQ ID NO:2. The mature portion of any polypeptide of NO:2, 3 and 4 has at least 60%, such as at least 70%, such as at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, preferably at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, more preferably at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, more preferably at least 90%, more preferably at least 91%, more preferably at least 92%, at least 93%, at least 94%, or at least 95%, such as at least 96%, at least 97%, at least 98%, at least 99%, or at least 100% identity.

[0017] In another aspect, the present invention relates to a composition comprising: - α-amylase; - metal ion-resistant xylanase having a melting point (DSC) greater than 80°C, preferably greater than 85°C, especially greater than 90°C, particularly greater than 95°C; - optionally, endoglucanase; - optionally, protease; - optionally, a carbohydrate-producing enzyme.

[0018] Other enzymes (such as pullulanase and phytase) may also be included in the compositions of the present invention.

[0019] In a preferred embodiment, the composition of the present invention comprises - α-amylase, preferably bacterial α-amylase; - metal ion-resistant xylanase having a melting point (DSC) greater than 80°C, preferably greater than 85°C, especially greater than 90°C, particularly greater than 95°C; - protease having a melting point (DSC) greater than 80°C, preferably greater than 85°C, especially greater than 90°C, particularly greater than 95°C.

[0020] In a preferred embodiment, the composition of the present invention comprises - α-amylase, preferably a thermostable bacterial α-amylase; - a thermostable metal ion-resistant xylanase having a melting point (DSC) greater than 80°C, preferably greater than 85°C, especially greater than 90°C, particularly greater than 95°C; and - a thermostable protease having a melting point (DSC) greater than 80°C, preferably greater than 85°C, especially greater than 90°C, particularly greater than 95°C. Attached Figure Description

[0021] Figure 1 This is a graph showing the optimal temperature for an exemplary metal ion-resistant xylanase, such as Tm xylanase (SEQ ID NO: 2), according to the present invention.

[0022] Figure 2 This is a graph showing the temperature stability of an exemplary metal ion-resistant xylanase of the present invention, such as Tm xylanase (SEQ ID NO: 2). Detailed Implementation

[0023] The inventors have discovered that certain thermostable xylanases, such as the Dictyoglomus thermophilum xylanase of SEQ ID NO:1, are significantly inhibited by metal ions. In contrast, certain thermostable xylanases (such as xylanases from the Thermophilus genus, such as the Thermophilus marine xylanase of SEQ ID NO:2) exhibit resistance to metal ion inhibition. Surprisingly, the inventors unexpectedly discovered that, despite the presence of average concentrations of iron (Fe), zinc (Zn), and copper (Cu) ions typically found in liquefied corn mash, the relative activity of the *Thermophilus fasciatus* xylanase of SEQ ID NO:1 decreased by 40% to 80%, while xylanases from the *Thermophilus* genus, such as the *Thermophilus marinei* xylanase of SEQ ID NO:2, retained 86% of their relative activity in the presence of average concentrations of copper ions in liquefied corn mash, 73% in the presence of average concentrations of iron ions in liquefied corn mash, and 98% in the presence of average concentrations of zinc ions in liquefied corn mash. This demonstrates significant resistance to metal ion inhibition (see Example 6).

[0024] The inventors also unexpectedly discovered that, compared with non-metal-resistant xylanases, such as the thermophilic xylanase of SEQ ID NO:1, the metal-resistant thermostable xylanases described herein, such as xylanases from the genus Thermophyton, such as the marine Thermophyton xylanase of SEQ ID NO:2, exhibited improved activity in hydrolyzing corn fiber and releasing more fiber-bound starch.

[0025] Furthermore, the inventors surprisingly discovered that, compared with non-metal ion-resistant xylanases, the metal ion-resistant thermostable xylanases described herein, such as xylanases from the genus Thermophyton, such as the marine Thermophyton xylanase of SEQ ID NO:2, produce a greater amount of short-chain oligosaccharides, such as DP1 to DP6 oligosaccharides, after liquefaction.

[0026] The xylanases of the present invention derived from the genus *Thermophyton* have been observed to contain a motif comprising the amino acids tyrosine (Y), isoleucine (I), threonine (T), glutamic acid (E), methionine (M), and aspartic acid (D), wherein the glutamic acid residue is a catalytic residue. This invention covers any *Thermophyton* xylanase (e.g., from the GH10 family) containing the motif YITEMD (SEQ ID NO:30) used in the compositions or methods of the invention.

[0027] In a first aspect, the present invention relates to a method for producing fermentation products (preferably ethanol) from starch-containing materials, the method comprising the steps of: i) liquefying the starch-containing material at a temperature above the initial gelatinization temperature in the presence of a thermostable xylanase, the thermostable xylanase being resistant to inhibition by metal ions during liquefaction of the starch-containing material; ii) saccharification using an enzyme that produces a carbohydrate source; and iii) fermentation using a fermentation organism. In one embodiment, the liquefaction step i) is carried out in the presence of an α-amylase, i.e., a thermostable α-amylase, preferably a thermostable bacterial α-amylase, and / or a thermostable protease.

[0028] In one embodiment of the first aspect, the amount of residual starch present at the end of liquefaction step i) is reduced by using a thermostable xylanase resistant to metal ion inhibition during liquefaction of starch-containing materials in step i) compared to the amount of residual starch present at the end of liquefaction step i) when using a thermostable xylanase resistant to metal ion inhibition during liquefaction.

[0029] In one embodiment of the first aspect, the amount of short-chain oligosaccharides at the end of liquefaction step i) is increased by using a thermostable xylanase resistant to metal ion inhibition when liquefying starch-containing materials in step i) compared to the amount of short-chain oligosaccharides at the end of liquefaction step i) when using a thermostable xylanase that is resistant to metal ion inhibition when liquefying starch-containing materials.

[0030] In a second aspect, the present invention relates to a method for reducing the amount of residual starch present at the end of liquefaction in a method for producing a fermentation product from a starch-containing material, the method comprising: i) liquefying the starch-containing material with a thermostable xylanase to produce a liquefaction, the thermostable xylanase being resistant to inhibition by metal ions during the liquefaction of the starch-containing material, wherein the liquefaction has a reduced amount of residual starch compared to liquefaction produced using a xylanase that is not resistant to inhibition by the presence of metal ions during the liquefaction of the starch-containing material. In one embodiment of the second aspect, the liquefaction is subjected to step ii) saccharification using an enzyme producing a carbohydrate source; and iii) fermentation using a fermentation organism.

[0031] As used herein, “thermal stability” means that a polypeptide (i.e., an enzyme, such as xylanase, α-amylase, protease) retains a significant amount of its activity (e.g., specific activity, relative activity, etc.) within a relevant temperature range for a specific period of time required for the enzyme to perform its function. For example, the enzyme disclosed herein for liquefaction step i) exhibits thermal stability in a temperature range of about 75°C to 100°C, preferably about 80°C to 95°C, more preferably about 82°C to 92°C, or about 85°C, about 88°C, or about 90°C. The term “thermal stability” also encompasses enzymes having an optimal temperature within the relevant temperature range, although this disclosure covers enzymes having a higher or lower optimal temperature, provided that the enzyme retains a significant amount of its activity within the relevant temperature range for the relevant period of time (e.g., the enzyme used in liquefaction will retain its activity at any time from 10 minutes to 2 hours within a temperature range of 75°C to 100°C). The thermostable enzymes of the present invention (e.g., thermostable xylanases resistant to metal ion inhibition, thermostable proteases, thermostable α-amylases, thermostable endoglucanases, thermostable glucosylamylases, thermostable pullulanases, phytases, etc.) are used for liquefaction for up to 10 minutes, 15 minutes, 20 minutes, 25 minutes, 30 minutes, or 45 minutes at temperatures of at least 75°C, 80°C, 82°C, 84°C, 85°C, 86°C, 88°C, 90°C, 92°C, 94°C, 95°C, 96°C, 98°C, or up to 100°C. They retain at least 70%, at least 75%, at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, and at least 99% of their activity for minutes, 1 hour, 1.2 hours, 1.4 hours, 1.5 hours, 1.6 hours, 1.8 hours, or up to 2 hours. The thermostable enzymes of the present invention (e.g., thermostable xylanases resistant to metal ion inhibition, thermostable proteases, thermostable α-amylases, thermostable endoglucanases, thermostable glucosylamylases, thermostable pullulanases, phytases, etc.) preferably have a melting point (DSC) of about 75°C to about 110°C, for example, greater than about 80°C, about 82°C, about 84°C, about 85°C, about 86°C, about 88°C, about 90°C, about 92°C, about 94°C, about 95°C, about 96°C, about 98°C, about 100°C, about 105°C, or up to about 110°C. The DSC melting point can be determined using techniques available to those skilled in the art, for example, by differential scanning calorimetry as described below for xylanases. Furthermore, activity assays can be used to determine the activity of the enzyme at different temperatures to determine the optimal temperature for a specific thermostable enzyme of the present invention, and to determine how much activity the thermostable enzyme retains within a specific temperature range or over a period of time. Examples of activity assays are described in the following examples.

[0032] Those skilled in the art will understand that the degree of reduction in residual starch in the liquefaction can vary, for example, depending on the concentration of xylanase, and other factors that are obvious to those skilled in the art. For example, the amount of residual starch in the liquefaction can be reduced by at least 1%, at least 1.5%, at least 2%, at least 2.5%, at least 3%, at least 3.5%, at least 4%, at least 4.5%, at least 5%, at least 6%, at least 7%, at least 8%, at least 9%, at least 10%, at least 15%, at least 20%, at least 25%, at least 30%, at least 35%, at least 40%, or at least 50% compared to the amount of residual starch in the liquefaction without the presence of thermostable metal ion-resistant xylanase. When using metal ion-resistant xylanase to liquefy starch-containing materials, the determination described in Example 7 can be used to determine the amount of residual starch present in the liquefaction and to compare it with a control (e.g., using a non-metal ion-resistant xylanase, such as the xylanase of SEQ ID NO: 1) to determine the degree of reduction in residual starch using the metal ion-resistant xylanase of the present invention.

[0033] In a third aspect, the present invention relates to a method for increasing the amount of short-chain oligosaccharides present at the end of liquefaction in a method for producing a fermentation product from a starch-containing material, the method comprising: i) liquefying the starch-containing material with a thermostable xylanase to produce a liquefaction, the thermostable xylanase being resistant to inhibition by metal ions during the liquefaction of the starch-containing material, wherein the liquefaction has an increased amount of short-chain oligosaccharides compared to liquefaction produced using a xylanase that is not resistant to inhibition by the presence of metal ions during the liquefaction of the starch-containing material. In one embodiment of the third aspect, the liquefaction is subjected to step ii) saccharification using an enzyme producing a carbohydrate source; and iii) fermentation using a fermentation organism.

[0034] As used herein, the phrase "short-chain oligosaccharide" refers to oligosaccharides from DP1 to DP6, including, for example, glucose (DP1), maltose (DP2), maltotriose (DP3), maltotetraose (DP4), maltopentose (DP5), and maltohexaose (DP6). Those skilled in the art will understand that the extent of the increase in short-chain oligosaccharides in a liquefaction can vary, for example, depending on the concentration of xylanase, and other factors that are obvious to those skilled in the art. For example, the total amount of short-chain oligosaccharides can be increased by at least 1%, at least 1.5%, at least 2%, at least 2.5%, at least 3%, at least 3.5%, at least 4%, at least 4.5%, at least 5%, at least 6%, at least 7%, at least 8%, at least 9%, at least 10%, at least 15%, at least 20%, at least 25%, at least 30%, at least 35%, at least 40%, or at least 50%. When using xylanase inhibitors against metal ions to liquefy starch-containing materials, the assay described in Example 8 can be used to determine the amount of short-chain oligosaccharides present in the liquefaction and to compare with a control (e.g., using a non-metal-inhibitory xylanase, such as the xylanase of SEQ ID NO: 1) to determine the extent to which the xylanase inhibitors against metal ions of the present invention increase the amount of short-chain oligosaccharides.

[0035] In one embodiment, the amount of DP1 present in the liquefaction is increased by at least 1%, at least 1.5%, at least 2%, at least 2.5%, at least 3%, at least 3.5%, at least 4%, at least 4.5%, at least 5%, at least 6%, at least 7%, at least 8%, at least 9%, at least 10%, at least 15%, at least 20%, at least 25%, at least 30%, at least 35%, at least 40%, or at least 50% compared to the amount of DP1 in the liquefaction in the absence of the thermostable metal ion-resistant xylanase of the present invention. In one embodiment, the amount of DP2 present in the liquefaction is increased by at least 1%, at least 1.5%, at least 2%, at least 2.5%, at least 3%, at least 3.5%, at least 4%, at least 4.5%, at least 5%, at least 6%, at least 7%, at least 8%, at least 9%, at least 10%, at least 15%, at least 20%, at least 25%, at least 30%, at least 35%, at least 40%, or at least 50% compared to the amount of DP2 present in the absence of the thermostable metal ion-resistant xylanase of the present invention. In one embodiment, the amount of DP3 present in the liquefaction is increased by at least 1%, at least 1.5%, at least 2%, at least 2.5%, at least 3%, at least 3.5%, at least 4%, at least 4.5%, at least 5%, at least 6%, at least 7%, at least 8%, at least 9%, at least 10%, at least 15%, at least 20%, at least 25%, at least 30%, at least 35%, at least 40%, or at least 50% compared to the amount of DP3 in the liquefaction in the absence of the thermostable metal ion-resistant xylanase of the present invention. In one embodiment, the amount of DP4 present in the liquefaction is increased by at least 1%, at least 1.5%, at least 2%, at least 2.5%, at least 3%, at least 3.5%, at least 4%, at least 4.5%, at least 5%, at least 6%, at least 7%, at least 8%, at least 9%, at least 10%, at least 15%, at least 20%, at least 25%, at least 30%, at least 35%, at least 40%, or at least 50% compared to the amount of DP4 present in the absence of the thermostable metal ion-resistant xylanase of the present invention. In one embodiment, the amount of DP5 present in the liquefaction is increased by at least 1%, at least 1.5%, at least 2%, at least 2.5%, at least 3%, at least 3.5%, at least 4%, at least 4.5%, at least 5%, at least 6%, at least 7%, at least 8%, at least 9%, at least 10%, at least 15%, at least 20%, at least 25%, at least 30%, at least 35%, at least 40%, or at least 50% compared to the amount of DP5 in the liquefaction in the absence of the thermostable metal ion-resistant xylanase of the present invention.In one embodiment, the amount of DP6 present in the liquefaction is increased by at least 1%, at least 1.5%, at least 2%, at least 2.5%, at least 3%, at least 3.5%, at least 4%, at least 4.5%, at least 5%, at least 6%, at least 7%, at least 8%, at least 9%, at least 10%, at least 15%, at least 20%, at least 25%, at least 30%, at least 35%, at least 40%, or at least 50% compared to the amount of DP6 in the liquefaction without the thermostable metal ion-resistant xylanase of the present invention.

[0036] Steps ii) and iii) can be performed sequentially or simultaneously. In a preferred embodiment, steps ii) and iii) are performed simultaneously. Xylanase, preferably having a melting point (DSC) greater than 80°C, can be added before and / or during liquefaction step i), preferably a thermostable bacterial α-amylase, and optionally a thermostable endoglucanase having a melting point (DSC) greater than 70°C. Optionally, proteases, carbohydrate-producing enzymes, preferably glucosylamylase, pullulanase, and / or phytase may also be present and / or added. In a preferred embodiment, the compositions of the present invention as defined below are applicable to liquefaction in the method of the present invention. Enzymes can be added alone or as one or more mixed compositions comprising α-amylase, preferably a xylanase having a melting point (DSC) greater than 80°C, and optionally an endoglucanase, and optionally a protease, a carbohydrate-producing enzyme, pullulanase, and / or phytase.

[0037] Examples of α-amylase can be found in the section "α-amylase present and / or added during liquefaction" below.

[0038] In one embodiment, the α-amylase is a variant of the α-amylase shown in SEQ ID NO:5 herein, such as a variant derived from a strain of Bacillus stearomthermphilus, having mutations selected from the group consisting of: -I181*+G182*; -I181*+G182*+N193F; preferably -I181*+G182*+E129V+K177L+R179E; -I181*+G182*+N193F+E129V+K177L+R179E; -I181*+G182*+N193F+V59A+Q89R+E129V+K177L+R179E+H208Y+K220P+N2 24L+Q254S; -I181*+G182*+N193F+V59A+Q89R+E129V+K177L+R179E+Q254S+M284V; -I181*+G182*+N193F+E129V+K177L+R179E+K220P+N224L+S242Q+Q254S; and -I181*+G182*+N193F+E129V+K177L+R179S+K220P+N224L+S242Q+Q254S (using SEQ ID NO:5 for numbering).

[0039] When produced by Bacillus stearothermophilus α-amylase, it is usually naturally truncated to about 491 amino acids in length (compared to SEQ ID NO:3 in WO99 / 19467 or SEQ ID NO:5 in this article), such as from about 480 to 495 amino acids in length.

[0040] In one embodiment, the bacterial α-amylase, for example, Bacillus α-amylase, such as especially Bacillus stearothermophilus α-amylase, is added in a dose-dependent manner in the liquefaction at a concentration between 0.01 and 10 KNU-A / g DS, for example, between 0.02 and 5 KNU-A / g DS, such as 0.03 and 3 KNU-A, preferably 0.04 and 2 KNU-A / g DS, such as especially 0.01 and 2 KNU-A / g DS.

[0041] In one embodiment, the bacterial α-amylase, for example, Bacillus α-amylase, such as especially Bacillus stearothermophilus α-amylase, is added in the liquefaction dose at a concentration of 0.0001 to 1 mg EP (enzyme protein) / g DS, for example, 0.0005 to 0.5 mg EP / g DS, such as 0.001 to 0.1 mg EP / g DS.

[0042] In one aspect, a GH10 xylanase containing the motif YITEMD (SEQ ID NO:30) from the genus *Thermophyton* is used in the methods or compositions of the present invention. Examples of suitable thermostable xylanases, particularly those from the genus *Thermophyton*, include the xylanase shown herein in SEQ ID NO:2, for example, from strains derived from *Thermophyton nautiloides*; the xylanase shown herein in SEQ ID NO:3, for example, from strains derived from *Thermophyton nautiloides*; the xylanase shown herein in SEQ ID NO:4, for example, from strains derived from *Thermophyton nautiloides*; or, respectively, those associated with SEQ ID NO:30. The mature portion of any polypeptide of NO:2, 3 and 4 has at least 60%, such as at least 70%, such as at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, preferably at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, more preferably at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, more preferably at least 90%, more preferably at least 91%, more preferably at least 92%, at least 93%, at least 94%, or at least 95%, such as at least 96%, at least 97%, at least 98%, at least 99%, or at least 100% identity.

[0043] In one embodiment, the thermostable, metal ion-resistant xylanase is a xylanase from the GH10 family of *Thermomyces*, containing the motif YITEMD (SEQ ID NO: 30) and further associated with SEQ ID NO: 30. The mature portion of any polypeptide of NO:2 has at least 60%, such as at least 70%, such as at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, preferably at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, more preferably at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, more preferably at least 90%, more preferably at least 91%, more preferably at least 92%, at least 93%, at least 94%, or at least 95%, such as at least 96%, at least 97%, at least 98%, at least 99%, or at least 100% identity.

[0044] In one embodiment, the thermostable, metal ion-resistant xylanase is a xylanase from the GH10 family of *Thermomyces*, containing the motif YITEMD (SEQ ID NO: 30) and further associated with SEQ ID NO: 30. The mature portion of any polypeptide of NO:3 has at least 60%, such as at least 70%, such as at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, preferably at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, more preferably at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, more preferably at least 90%, more preferably at least 91%, more preferably at least 92%, at least 93%, at least 94%, or at least 95%, such as at least 96%, at least 97%, at least 98%, at least 99%, or at least 100% identity.

[0045] In one embodiment, the thermostable, metal ion-resistant xylanase is a xylanase from the GH10 family of *Thermomyces*, containing the motif YITEMD (SEQ ID NO: 30) and further associated with SEQ ID NO: 30. The mature portion of any polypeptide of NO:4 has at least 60%, such as at least 70%, such as at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, preferably at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, more preferably at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, more preferably at least 90%, more preferably at least 91%, more preferably at least 92%, at least 93%, at least 94%, or at least 95%, such as at least 96%, at least 97%, at least 98%, at least 99%, or at least 100% identity.

[0046] Examples of suitable optional endoglucanases with a melting point (DSC) greater than 70°C can be found in the section below, “Thermostable endoglucanases present and / or added during liquefaction”.

[0047] In a preferred embodiment, the endoglucanase is the endoglucanase shown in SEQ ID NO:7 herein, such as an endoglucanase derived from a strain of *Talaromyces leycettanus* (WO 2013 / 019780), or an endoglucanase having at least 80%, at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99% identity with SEQ ID NO:7 herein.

[0048] In a preferred embodiment, the endoglucanase is the endoglucanase shown in SEQ ID NO:7 herein, such as an endoglucanase derived from a strain of *Basilella repens* (WO2013 / 019780 – incorporated herein by reference), or an endoglucanase having a melting point (DSC) greater than 70°C that is at least 80%, at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99% identity with SEQ ID NO:7 herein.

[0049] Examples of optional proteases can be found in the "Proteases present and / or added during liquefaction" section below.

[0050] Examples of suitable optional carbohydrate-producing enzymes, preferably thermostable carbohydrate-producing enzymes, particularly glucosylamylases, can be found in the section below, “Carbohydrate-producing enzymes present and / or added during liquefaction”.

[0051] Suitable optional pullulanases may be found in the "Pululanases present and / or added during liquefaction" section below. In a preferred embodiment, the pullulanase is derived from a Bacillus species.

[0052] Examples of optional phytases can be found in the "Phytases present and / or added during liquefaction" section below. In a preferred embodiment, the phytase is derived from strains of the genus *Buttiauxella*.

[0053] Suitable cellulase or cellulolytic enzyme compositions present and / or added during saccharification and / or fermentation or simultaneous saccharification and fermentation (SSF) can be found in the "Cellulase or Cellulolytic Enzyme Compositions Present and / or Added During Saccharification and / or Fermentation or SSF" section below. In one embodiment, the cellulase or cellulolytic enzyme composition is derived from Trichoderma reesei.

[0054] In a preferred embodiment, the cellulase or cellulolytic enzyme composition is a Trichoderma reesei cellulolytic enzyme composition, which further comprises a Thermophilic Ascomycota orange GH61A polypeptide (SEQ ID NO:6 in WO 2005 / 074656 or SEQ ID NO:18 herein) having cellulolytic-enhancing activity, and Aspergillus fumigatus β-glucosidase (SEQ ID NO:2 in WO 2005 / 047499 or SEQ ID NO:16 herein).

[0055] In one embodiment, the cellulase or cellulolytic enzyme composition is a Trichoderma reesei cellulolytic enzyme composition, further comprising the Penicillium emersonii GH61A polypeptide disclosed in WO 2011 / 041397 SEQ ID NO:2 or SEQ ID NO:19 herein, and Aspergillus fumigatus β-glucosidase or a variant thereof disclosed in WO 2005 / 047499 SEQ ID NO:2 or SEQ ID NO:16 herein, the variant having one of the following substitutions, preferably all of the following substitutions: F100D, S283G, N456E, F512Y (using SEQ ID NO:16 herein for numbering).

[0056] In one embodiment, the cellulase or cellulolytic enzyme composition is a Trichoderma reesei cellulolytic enzyme composition, which further comprises Aspergillus fumigatus β-glucosidase or a variant thereof disclosed in WO 2005 / 047499 or SEQ ID NO:16 herein, the variant having one of the following substitutions, preferably all of the following substitutions: F100D, S283G, N456E, F512Y (SEQ ID NO:16 herein is used for numbering).

[0057] According to the method of the present invention, the pH during liquefaction can be between 4.0 and 6.5, such as 4.5 to 6.2, greater than 4.8 to 6.0, or between 5.0 and 5.8.

[0058] According to the present invention, the temperature can be higher than the initial gelatinization temperature. The term "initial gelatinization temperature" refers to the lowest temperature at which starch typically begins to dissolve upon heating. This temperature can vary for different starches. The initial gelatinization temperature can range from 50°C to 70°C.

[0059] In one embodiment, the temperature during liquefaction step i) is in the range of 70°C to 100°C, such as between 70°C and 95°C, such as between 75°C and 90°C, preferably between 80°C and 90°C, such as about 85°C.

[0060] In one embodiment, the method of the present invention further includes the following steps prior to step i):

[0061] a) Preferably, the particle size of starch-containing materials is reduced by dry grinding;

[0062] b) Form a slurry containing the starch-containing material and water.

[0063] The starch-containing starting material (such as whole grains) can, for example, be milled to reduce particle size in order to develop its structure, increase its surface area, and allow for further processing. There are generally two types of methods: wet milling and dry milling. In dry milling, the whole grain is milled and used. Wet milling allows for good separation of the germ from the coarse flour (starch granules and protein). Wet milling is often used in applications where starch hydrolysates are used to produce, for example, syrups. Both dry and wet milling are well-known in the field of starch processing. According to the invention, dry milling is preferred. The particle size can be reduced even further, for example, by Turkish grinding. In one embodiment, the particle size is reduced to 0.05 to 3.0 mm, preferably 0.1-0.5 mm, or such that at least 30%, preferably at least 50%, more preferably at least 70%, and even more preferably at least 90% of the starch-containing material is suitable for passing through a sieve with a sieve having a mesh size of 0.05 to 3.0 mm, preferably 0.1-0.5 mm. In another embodiment, at least 50%, preferably at least 70%, more preferably at least 80%, and especially at least 90% of the starch-containing material is suitable for passing through a sieve with a #6 mesh. In one embodiment, at least 75% of the starch-containing material is suitable for passing through a sieve with a mesh size of less than 0.5 mm, more preferably at least 79% or 80% of the starch-containing material is suitable for passing through a sieve with a mesh size of less than 0.425 mm. In one embodiment, at least 50% of the starch-containing material is suitable for passing through a sieve with a mesh size of 0.25 mm to 0.425 mm, more preferably at least 59% or 60% of the starch-containing material is suitable for passing through a sieve with a mesh size of 0.25 mm to 0.425 mm.

[0064] The aqueous slurry may contain starch-containing materials at 10-55 w / w-% dry solids (DS), preferably 25-45 w / w-% dry solids (DS), and more preferably 30-40 w / w-% dry solids (DS).

[0065] The slurry can be heated to above the initial gelatinization temperature, preferably between 70°C and 95°C, such as between 80°C and 90°C, with a pH between 5.0 and 7.0, preferably between 5.0 and 6.0, for 30 minutes to 5 hours, such as about 2 hours.

[0066] In one embodiment, liquefaction step i) is carried out for 0.5 to 5 hours at a temperature ranging from 70°C to 95°C and a pH ranging from 4 to 6.

[0067] In a preferred embodiment, the liquefaction step i) is carried out for 0.5 to 3 hours at a temperature of 80°C to 90°C and a pH of 4 to 6.

[0068] α-Amylase, metal-resistant xylanase, and optionally thermostable endoglucanase, optionally protease, optionally carbohydrate-producing enzyme, particularly glucosylamylase, optionally pullulanase, and / or optionally phytase may be initially added to the aqueous slurry to initiate liquefaction (dilution). In one embodiment, only a portion of these enzymes are added to the aqueous slurry, while the remainder is added during liquefaction step i).

[0069] In one embodiment, the aqueous slurry may be spray-cooked to further gelatinize the slurry before liquefaction in step i). This spray-cooking may be performed at a temperature between 95°C and 160°C, such as between 110°C and 145°C, preferably between 120°C and 140°C, such as between 125°C and 135°C, preferably about 130°C, for about 1 to 15 minutes, preferably about 3 to 10 minutes, and especially about 5 minutes.

[0070] Saccharification and fermentation

[0071] According to the method of the invention, one or more carbohydrate-producing enzymes, particularly glucosylamylase, may be present and / or added during saccharification step ii) and / or fermentation step iii). The carbohydrate-producing enzyme is preferably glucosylamylase, but may also be an enzyme selected from the group consisting of β-amylase, maltose amylase, and α-glucosidase. The carbohydrate-producing enzyme added during saccharification step ii) and / or fermentation step iii) is typically different from the optional carbohydrate-producing enzyme, particularly glucosylamylase, added during liquefaction step i). In one embodiment, the carbohydrate-producing enzyme, particularly glucosylamylase, is added together with fungal α-amylase.

[0072] Examples of carbohydrate-producing enzymes (including glucosylamylase) can be found in the section below, “Carbohydrate-producing enzymes present and / or added during saccharification and / or fermentation”.

[0073] When saccharification and fermentation are carried out sequentially, the saccharification step ii) can be performed under conditions well known in the art. For example, the saccharification step ii) can last from about 24 to about 72 hours.

[0074] In one embodiment, a pre-saccharification step is performed. In one embodiment, a carbohydrate-producing enzyme is added during pre-saccharification prior to saccharification step ii) and / or fermentation step iii). Alternatively, a carbohydrate-producing enzyme may be added during pre-saccharification prior to simultaneous saccharification and fermentation (SSF).

[0075] In one embodiment, a carbohydrate-producing enzyme, preferably glucosylamylase, and / or a combination of cellulase or cellulolytic enzymes, is added during presaccharification, prior to saccharification step ii) and / or fermentation step iii). Alternatively, a carbohydrate-producing enzyme, preferably glucosylamylase, and a combination of cellulase or cellulolytic enzymes may be added during presaccharification, prior to simultaneous saccharification and fermentation (SSF). Presaccharification is typically carried out at temperatures between 30°C and 65°C (typically about 60°C) for 40 to 90 minutes. In simultaneous saccharification and fermentation (SSF), saccharification may follow presaccharification during fermentation. Saccharification is typically carried out at temperatures between 20°C and 75°C, preferably between 40°C and 70°C, typically about 60°C, and at a pH between 4 and 5, such as at about pH 4.5.

[0076] Simultaneous saccharification and fermentation (“SSF”) is widely used in industrial-scale fermentation product production methods, particularly in ethanol production. When performing SSF, saccharification step ii) and fermentation step iii) are carried out simultaneously. Saccharification may not have a hold phase, meaning that the fermentation organism (e.g., yeast) and one or more enzymes (in a preferred embodiment according to the invention, a combination of glucoamylase and cellulase or cellulolytic enzyme) can be added together. However, the addition of the fermentation organism and one or more enzymes separately is also covered. According to the invention, fermentation or SSF can typically be carried out at temperatures from 25°C to 40°C, such as 28°C to 35°C, such as 30°C to 34°C, preferably around 32°C. In one embodiment, fermentation takes place for 6 to 120 hours, particularly 24 to 96 hours. In one embodiment, the pH is between 3.5 and 5, particularly between 3.8 and 4.3.

[0077] Fermentation medium

[0078] "Fermentation media" refers to the environment in which fermentation takes place. Fermentation media includes the fermentation substrate, i.e., the source of carbohydrates metabolized by the fermenting organism. According to the present invention, the fermentation media may contain one or more nutrients and growth stimulants for one or more fermenting organisms. Nutrients and growth stimulants are widely used in the field of fermentation and include nitrogen sources such as ammonia; urea; vitamins and minerals, or combinations thereof.

[0079] Fermented organisms

[0080] The term "fermentation organism" refers to any organism suitable for the fermentation process and capable of producing the desired fermentation product, including bacteria and fungi, especially yeast. Particularly suitable fermentation organisms are those capable of fermenting sugars (such as glucose or maltose) directly or indirectly into (i.e., converting them into) the desired fermentation product (such as ethanol). Examples of fermentation organisms include fungi, such as yeast. Preferred yeasts include strains of the genus *Saccharomyces*, particularly *Saccharomyces cerevisiae*.

[0081] During fermentation (such as SSF), the appropriate concentration of viable fermentation organisms is well known in the art or can be readily determined by those skilled in the art. In one embodiment, a fermentation organism (such as an ethanol fermentation yeast (e.g., Saccharomyces cerevisiae)) is added to the fermentation medium such that the count of viable fermentation organisms (such as yeast) per mL of fermentation medium is from 10 5 Up to 10 12 Preferred from 10 7 Up to 10 10 Within that range, especially about 5 x 10 7 indivual.

[0082] Examples of commercially available yeast include, for example, RED STAR. TM and ETHANOL RED TM Yeast (available from Fermentisis / Lesaffre, USA), FALI (available from Fleischmann's Yeast, USA), SUPERSTART, and THERMOSACC TM Fresh yeast (available from Ethanol Technology, Wisconsin, USA), BIOFERM AFT and XR (available from North American Bioproducts Corporation, Georgia, USA), GERT STRAND (available from Gert Strand AB, Sweden), and FERMIOL (available from DSM Specialties).

[0083] Starch-containing materials

[0084] Any suitable starch-containing material can be used according to the present invention. The starting material is typically selected based on the desired fermentation product. Examples of starch-containing materials suitable for use in the methods of the present invention include whole grains, corn, wheat, barley, rye, sorghum, sago, cassava, cassava starch, sorghum, rice, peas, beans, or sweet potatoes or mixtures thereof, or starches derived therefrom, or cereals. Waxy and non-waxy types of corn and barley are also included.

[0085] In a preferred embodiment, the starch-containing material used for ethanol production according to the present invention is corn or wheat.

[0086] Fermentation products

[0087] The term "fermentation product" refers to a product produced by a method that includes a fermentation step using fermenting organisms. Fermentation products covered by this invention include alcohols (e.g., ethanol, methanol, butanol; polyols such as glycerol, sorbitol, and inositol); organic acids (e.g., citric acid, acetic acid, itaconic acid, lactic acid, succinic acid, gluconic acid); ketones (e.g., acetone); amino acids (e.g., glutamic acid); gases (e.g., H2 and CO2); antibiotics (e.g., penicillin and tetracycline); enzymes; vitamins (e.g., riboflavin, B vitamins). 12 (β-carotene); and hormones. In a preferred embodiment, the fermentation product is ethanol, for example, fuel ethanol; drinking ethanol, i.e., neutral drinking alcohol; or industrial ethanol or products used in the consumer alcohol industry (e.g., beer and wine), dairy industry (e.g., fermented dairy products), leather industry, and tobacco industry. Preferred beer types include ale, stout, porter, lager, bitters, malt liquor, happyhu, high-alcohol beer, low-alcohol beer, low-calorie beer, or light beer. Preferably, the method of the invention is used to produce alcohols, such as ethanol. The fermentation product (such as ethanol) obtained according to the invention can be used as a fuel typically blended with gasoline. However, in the case of ethanol, it can also be used as drinking ethanol.

[0088] Recycle

[0089] Following fermentation or SSF, the fermentation products can be separated from the fermentation medium. The slurry can be distilled to extract the desired fermentation product (e.g., ethanol). Alternatively, the desired fermentation product can be extracted from the fermentation medium using microfiltration or membrane filtration techniques. The fermentation products can also be recovered by stripping or other methods well known in the art.

[0090] α-Amylase present and / or added during liquefaction

[0091] According to the invention, α-amylase is present and / or added during liquefaction with a metal ion-resistant xylanase preferably having a melting point (DSC) greater than 80°C, such as between 80°C and 95°C, and optionally an endoglucanase, optionally a protease, optionally a carbohydrate-producing enzyme, particularly glucosylamylase, optionally pullulanase, and / or optionally phytase.

[0092] The α-amylase added during liquefaction step i) can be any α-amylase. Bacterial α-amylases are preferred, such as, in particular, Bacillus α-amylases, such as thermophilic Bacillus stearothermophilus α-amylase, which is stable at the temperatures used during liquefaction.

[0093] Bacterial α-amylase

[0094] The term "bacterial α-amylase" means any bacterial α-amylase classified under EC 3.2.1.1. The bacterial α-amylase used according to the invention may, for example, be derived from strains of the genus *Bacillus* (sometimes also called *Geobryophyte*). In one embodiment, the *Bacillus* α-amylase is derived from strains of *Bacillus amyloliquefaciens*, *Bacillus licheniformis*, *Bacillus thermophilus*, *Bacillus* species TS-23, or *Bacillus subtilis*, but may also be derived from other *Bacillus* species.

[0095] Specific examples of bacterial α-amylases include the thermophilic Bacillus stearothermophilus α-amylase of SEQ ID NO:3 in WO 99 / 19467 or SEQ ID NO:5 herein, the amylolytic Bacillus amyloliquefaciens α-amylase of SEQ ID NO:5 in WO 99 / 19467, the Bacillus licheniformis α-amylase of SEQ ID NO:4 in WO 99 / 19467, and the Bacillus species TS-23 α-amylase disclosed as SEQ ID NO:1 in WO 2009 / 061380 (all sequences are hereby incorporated by reference).

[0096] In one embodiment, the bacterial α-amylase may be an enzyme having at least 60%, such as at least 70%, at least 80%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99% identity with any sequence shown in SEQ ID NO:3, 4, or 5 in WO 99 / 19467 and SEQ ID NO:1 in WO 2009 / 061380.

[0097] In one embodiment, the α-amylase may be an enzyme having at least 60%, such as at least 70%, at least 80%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99% identity with any sequence shown in SEQ ID NO:3 of WO 99 / 19467 or SEQ ID NO:5 herein.

[0098] In a preferred embodiment, the α-amylase is derived from *Bacillus thermophilus*. This *Bacillus thermophilus* α-amylase can be a mature wild type or a mature variant thereof. The mature *Bacillus thermophilus* α-amylase or a variant thereof can be naturally truncated during recombinant production. For example, the mature *Bacillus thermophilus* α-amylase can be truncated at the C-terminus, so that it is about 491 amino acids long (compared to SEQ ID NO:3 in WO 99 / 19467 or SEQ ID NO:1 herein), such as from 480 to 495 amino acids long.

[0099] This Bacillus α-amylase can also be a variant and / or a heterozygote. Examples of such variants can be found in any of the following: WO 96 / 23873, WO 96 / 23874, WO 97 / 41213, WO 99 / 19467, WO 00 / 60059, WO 02 / 10355 and WO 2009 / 061380 (all documents are hereby incorporated by reference). Specific α-amylase variants are disclosed in U.S. Patent Nos. 6,093,562, 6,187,576, 6,297,038, and 7,713,723 (incorporated hereby by reference) and include variants of *Bacillus stearothermophilus* α-amylase (often referred to as BSG α-amylase) having the following: deletion of one or two amino acids at any of positions R179, G180, I181, and / or G182, preferably a double deletion as disclosed in WO 96 / 23873—see, for example, page 20, lines 1–10 (incorporated hereby by reference), preferably corresponding to the deletion at positions I181 and G182 compared to the amino acid sequence of *Bacillus stearothermophilus* α-amylase described in SEQ ID NO:3 of WO 99 / 19467 or SEQ ID NO:5 herein, or using SEQ ID NO:3 of WO 99 / 19467 or SEQ ID NO:5 herein. The deletion of amino acids R179 and G180 in NO:5. Even more preferred are Bacillus α-amylases, especially Bacillus stearothermophilus (BSG) α-amylases, which, compared with the amino acid sequence of the wild-type BSG α-amylase described in SEQ ID NO:3 disclosed in WO 99 / 19467 or SEQ ID NO:5 herein, have one or two amino acid deletions at positions R179, G180, I181, and G182, preferably double deletions at positions R179 and G180, or preferably deletions at positions 181 and 182 (represented as I181*+G182*), and optionally, further comprising N193F substitutions (represented as I181*+G182*+N193F). Bacterial α-amylase may also have a substitution at the position of Bacillus licheniformis α-amylase corresponding to SEQ ID NO:4 in WO 99 / 19467, or the S242 variant of Bacillus stearothermophilus α-amylase of SEQ ID NO:3 in WO99 / 19467, or the S239 position in SEQ ID NO:5 herein.

[0100] In one embodiment, the variant is the S242A, E, or Q variant of Bacillus stearothermophilus α-amylase, preferably the S242Q or A variant (numbered using SEQ ID NO:5 herein).

[0101] In one embodiment, the variant is the E188 variant of Bacillus stearothermophilus α-amylase, preferably the E188P variant (numbered using SEQ ID NO:5 herein).

[0102] Other covered variants are the Bacillus species TS-23 variant disclosed in WO 2009 / 061380, and in particular the variant defined in claim 1 of WO 2009 / 061380 (which is hereby incorporated by reference).

[0103] Bacterial hybrid α-amylase

[0104] Bacterial α-amylases can also be hybrid bacterial α-amylases, such as those comprising 445 C-terminal amino acid residues of Bacillus licheniformis α-amylase (shown in SEQ ID NO:4 of WO99 / 19467) and 37 N-terminal amino acid residues of α-amylase derived from Bacillus amyloliquefaciens (shown in SEQ ID NO:5 of WO 99 / 19467). In a preferred embodiment, the hybrid has one or more, especially all, of the following substitutions: G48A+T49I+G107A+H156Y+A181T+N190F+I201F+A209V+Q264S (using the Bacillus licheniformis numbering scheme in SEQ ID NO:4 of WO 99 / 19467). Also preferred are variants having one or more of the following mutations (or corresponding mutations in other Bacillus α-amylases): H154Y, A181T, N190F, A209V, and Q264S and / or the deletion of two residues between positions 176 and 179, preferably the deletion of E178 and G179 (position numbered using SEQ ID NO:5 of WO 99 / 19467).

[0105] In one embodiment, the bacterial α-amylase is the mature portion of a chimeric α-amylase, disclosed in Richardson et al., 2002, The Journal of Biological Chemistry, 277(29): 267501-26507, and is referred to as BD5088 or a variant thereof. This α-amylase is identical to the α-amylase shown in SEQ ID NO:2 of WO 2007134207. The mature enzyme sequence begins after the initial "Met" amino acid at position 1.

[0106] Thermostable α-amylase

[0107] According to the invention, a thermostable α-amylase can be used in combination with a thermostable xylanase in the liquefaction step i), the thermostable xylanase being resistant to inhibition by metal ions therein and preferably having a melting point (DSC) greater than 80°C. The thermostable α-amylase can be added together with an enzyme of optional carbohydrate-producing origin, particularly a thermostable glucosylase and / or optionally pullulanase. Optionally, an endoglucanase having a melting point (DSC) greater than 70°C, such as greater than 75°C, particularly greater than 80°C may be included. The thermostable α-amylase (such as bacterial α-amylase) is preferably derived from *Bacillus stearothermophilus* or *Bacillus* species TS-23. In one embodiment, the α-amylase has a T1 / 2 (min) of at least 10 at pH 4.5, 85°C, and 0.12 mM CaCl2.

[0108] The term "bacterial α-amylase" means any bacterial α-amylase classified under EC 3.2.1.1. The bacterial α-amylase used according to the invention may, for example, be derived from strains of the genus *Bacillus* (sometimes also called *Bacillus geosporus*). In one embodiment, the *Bacillus* α-amylase is derived from strains of *Bacillus amyloliquefaciens*, *Bacillus licheniformis*, *Bacillus thermophilus*, or *Bacillus subtilis*, but may also be derived from other *Bacillus* species.

[0109] Specific examples of bacterial α-amylases include the thermophilic Bacillus stearothermophilus α-amylase of SEQ ID NO:3 in WO 99 / 19467, the amylolytic Bacillus amyloliquefaciens α-amylase of SEQ ID NO:5 in WO 99 / 19467, and the licheniformis α-amylase of SEQ ID NO:4 in WO 99 / 19467 (all sequences are hereby incorporated by reference). In one embodiment, the α-amylase may be an enzyme having at least 60%, for example, at least 70%, at least 80%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99% identity with any sequence shown in SEQ ID NO:3, 4, or 5 in WO 99 / 19467.

[0110] In one embodiment, the α-amylase may be an enzyme having at least 60%, such as at least 70%, at least 80%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99% identity with any sequence shown in SEQ ID NO:3 of WO 99 / 19467 or SEQ ID NO:5 herein.

[0111] In a preferred embodiment, the α-amylase is derived from *Bacillus thermophilus*. This *Bacillus thermophilus* α-amylase can be a mature wild type or a mature variant thereof. The mature *Bacillus thermophilus* α-amylase can be naturally truncated during recombinant production. For example, the *Bacillus thermophilus* α-amylase can be truncated, thus having approximately 491 amino acids (compared to SEQ ID NO:3 in WO 99 / 19467).

[0112] This Bacillus α-amylase can also be a variant and / or a heterozygote. Examples of such variants can be found in any of the following: WO 96 / 23873, WO 96 / 23874, WO 97 / 41213, WO 99 / 19467, WO 00 / 60059, and WO 02 / 10355 (all documents are hereby incorporated by reference). Specific α-amylase variants are disclosed in U.S. Patent Nos. 6,093,562, 6,187,576, 6,297,038, and 7,713,723 (incorporated by reference), including variants of *Bacillus stearothermophilus* α-amylase (often referred to as BSG α-amylase) with deletions of one or two amino acids at positions R179, G180, I181, and / or G182, preferably the double deletion disclosed in WO 96 / 23873 – see, for example, page 20, lines 1–10 (incorporated by reference), preferably corresponding to the deletions at positions I181 and G182 as illustrated in SEQ ID NO:3 disclosed in WO 99 / 19467 or SEQ ID NO:5 herein, or using SEQ ID NO:3 in WO 99 / 19467 (incorporated by reference hereafter). The deletion of amino acids R179 and G180, as numbered in NO:3 or SEQ ID NO:5 herein, is even more preferred. Even more preferred are Bacillus α-amylases, particularly Bacillus stearothermophilus α-amylase, which, compared to the amino acid sequence of the wild-type BSG α-amylase described in SEQ ID NO:3 of WO 99 / 19467 or SEQ ID NO:5 herein, have a double deletion corresponding to positions 181 and 182 and further include an N193F substitution (also represented as I181*+G182*+N193F). Bacterial α-amylases may also have substitutions at positions corresponding to Bacillus licheniformis α-amylase shown in SEQ ID NO:4 of WO 99 / 19467, or the S242 variant of Bacillus stearothermophilus α-amylase of SEQ ID NO:3 of WO 99 / 19467, or S239 of SEQ ID NO:5 herein.

[0113] In one embodiment, the variant is an S242A, E, or Q variant of Bacillus stearothermophilus α-amylase, preferably the S242Q variant (numbered using SEQ ID NO:5 herein).

[0114] In one embodiment, the variant is the E188 variant of Bacillus stearothermophilus α-amylase, preferably the E188P variant (numbered using SEQ ID NO:5 herein).

[0115] In one embodiment, the bacterial α-amylase may be a truncated Bacillus α-amylase. In particular, the truncation is such that the thermophilic Bacillus α-amylase shown in SEQ ID NO:3 of WO 99 / 19467 or SEQ ID NO:5 herein is about 491 amino acids long, such as from 480 to 495 amino acids long.

[0116] Most importantly, the suitable α-amylase for use in liquefaction must have sufficient thermal stability so that any α-amylase can be used at pH 4.5, 85°C, and 0.12 mM CaCl2 with a T1 / 2 (min) of at least 10, such as at least 15, such as at least 20, such as at least 25, such as at least 30, such as at least 40, such as at least 50, such as at least 60, such as between 10 and 70, such as between 15 and 70, such as between 20 and 70, such as between 25 and 70, such as between 30 and 70, such as between 40 and 70, such as between 50 and 70, or such as between 60 and 70.

[0117] According to the present invention, the α-amylase can be a thermostable α-amylase, such as a thermostable bacterial α-amylase, preferably derived from thermophilic Bacillus stearothermophilus. In one embodiment, the α-amylase used according to the present invention has a T1 / 2 (min) of at least 10 at pH 4.5, 85°C, and 0.12 mM CaCl2.

[0118] In one embodiment, the thermostable α-amylase has a T1 / 2 (min) of at least 15 at pH 4.5, 85°C, and 0.12 mM CaCl2.

[0119] In one embodiment, the thermostable α-amylase has a T1 / 2 (min) of at least 20 at pH 4.5, 85°C, and 0.12 mM CaCl2.

[0120] In one embodiment, the thermostable α-amylase has a T1 / 2 (min) of at least 25 at pH 4.5, 85°C, and 0.12 mM CaCl2.

[0121] In one embodiment, the thermostable α-amylase has a T1 / 2 (min) of at least 30 at pH 4.5, 85°C, and 0.12 mM CaCl2.

[0122] In one embodiment, the thermostable α-amylase has a T1 / 2 (min) of at least 40 at pH 4.5, 85°C, and 0.12 mM CaCl2.

[0123] In one embodiment, the thermostable α-amylase has a T1 / 2 (min) of at least 50 at pH 4.5, 85°C, and 0.12 mM CaCl2.

[0124] In one embodiment, the thermostable α-amylase has a T1 / 2 (min) of at least 60 at pH 4.5, 85°C, and 0.12 mM CaCl2.

[0125] In one embodiment, the thermostable α-amylase has a T1 / 2 (min) between 10 and 70 at pH 4.5, 85°C, and 0.12 mM CaCl2.

[0126] In one embodiment, the thermostable α-amylase has a T1 / 2 (min) between 15 and 70 at pH 4.5, 85°C, and 0.12 mM CaCl2.

[0127] In one embodiment, the thermostable α-amylase has a T1 / 2 (min) between 20 and 70 at pH 4.5, 85°C, and 0.12 mM CaCl2.

[0128] In one embodiment, the thermostable α-amylase has a T1 / 2 (min) between 25 and 70 at pH 4.5, 85°C, and 0.12 mM CaCl2.

[0129] In one embodiment, the thermostable α-amylase has a T1 / 2 (min) between 30 and 70 at pH 4.5, 85°C, and 0.12 mM CaCl2.

[0130] In one embodiment, the thermostable α-amylase has a T1 / 2 (min) between 40 and 70 at pH 4.5, 85°C, and 0.12 mM CaCl2.

[0131] In one embodiment, the thermostable α-amylase has a T1 / 2 (min) between 50 and 70 at pH 4.5, 85°C, and 0.12 mM CaCl2.

[0132] In one embodiment, the thermostable α-amylase has a T1 / 2 (min) between 60 and 70 at pH 4.5, 85°C, and 0.12 mM CaCl2.

[0133] In one embodiment of the invention, the α-amylase is a bacterial α-amylase, preferably derived from the genus Bacillus, especially strains of Bacillus thermophilus, particularly Bacillus thermophilus disclosed as SEQ ID NO:3 (SEQ ID NO:5 herein) in WO99 / 019467, which has one or two amino acid deletions at positions R179, G180, I181 and / or G182, particularly deletions of R179 and G180, or deletions of I181 and G182, and has mutations from the following mutation list.

[0134] In a preferred embodiment, the thermophilic Bacillus stearothermophilus α-amylase has a double deletion I181+G182 and an optional substitution N193F, further including mutations selected from the following list.

[0135] In a preferred embodiment, the α-amylase is selected from the group consisting of the following thermophilic Bacillus α-amylase variants (numbered using SEQ ID NO:5):

[0136] -I181*+G182*+N193F+E129V+K177L+R179E;

[0137] -I181*+G182*+N193F+V59A+Q89R+E129V+K177L+R179E+H208Y+K220P+N224L+Q254S

[0138] -I181*+G182*+N193F+V59A+Q89R+E129V+K177L+R179E+Q254S+M284V;

[0139] -I181*+G182*+N193F+V59A+E129V+K177L+R179E+Q254S+M284V;

[0140] -I181*+G182*+N193F+E129V+K177L+R179E+K220P+N224L+S242Q+Q254S;

[0141] -I181*+G182*+V59A+E129V+K177L+R179E+Q254S+M284V+V212T+Y268G+N293Y+T297N;

[0142] -I181*+G182*+V59A+E129V+K177L+R179E+Q254S+M284V+V212T+Y268G+N293Y+T297N+S173N+E188P+H208Y+S242Y+K279I;

[0143] -I181*+G182*+V59A+E129V+K177L+R179S+Q254S+M284V+V212T+Y268G+N293Y+T297N+A184Q+E188P+T191N;

[0144] -I181*+G182*+V59A+E129V+K177L+R179S+Q254S+M284V+V212T+Y268G+N293Y+T297N+A184Q+E188P+T191N+S242Y+K279I;

[0145] -I181*+G182*+V59A+E129V+K177L+R179S+Q254S+M284V+V212T+Y268G+N293Y+T297N+A184Q+E188P+T191N+N193F+S242Y+K279I;

[0146] -I181*+G182*+V59A+E129V+K177L+R179E+Q254S+M284V+V212T+Y268G+N293Y+T297N+E188P+K279W;

[0147] -I181*+G182*+V59A+E129V+K177L+R179E+Q254S+M284V+V212T+Y268G+N293Y+T297N+W115D+D117Q+T133P; and

[0148] The variant has at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99% sequence identity with SEQ ID NO:5.

[0149] It should be understood that when referring to Bacillus stearothermophilus α-amylase and its variants, they are typically referred to in truncated form. In particular, truncation can be such that the Bacillus stearothermophilus α-amylase or its variants shown in SEQ ID NO:3 of WO99 / 19467 or SEQ ID NO:5 herein are truncated at the C-terminus and are typically about 491 amino acids long, such as from 480 to 495 amino acids.

[0150] In a preferred embodiment, the α-amylase variant may be an enzyme having at least 60%, for example, at least 70%, at least 80%, at least 85%, at least 90%, at least 95%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99%, but less than 100%, of the sequence shown in SEQ ID NO:3 in WO 99 / 19467 or SEQ ID NO:5 herein.

[0151] Thermostable anti-metal ion xylanase present and / or added during liquefaction

[0152] According to the present invention, a metal ion-resistant xylanase having a melting point (DSC) greater than 80°C is preferably present in combination with, for example, an α-amylase (such as bacterial α-amylase (described above)) and / or added to the liquefaction step i). The phrases "metal ion-resistant xylanase" and "xylanase resistant to metal ion inhibition" are used interchangeably herein and refer to a xylanase that retains a significant amount of relative activity in the presence of metal ions compared to a xylanase that loses a significant amount of activity in the presence of metal ions. For example, compared to non-metal-ion-resistant xylanase activity in the absence of metal ions, non-metal-ion-resistant xylanase activity in the presence of metal ions will result in a loss of at least 40%, at least 50%, at least 55%, at least 60%, at least 65%, at least 70%, at least 71%, at least 72%, at least 73%, at least 74%, at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, or at least 80% of the relative activity of xylanase in the presence of metal ions. Conversely, compared to metal-ion-resistant xylanase activity in the absence of metal ions, metal-ion-resistant xylanase activity in the presence of metal ions will result in a loss of at least 40%, at least 50%, at least 55%, at least 60%, at least 65%, at least 70%, at least 71%, at least 72%, at least 73%, at least 74%, at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, or at least 80% of the relative activity of xylanase in the presence of metal ions. Metal ion inhibition of xylanase will preserve at least 60%, at least 65%, at least 70%, at least 71%, at least 72%, at least 73%, at least 74%, at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99% of its relative activity. To determine whether xylanase is resistant to metal ion inhibition, the relative activity of xylanase in the presence of one or more metal ions can be measured compared to the relative activity of xylanase in the absence of those metal ions.

[0153] The metal ion-resistant xylanase not only retains 100% of its relative activity in the presence of metal ions, but also exhibits increased relative activity in the presence of metal ions. For example, compared with the relative activity of xylanase in the absence of metal ions, the metal ion-resistant xylanase of the present invention can exhibit an increase in relative activity of at least 1%, at least 2%, at least 3%, at least 4%, at least 5%, at least 6%, at least 7%, at least 8%, at least 9%, at least 10%, at least 11%, at least 12%, at least 13%, at least 14%, at least 15%, at least 16%, at least 17%, at least 18%, at least 19%, or at least 20%.

[0154] The thermal stability of xylanase can be determined by differential scanning calorimetry, as described in the "Materials and Methods" section. d As described in the document, this is used to determine the nature of the problem.

[0155] In one embodiment, the metal ion-resistant xylanase, particularly xylanase from the genus Thermophyton, has a melting point (DSC) greater than 82°C, such as greater than 84°C, such as greater than 86°C, such as greater than 88°C, such as greater than 88°C, such as greater than 90°C, such as greater than 92°C, such as greater than 94°C, such as greater than 96°C, such as greater than 98°C, such as greater than 100°C, such as between 80°C and 110°C, such as between 82°C and 110°C, such as between 84°C and 110°C.

[0156] In one embodiment, the metal ion-resistant xylanase, particularly the GH10 family xylanase from Thermomyces genus, contains the motif YITEMD (SEQ ID NO:30).

[0157] In one embodiment of the first, second, and third aspects, the use of a thermostable xylanase from *Thermophyton* species in step i) to liquefy starch-containing materials increases the amount of short-chain oligosaccharides (e.g., the amount of short-chain oligosaccharides in the liquefaction product) at the end of liquefaction step i) compared to the amount of short-chain oligosaccharides at the end of liquefaction step i) when using a thermostable xylanase from *Thermophyton* species containing the motif YITEMD (SEQ ID NO: 30). In one embodiment, a thermostable xylanase from *Thermophyton* species containing the motif YITEMD (SEQ ID NO: 30) is used in liquefaction to increase the amount of short-chain oligosaccharides in the liquefaction product.

[0158] In one embodiment of the first, second, and third aspects, the use of a thermostable xylanase from *Thermophyton* in step i) to liquefy starch-containing materials reduces the amount of residual starch present at the end of liquefaction step i) compared to the amount of residual starch present at the end of liquefaction step i) when using a thermostable xylanase from *Thermophyton* (such as, for example, Dt xylanase of SEQ ID NO: 1) in liquefaction step i). In one embodiment, a thermostable xylanase from *Thermophyton* containing the motif YITEMD (SEQ ID NO: 30) is used in liquefaction to reduce the amount of residual starch present at the end of liquefaction step i).

[0159] In a preferred embodiment, the anti-metal ion xylanase has at least 60%, such as at least 70%, such as at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, preferably at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, more preferably at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, more preferably at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, or at least 95%, such as at least 96%, at least 97%, at least 98%, at least 99%, or 100% identity with the mature portion of the polypeptide of SEQ ID NO:2 herein, preferably derived from a strain of the genus Thermophyton, such as a strain of Thermophyton floccosum.

[0160] In one embodiment of the first, second, and third aspects, the amount of short-chain oligosaccharides used in step i) at the end of liquefaction step i) is compared to the amount of short-chain oligosaccharides used in step i) when a non-metal ion-resistant thermostable xylanase (such as, for example, Dt xylanase of SEQ ID NO: 1) is used. The mature portion of the polypeptide of NO:2 has at least 60%, such as at least 70%, such as at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, preferably at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, more preferably at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, more preferably at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, or at least 95%, such as at least 96%, at least 97%, at least 98%, at least 99%, such as 100% identical thermostable xylanase (preferably derived from strains of the genus Thermophyton, such as strains of Thermophyton spp.) liquefying starch-containing material to increase the amount of short-chain oligosaccharides (e.g., the amount of short-chain oligosaccharides in the liquefaction) at the end of liquefaction step i).

[0161] In one embodiment of the first, second, and third aspects, the amount of residual starch present at the end of liquefaction step i) is compared to the amount of residual starch present when a non-metal ion-resistant thermostable xylanase (such as, for example, Dt xylanase of SEQ ID NO: 1) is used in step i). The mature portion of the polypeptide of NO:2 has at least 60%, such as at least 70%, such as at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, preferably at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, more preferably at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, more preferably at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, or at least 95%, such as at least 96%, at least 97%, at least 98%, at least 99%, such as 100% identical thermostable xylanase (preferably derived from strains of the genus Thermophyton, such as strains of Thermophyton spp.) to liquefy starch-containing material and reduce the amount of residual starch present at the end of liquefaction step i) (e.g., the amount of short-chain oligosaccharides in the liquefaction).

[0162] In one embodiment, the anti-metal ion xylanase has at least 60%, such as at least 70%, such as at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, preferably at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, more preferably at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, more preferably at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, or at least 95%, such as at least 96%, at least 97%, at least 98%, or at least 99%, identity with the amino acid sequence of SEQ ID NO:2, and in the presence of an average The metal ions retain at least 60%, at least 65%, at least 70%, at least 71%, at least 72%, at least 73%, at least 74%, at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, or at least 98% of their relative activity at certain concentrations.

[0163] In one embodiment, the amino acid sequence of the anti-metal ion xylanase has at least 60%, such as at least 70%, such as at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, preferably at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, more preferably at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, more preferably at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, or at least 95%, such as at least 96%. It possesses at least 97%, at least 98%, or at least 99% identity, and retains at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, or at least 98% of its relative activity in the presence of copper ions when liquefying starch-containing materials.

[0164] In one embodiment, the anti-metal ion xylanase has at least 60%, such as at least 70%, such as at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, preferably at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, more preferably at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, more preferably at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, or at least 95%, such as at least 96%, at least 97%, at least 98%, or at least 99%, identity with the liquefied starch-containing... The powdered material retains at least 70%, at least 71%, at least 72%, at least 73%, at least 74%, at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, or at least 98% of its relative activity in the presence of iron ions.

[0165] In one embodiment, the anti-metal ion xylanase has at least 60%, such as at least 70%, such as at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, preferably at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, more preferably at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, more preferably at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, or at least 95%, such as at least 96%, at least 97%, at least 98%, or at least 99%, identity with the amino acid sequence of SEQ ID NO:2.

[0166] In one embodiment, the amino acid sequence of the anti-metal ion xylanase and SEQ ID NO:2 has at least 60%, such as at least 70%, such as at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, preferably at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, more preferably at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, more preferably at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, or at least 95%, such as at least 96%, at least 97%, at least 98%, or at least 99% identity, and: (i) retaining at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, or at least 95% of the relative activity of the starch-containing material in the presence of up to 0.25 mM copper ions. (i) at least 96%, at least 97%, or at least 98%; (ii) in the presence of up to 0.125 mM iron ions, retaining at least 70%, at least 71%, at least 72%, at least 73%, at least 74%, at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, at least 85%, at least 86%, or at least 87% of the relative activity of the starch-containing material. (iii) retaining at least 90%, at least 88%, at least 89%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, or at least 98% of the relative activity of starch-containing materials in the presence of up to 0.25 mM of zinc ions.

[0167] In one embodiment, the anti-metal ion xylanase has at least 60%, such as at least 70%, such as at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, preferably at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, more preferably at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, more preferably at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, or at least 95%, such as at least 96%, at least 97%, at least 98%, at least 99%, or 100% identity with the mature portion of the polypeptide of SEQ ID NO:3 herein, preferably derived from a strain of the genus Thermotoga, such as a strain of Thermotoga neopolitana.

[0168] In one embodiment of the first, second, and third aspects, the amount of short-chain oligosaccharides used in step i) at the end of liquefaction step i) is compared to the amount of short-chain oligosaccharides used in step i) when a non-metal ion-resistant thermostable xylanase (such as, for example, Dt xylanase of SEQ ID NO: 1) is used. The mature portion of the polypeptide of NO:3 has at least 60%, such as at least 70%, such as at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, preferably at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, more preferably at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, more preferably at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, or at least 95%, such as at least 96%, at least 97%, at least 98%, at least 99%, such as 100% identical thermostable xylanase (preferably derived from strains of the genus Thermophyton, such as strains of Thermophyton naplesus) liquefies starch-containing material to increase the amount of short-chain oligosaccharides at the end of liquefaction step i) (e.g., the amount of short-chain oligosaccharides in the liquefaction).

[0169] In one embodiment of the first, second, and third aspects, the amount of residual starch present at the end of liquefaction step i) is compared to the amount of residual starch present when a non-metal ion-resistant thermostable xylanase (such as, for example, Dt xylanase of SEQ ID NO: 1) is used in step i). The mature portion of the polypeptide of NO:3 has at least 60%, such as at least 70%, such as at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, preferably at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, more preferably at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, more preferably at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, or at least 95%, such as at least 96%, at least 97%, at least 98%, at least 99%, such as 100% identical thermostable xylanase (preferably derived from strains of Thermophyton, such as strains of Thermophyton naplesus) liquefies starch-containing material to reduce the amount of residual starch present at the end of liquefaction step i) (e.g., the amount of short-chain oligosaccharides in the liquefaction).

[0170] In one embodiment, the anti-metal ion xylanase has at least 60%, such as at least 70%, such as at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, preferably at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, more preferably at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, more preferably at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, or at least 95%, such as at least 96%, at least 97%, at least 98%, or at least 99%, identity with the amino acid sequence of SEQ ID NO:3, and in the presence of average The metal ions retain at least 60%, at least 65%, at least 70%, at least 71%, at least 72%, at least 73%, at least 74%, at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, or at least 98% of their relative activity at certain concentrations.

[0171] In one embodiment, the amino acid sequence of the anti-metal ion xylanase has at least 60%, such as at least 70%, such as at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, preferably at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, more preferably at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, more preferably at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, or at least 95%, such as at least 96%. It possesses at least 97%, at least 98%, or at least 99% identity, and retains at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, or at least 98% of its relative activity in the presence of copper ions when liquefying starch-containing materials.

[0172] In one embodiment, the anti-metal ion xylanase has at least 60%, such as at least 70%, such as at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, preferably at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, more preferably at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, more preferably at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, or at least 95%, such as at least 96%, at least 97%, at least 98%, or at least 99%, identity with the liquefied starch-containing... The powdered material retains at least 70%, at least 71%, at least 72%, at least 73%, at least 74%, at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, or at least 98% of its relative activity in the presence of iron ions.

[0173] In one embodiment, the anti-metal ion xylanase has at least 60%, such as at least 70%, such as at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, preferably at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, more preferably at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, more preferably at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, or at least 95%, such as at least 96%, at least 97%, at least 98%, or at least 99%, identity with the amino acid sequence of SEQ ID NO:3, and retains at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, or at least 98% of its relative activity in the presence of zinc ions when liquefying starch-containing materials.

[0174] In one embodiment, the amino acid sequence of the anti-metal ion xylanase and SEQ ID NO:3 has at least 60%, such as at least 70%, such as at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, preferably at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, more preferably at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, more preferably at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, or at least 95%, such as at least 96%, at least 97%, at least 98%, or at least 99% identity, and: (i) retaining at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, or at least 95% of the relative activity of the starch-containing material in the presence of up to 0.25 mM copper ions. (i) at least 96%, at least 97%, or at least 98%; (ii) in the presence of up to 0.125 mM iron ions, retaining at least 70%, at least 71%, at least 72%, at least 73%, at least 74%, at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, at least 85%, at least 86%, or at least 87% of the relative activity of the starch-containing material. (iii) retaining at least 90%, at least 88%, at least 89%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, or at least 98% of the relative activity of starch-containing materials in the presence of up to 0.25 mM of zinc ions.

[0175] In one embodiment, the anti-metal ion xylanase has at least 60%, such as at least 70%, such as at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, preferably at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, more preferably at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, more preferably at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, or at least 95%, such as at least 96%, at least 97%, at least 98%, at least 99%, or 100% identity with the mature portion of the polypeptide of SEQ ID NO:4 herein, preferably derived from a strain of the genus Thermophyton, such as a strain of Thermophyton naphthaleneophilus.

[0176] In one embodiment of the first, second, and third aspects, the amount of short-chain oligosaccharides used in step i) at the end of liquefaction step i) is compared to the amount of short-chain oligosaccharides at the end of liquefaction step i) when a non-metal ion-resistant thermostable xylanase (such as, for example, Dt xylanase of SEQ ID NO: 1) is used in step i). The mature portion of the polypeptide of NO:4 has at least 60%, such as at least 70%, such as at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, preferably at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, more preferably at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, more preferably at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, or at least 95%, such as at least 96%, at least 97%, at least 98%, at least 99%, such as 100% identical thermostable xylanase (preferably derived from strains of Thermophyton, such as strains of Thermophyton naphthaleneophilus) liquefies starch-containing material to increase the amount of short-chain oligosaccharides at the end of liquefaction step i) (e.g., the amount of short-chain oligosaccharides in the liquefaction).

[0177] In one embodiment of the first, second, and third aspects, the amount of residual starch present at the end of liquefaction step i) is compared to the amount of residual starch present when a non-metal ion-resistant thermostable xylanase (such as, for example, Dt xylanase of SEQ ID NO: 1) is used in step i). The mature portion of the polypeptide of NO:4 has at least 60%, such as at least 70%, such as at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, preferably at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, more preferably at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, more preferably at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, or at least 95%, such as at least 96%, at least 97%, at least 98%, at least 99%, such as 100% identical thermostable xylanase (preferably derived from strains of Thermophyton, such as strains of Thermophyton naphthaleneophilus) liquefies starch-containing material to reduce the amount of residual starch present at the end of liquefaction step i) (e.g., the amount of short-chain oligosaccharides in the liquefaction).

[0178] In one embodiment, the anti-metal ion xylanase has at least 60%, such as at least 70%, such as at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, preferably at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, more preferably at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, more preferably at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, or at least 95%, such as at least 96%, at least 97%, at least 98%, or at least 99%, identity with the amino acid sequence of SEQ ID NO:4, and in the presence of average The metal ions retain at least 60%, at least 65%, at least 70%, at least 71%, at least 72%, at least 73%, at least 74%, at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, or at least 98% of their relative activity at certain concentrations.

[0179] In one embodiment, the amino acid sequence of the anti-metal ion xylanase has at least 60%, such as at least 70%, such as at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, preferably at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, more preferably at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, more preferably at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, or at least 95%, such as at least 96%. It possesses at least 97%, at least 98%, or at least 99% identity, and retains at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, or at least 98% of its relative activity in the presence of copper ions when liquefying starch-containing materials.

[0180] In one embodiment, the anti-metal ion xylanase has at least 60%, such as at least 70%, such as at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, preferably at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, more preferably at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, more preferably at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, or at least 95%, such as at least 96%, at least 97%, at least 98%, or at least 99%, identity with the liquefied starch-containing... The powdered material retains at least 70%, at least 71%, at least 72%, at least 73%, at least 74%, at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, or at least 98% of its relative activity in the presence of iron ions.

[0181] In one embodiment, the anti-metal ion xylanase has at least 60%, such as at least 70%, such as at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, preferably at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, more preferably at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, more preferably at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, or at least 95%, such as at least 96%, at least 97%, at least 98%, or at least 99%, identity with the amino acid sequence of SEQ ID NO:4.

[0182] In one embodiment, the amino acid sequence of the anti-metal ion xylanase has at least 60%, such as at least 70%, such as at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, preferably at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, more preferably at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, more preferably at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, or at least 95%, such as at least 96%, at least 97%, at least 98%, or at least 99% identity, and: (i) retaining at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, or at least 95% of the relative activity of the starch-containing material in the presence of up to 0.25 mM copper ions. (i) at least 96%, at least 97%, or at least 98%; (ii) in the presence of up to 0.125 mM iron ions, retaining at least 70%, at least 71%, at least 72%, at least 73%, at least 74%, at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, at least 85%, at least 86%, or at least 87% of the relative activity of the starch-containing material. (iii) retaining at least 90%, at least 88%, at least 89%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, or at least 98% of the relative activity of starch-containing materials in the presence of up to 0.25 mM of zinc ions.

[0183] Thermostable endoglucanase present and / or added during liquefaction

[0184] According to the invention, in the liquefaction step i), an optional endoglucanase (“EG”) with a melting point (DSC) greater than 80°C (e.g., between 70°C and 95°C) may be present in combination with and / or added with an anti-metal ion xylanase (preferably having a melting point (DSC) greater than 70°C), and optionally with a thermally stable α-amylase, an endoglucanase, a carbohydrate-producing enzyme, particularly glucosylamylase, optionally pullulanase and / or optionally phytase.

[0185] The thermal stability of endoglucanase can be determined as described in the "Materials and Methods" section.

[0186] In one embodiment, the endoglucanase has a melting point (DSC) greater than 72°C, such as greater than 74°C, such as greater than 76°C, such as greater than 78°C, such as greater than 80°C, such as greater than 82°C, such as greater than 84°C, such as greater than 86°C, such as greater than 88°C, such as between 70°C and 95°C, such as between 76°C and 94°C, such as between 78°C and 93°C, such as between 80°C and 92°C, such as between 82°C and 91°C, such as between 84°C and 90°C.

[0187] In a preferred embodiment, the endoglucanase used in the method of the invention or included in the composition of the invention is a glycoside hydrolase family 5 endoglucanase or a GH5 endoglucanase (see the CAZy database on the World Wide Web). In one embodiment, the GH5 endoglucanase is derived from family EG II, such as the *Basilella repens* endoglucanase shown in SEQ ID NO:7 herein; the *Penicillium capsulatum* endoglucanase shown in SEQ ID NO:22 herein; and the *Trichophaea saccata* endoglucanase shown in SEQ ID NO:23 herein. In one embodiment, the endoglucanase is a family GH45 endoglucanase. In one embodiment, the GH45 endoglucanase is derived from the EG V family, such as *Ordaria fimicola* as shown in SEQ ID NO:25 herein, or *Thielavia terrestris* as shown in SEQ ID NO:24 herein.

[0188] In one embodiment, the endoglucanase has at least 60%, such as at least 70%, such as at least 75%, preferably at least 80%, more preferably at least 85%, more preferably at least 90%, more preferably at least 91%, more preferably at least 92%, even more preferably at least 93%, most preferably at least 94%, and even most preferably at least 95%, such as even at least 96%, at least 97%, at least 98%, at least 99%, such as 100%, identity with the mature portion of the polypeptide of SEQ ID NO:7 herein. In one embodiment, the endoglucanase is derived from a strain of the genus *Basilella*, such as *Basilella repens*.

[0189] In one embodiment, the endoglucanase has at least 60%, such as at least 70%, such as at least 75%, preferably at least 80%, more preferably at least 85%, more preferably at least 90%, more preferably at least 91%, more preferably at least 92%, even more preferably at least 93%, most preferably at least 94%, and even most preferably at least 95%, such as even at least 96%, at least 97%, at least 98%, at least 99%, such as 100%, identity with the mature portion of the polypeptide of SEQ ID NO:22 herein, preferably derived from a strain of Penicillium, such as a strain of Penicillium capsuleum.

[0190] In one embodiment, the endoglucanase has at least 60%, such as at least 70%, such as at least 75%, preferably at least 80%, more preferably at least 85%, more preferably at least 90%, more preferably at least 91%, more preferably at least 92%, even more preferably at least 93%, most preferably at least 94%, and even most preferably at least 95%, such as even at least 96%, at least 97%, at least 98%, at least 99%, such as 100%, identity with the mature portion of the polypeptide of SEQ ID NO:23 herein, preferably derived from a strain of the genus Trichophaea, such as a strain of Trichophaea brownis.

[0191] In one embodiment, the endoglucanase has at least 60%, such as at least 70%, such as at least 75%, preferably at least 80%, more preferably at least 85%, more preferably at least 90%, more preferably at least 91%, more preferably at least 92%, even more preferably at least 93%, most preferably at least 94%, and even most preferably at least 95%, such as even at least 96%, at least 97%, at least 98%, at least 99%, such as 100%, identity with the mature portion of the polypeptide of SEQ ID NO:24 herein, preferably derived from a strain of the genus *Clostridium*, such as a strain of *Clostridium terreum*.

[0192] In one embodiment, the endoglucanase has at least 60%, such as at least 70%, such as at least 75%, preferably at least 80%, more preferably at least 85%, more preferably at least 90%, more preferably at least 91%, more preferably at least 92%, even more preferably at least 93%, most preferably at least 94%, and even most preferably at least 95%, such as even at least 96%, at least 97%, at least 98%, at least 99%, such as 100%, identity with the mature portion of the polypeptide of SEQ ID NO:25 herein, preferably derived from a strain of the genus *Ceratophyllum*, such as a strain of *Ceratophyllum commune*.

[0193] In one embodiment, endoglucanase is added in liquefaction step i) at a dose of 1-10,000 μg EP (enzyme protein) / g DS, such as 10-1,000 μg EP / g DS.

[0194] Proteases present and / or added during liquefaction

[0195] In one embodiment of the invention, during liquefaction, optional proteases (such as thermostable proteases) may be present and / or added together with thermostable metal ion-inhibited resistant xylanases (preferably having a melting point (DSC) greater than 80°C), and optionally thermostable α-amylases, endoglucanases, carbohydrate-producing enzymes, particularly glucosylamylases, optionally pullulanases, and / or optionally phytases.

[0196] Based on their catalytic mechanisms, proteases are classified into the following groups: serine proteases (S), cysteine ​​proteases (C), aspartic proteases (A), metalloproteinases (M), and unknown or unclassified proteases (U). See Handbook of Proteolytic Enzymes, A.J. Barrett, N.D. Wawlings, J.F. Woessner (eds.), Academic Press (1998), especially the overview section.

[0197] In a preferred embodiment, the thermostable protease used according to the invention is a "metalloproteinase", which is defined as a protease belonging to EC 3.4.24 (metalloendopeptidase), preferably EC 3.4.24.39 (acidic metalloproteinase).

[0198] To determine whether a given protease is a metalloproteinase, refer to the aforementioned "Handbook of Proteolytic Enzymes" and the principles indicated therein. This determination can be made for all types of proteases, regardless of whether they are naturally occurring or wild-type, or genetically engineered or synthetic.

[0199] Protease activity can be measured using any suitable assay employing a substrate comprising peptide bonds specific to the protease in question. Assays of pH and temperature are equally applicable to the protease in question. Examples of pH measurements are pH 6, 7, 8, 9, 10, or 11. Examples of temperatures are 30°C, 35°C, 37°C, 40°C, 45°C, 50°C, 55°C, 60°C, 65°C, 70°C, or 80°C.

[0200] Examples of protease substrates are casein, such as Azurine-Crosslinked Casein (AZCL-casein). Two protease assays are described in the “Materials and Methods” section below, of which the so-called “AZCL-casein assay” is the preferred assay.

[0201] In one embodiment, the thermostable protease, as determined by the AZCL-casein assay described in the “Materials and Methods” section, has at least 20%, such as at least 30%, such as at least 40%, such as at least 50%, such as at least 60%, such as at least 70%, such as at least 80%, such as at least 90%, such as at least 95%, such as at least 100% protease activity of the JTP196 variant or protease Pfu (SEQ ID NO: 11 herein).

[0202] There are no restrictions on the source of the thermostable protease used in the methods or compositions of the present invention, as long as it meets the thermostable properties defined below.

[0203] In one embodiment, the protease is of fungal origin.

[0204] In a preferred embodiment, the thermostable protease is a variant of the metalloproteinase as defined above. In one embodiment, the thermostable protease used in the method or composition of the present invention is fungal-derived, such as a fungal metalloproteinase, such as a strain derived from the genus *Thermophila*, preferably a strain of *Thermophila orangeensis*, especially a fungal metalloproteinase of *Thermophila orangeensis* CGMCC No. 0670 (classified as EC 3.4.24.39).

[0205] In one embodiment, the thermostable protease is a variant disclosed in: the mature portion of the metalloproteinase shown in SEQ ID NO:2 disclosed in WO2003 / 048353 or the mature portion of SEQ ID NO:1 in WO 2010 / 008841, and the variant shown herein as SEQ ID NO:6, which further has mutations selected from the following list:

[0206] -S5*+D79L+S87P+A112P+D142L;

[0207] -D79L+S87P+A112P+T124V+D142L;

[0208] -S5*+N26R+D79L+S87P+A112P+D142L;

[0209] -N26R+T46R+D79L+S87P+A112P+D142L;

[0210] -T46R+D79L+S87P+T116V+D142L;

[0211] -D79L+P81R+S87P+A112P+D142L;

[0212] -A27K+D79L+S87P+A112P+T124V+D142L;

[0213] -D79L+Y82F+S87P+A112P+T124V+D142L;

[0214] -D79L+Y82F+S87P+A112P+T124V+D142L;

[0215] -D79L+S87P+A112P+T124V+A126V+D142L;

[0216] -D79L+S87P+A112P+D142L;

[0217] -D79L+Y82F+S87P+A112P+D142L;

[0218] -S38T+D79L+S87P+A112P+A126V+D142L;

[0219] -D79L+Y82F+S87P+A112P+A126V+D142L;

[0220] -A27K+D79L+S87P+A112P+A126V+D142L;

[0221] -D79L+S87P+N98C+A112P+G135C+D142L;

[0222] -D79L+S87P+A112P+D142L+T141C+M161C;

[0223] -S36P+D79L+S87P+A112P+D142L;

[0224] -A37P+D79L+S87P+A112P+D142L;

[0225] -S49P+D79L+S87P+A112P+D142L;

[0226] -S50P+D79L+S87P+A112P+D142L;

[0227] -D79L+S87P+D104P+A112P+D142L;

[0228] -D79L+Y82F+S87G+A112P+D142L;

[0229] -S70V+D79L+Y82F+S87G+Y97W+A112P+D142L;

[0230] -D79L+Y82F+S87G+Y97W+D104P+A112P+D142L;

[0231] -S70V+D79L+Y82F+S87G+A112P+D142L;

[0232] -D79L+Y82F+S87G+D104P+A112P+D142L;

[0233] -D79L+Y82F+S87G+A112P+A126V+D142L;

[0234] -Y82F+S87G+S70V+D79L+D104P+A112P+D142L;

[0235] -Y82F+S87G+D79L+D104P+A112P+A126V+D142L;

[0236] -A27K+D79L+Y82F+S87G+D104P+A112P+A126V+D142L;

[0237] -A27K+Y82F+S87G+D104P+A112P+A126V+D142L;

[0238] -A27K+D79L+Y82F+D104P+A112P+A126V+D142L;

[0239] -A27K+Y82F+D104P+A112P+A126V+D142L;

[0240] -A27K+D79L+S87P+A112P+D142L;

[0241] -D79L+S87P+D142L.

[0242] In a preferred embodiment, the thermostable protease is a variant of a mature metalloproteinase disclosed as follows: the mature portion of SEQ ID NO:2 disclosed in WO 2003 / 048353 or the mature portion of SEQ ID NO:1 disclosed in WO 2010 / 008841 or SEQ ID NO:6 herein, the variant having the following mutation: D79L+S87P+A112P+D142L;

[0243] D79L+S87P+D142L; or

[0244] A27K+D79L+Y82F+S87G+D104P+A112P+A126V+D142L.

[0245] In one embodiment, the protease variant has at least 75% identity with the mature portion of the polypeptide of SEQ ID NO:2 disclosed in WO 2003 / 048353 or the mature portion of SEQ ID NO:1 disclosed in WO 2010 / 008841 or SEQ ID NO:6 herein, preferably at least 80%, more preferably at least 85%, more preferably at least 90%, more preferably at least 91%, more preferably at least 92%, even more preferably at least 93%, most preferably at least 94%, and even most preferably at least 95%, for example even at least 96%, at least 97%, at least 98%, at least 99% but less than 100% identity.

[0246] Thermostable proteases can also be derived from any bacteria, as long as the protease has the thermostable properties defined according to the present invention.

[0247] In one embodiment, the thermostable protease is derived from a strain of the genus *Pyrococcus*, such as a strain of *Pyrococcus furiosus* (pfu protease).

[0248] In one embodiment, the protease is a protease as shown in SEQ ID NO:1 of U.S. Patent No. 6,358,726-B1 (Takara Shuzo Company) and SEQ ID NO:11 herein.

[0249] In one embodiment, the thermostable protease is one disclosed in SEQ ID NO:11 herein or a protease having at least 80% identity, such as at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99% identity with SEQ ID NO:1 in U.S. Patent No. 6,358,726-B1 or SEQ ID NO:11 herein. The *Porcine virosa* protease can be purchased from Takara Bio, Japan.

[0250] Pf. fusiformis protease is a thermostable protease according to the present invention. As determined in Example 5 of US-2018-0371505 (which describes the determination of thermostable properties, particularly as described in Example 5, and is hereby incorporated by reference), the commercial product Pf. fusiformis protease (Pfu S) was found to have thermostable properties of 110% (80°C / 70°C) and 103% (90°C / 70°C) at pH 4.5 (see Example 5).

[0251] In one embodiment, as determined in Example 2 of US-2018-0371505 (which describes the determination of the determination of thermal stability, particularly as described in Example 2, is hereby incorporated by reference), the thermally stable protease has a thermal stability value of more than 20% of the relative activity at 80°C / 70°C.

[0252] In one embodiment, the protease has thermal stability defined as having a relative activity at 80°C / 70°C of more than 30%, more than 40%, more than 50%, more than 60%, more than 70%, more than 80%, more than 90%, more than 100%, more than 105%, more than 110%, more than 115%, or more than 120%.

[0253] In one embodiment, the protease has thermal stability defined as relative activity at 80°C / 70°C, between 20% and 50%, such as between 20% and 40%, such as between 20% and 30%.

[0254] In one embodiment, the protease has thermal stability defined as having relative activity at 80°C / 70°C, between 50% and 115%, such as between 50% and 70%, such as between 50% and 60%, such as between 100% and 120%, such as between 105% and 115%.

[0255] In one embodiment, as determined in Example 2 of US-2018-0371505 (which describes the determination of the determination of thermal stability, particularly as described in Example 2, is hereby incorporated by reference), the protease has a thermal stability value of more than 10% of the relative activity at 85°C / 70°C.

[0256] In one embodiment, the protease has thermal stability of more than 10%, such as more than 12%, more than 14%, more than 16%, more than 18%, more than 20%, more than 30%, more than 40%, more than 50%, more than 60%, more than 70%, more than 80%, more than 90%, more than 100%, or more than 110%, with relative activity at 85°C / 70°C.

[0257] In one embodiment, the protease has thermal stability defined as relative activity at 85°C / 70°C, between 10% and 50%, between 10% and 30%, or between 10% and 25%.

[0258] In one embodiment, the protease is defined as having more than 20%, more than 30%, more than 40%, more than 50%, more than 60%, more than 70%, more than 80%, or more than 90% residual activity at 80°C; and / or

[0259] In one embodiment, the protease is determined to have more than 20%, more than 30%, more than 40%, more than 50%, more than 60%, more than 70%, more than 80%, or more than 90% residual activity at 84°C.

[0260] The determination of “relative activity” and “residual activity” was performed as described in Example 2 of US-2018-0371505 (this document describes the determination of thermal stability, especially as described in Example 2, which is hereby incorporated by reference).

[0261] In one embodiment, the protease is derived from a strain of the genus *Thermobifida*, such as the cellulolytic thermophilic protease shown in SEQ ID NO:26 herein, or is derived from a strain of *Thermobifida cellulosytica*. The amino acid sequence of NO:26 has at least 60%, such as at least 70%, such as at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, preferably at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, more preferably at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, more preferably at least 90%, more preferably at least 91%, more preferably at least 92%, at least 93%, at least 94%, or at least 95%, such as at least 96%, at least 97%, at least 98%, at least 99%, as a protease.

[0262] In one embodiment, the protease is derived from a strain of the genus *Thermobifida*, such as the *Thermobifida fusca* protease shown in SEQ ID NO:27 herein (referred to as SEQ ID NO:8 in WO 2018 / 118815A1, the entire contents of which are incorporated herein by reference) or related to SEQ ID NO:27. The amino acid sequence of NO:27 has at least 60%, such as at least 70%, such as at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, preferably at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, more preferably at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, more preferably at least 90%, more preferably at least 91%, more preferably at least 92%, at least 93%, at least 94%, or at least 95%, such as at least 96%, at least 97%, at least 98%, at least 99%, as a protease.

[0263] In one embodiment, the protease is derived from a strain of the genus *Thermobifida*, such as the halophilic thermophilic protease *Thermobifida halotolerans* shown in SEQ ID NO:28 herein (referred to as SEQ ID NO:10 in WO 2018 / 118815 A1, the entire contents of which are incorporated herein by reference) or related to SEQ ID NO:28. The amino acid sequence of NO:28 has at least 60%, such as at least 70%, such as at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, preferably at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, more preferably at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, more preferably at least 90%, more preferably at least 91%, more preferably at least 92%, at least 93%, at least 94%, or at least 95%, such as at least 96%, at least 97%, at least 98%, at least 99%, as a protease.

[0264] In one embodiment, the protease is derived from a strain of the genus *Thermococcus*, such as the *Thermococcus nautili* protease shown in SEQ ID NO:29 herein (referred to as SEQ ID NO:3 in WO 2018 / 169780A1, the entire contents of which are incorporated herein by reference) or related to SEQ ID NO:29. The amino acid sequence of NO:29 has at least 60%, such as at least 70%, such as at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, preferably at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, more preferably at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, more preferably at least 90%, more preferably at least 91%, more preferably at least 92%, at least 93%, at least 94%, or at least 95%, such as at least 96%, at least 97%, at least 98%, at least 99%, as a protease.

[0265] In one embodiment, the protease may have thermal stability at 85°C greater than 90°C, such as greater than 100°C, as determined using the Zein-BCA assay disclosed in the Materials and Methods section below.

[0266] In one embodiment, the protease has a thermal stability of greater than 60%, such as greater than 90%, such as greater than 100%, such as greater than 110%, at 85°C, as determined by a Zein-BCA assay.

[0267] In one embodiment, the protease has thermal stability at 85°C between 60% and 120%, such as between 70% and 120%, between 80% and 120%, between 90% and 120%, between 100% and 120%, or between 110% and 120%, as determined by a Zein-BCA assay.

[0268] In one embodiment, the thermostable protease, as determined by the AZCL-casein assay described in the “Materials and Methods” section, has at least 20%, such as at least 30%, such as at least 40%, such as at least 50%, such as at least 60%, such as at least 70%, such as at least 80%, such as at least 90%, such as at least 95%, such as at least 100% protease activity of the JTP196 protease variant or protease Pfu.

[0269] Carbohydrate-producing enzymes present and / or added during liquefaction

[0270] According to the invention, during liquefaction, an optional carbohydrate-producing enzyme, particularly glucosylamylase, preferably a thermostable glucosylamylase, may be present and / or added together with a thermostable metal-ion-resistant xylanase (preferably having a melting point (DSC) greater than 80°C) and optionally an α-amylase, an endoglucanase having a melting point (DSC) greater than 70°C, a thermostable protease, and optionally pullulanase and / or optional phytase.

[0271] The term "carbohydrate-producing enzyme" includes any enzyme that produces fermentable sugars. Carbohydrate-producing enzymes are capable of producing carbohydrates that can be used as an energy source by one or more fermenting organisms discussed, for example, when used in the methods of the present invention for producing fermentation products such as ethanol. The produced carbohydrates can be directly or indirectly converted into the desired fermentation product, preferably ethanol. According to the present invention, mixtures of carbohydrate-producing enzymes can be used. Specific examples include glucosylamylase (for glucose production), β-amylase, and maltose-producing amylase (for maltose production).

[0272] In a preferred embodiment, the carbohydrate-producing enzyme is thermostable. The carbohydrate-producing enzyme, particularly a thermostable glucosylamylase, may be added together with or separately from α-amylase and a thermostable protease. In one embodiment, as determined by Example 4 (Thermal Stability) of US-2018-0371505 (which describes the determination of thermostableness, particularly as described in Example 4, is hereby incorporated by reference), the carbohydrate-producing enzyme, preferably a thermostable glucosylamylase, has a relative activity thermostableness of at least 20%, at least 30%, preferably at least 35% at 85°C.

[0273] In one embodiment, the carbohydrate-producing enzyme is glucosylamylase, which has a relative activity of at least 90%, preferably at least 95%, preferably at least 97%, for example 100%, at a pH optimum of pH 5.0, as determined as described in Example 4 (pH Optimum).

[0274] In one embodiment, the carbohydrate-producing enzyme is a glucosylamylase that has a pH stability of at least 80%, at least 85%, or at least 90% at pH 5.0, as determined in Example 4 (pH Stability).

[0275] In a specific and preferred embodiment, the carbohydrate-producing enzyme is a thermostable glucosylamylase, preferably of fungal origin, preferably of filamentous fungi, such as strains from the genus Penicillium, especially strains of Penicillium oxalate, particularly the Penicillium oxalate glucosylase disclosed in WO 2011 / 127802 (which is hereby incorporated by reference) as SEQ ID NO:2 and SEQ ID NO:12 herein.

[0276] In one embodiment, the thermostable glucosylamylase has at least 80%, more preferably at least 85%, more preferably at least 90%, more preferably at least 91%, more preferably at least 92%, even more preferably at least 93%, most preferably at least 94%, and even most preferably at least 95%, such as even at least 96%, at least 97%, at least 98%, at least 99%, or 100% identity with the mature polypeptide shown in SEQ ID NO:2 of WO 2011 / 127802 or SEQ ID NO:14 herein.

[0277] In one embodiment, the carbohydrate-producing enzyme, particularly the thermostable glucosylamylase, is the penicillium oxalate glucosylamylase shown in SEQ ID NO:12 herein.

[0278] In a preferred embodiment, the carbohydrate-producing enzyme is a variant of Penicillium oxalate glucosyl amylase disclosed in WO2011 / 127802 as SEQ ID NO:2 and shown herein as SEQ ID NO:14, having a K79V substitution (referred to as “PE001”) (numbered using the mature sequence shown in SEQ ID NO:12). As disclosed in WO2013 / 036526 (which is hereby incorporated by reference), this K79V glucosyl amylase variant exhibits reduced sensitivity to protease degradation relative to its parent.

[0279] The Penicillium oxalate glucoamylase variants covered are disclosed in WO 2013 / 053801 (which is hereby incorporated by reference).

[0280] In one embodiment, these variants exhibit reduced sensitivity to protease degradation.

[0281] In one embodiment, these variants exhibit improved thermal stability compared to the parent.

[0282] More specifically, in one embodiment, the glucosylamylase has a K79V substitution corresponding to the PE001 variant (numbered using SEQ ID NO:12 herein), and further comprises at least one of the following substitutions or combinations thereof:

[0283] T65A;Q327F;E501V;Y504T;Y504*;T65A+Q327F;T65A+E501V;T65A+Y504T;T65A+Y504*;Q327F+E501V;Q327F+Y504T;Q327F+Y504*;E501V+Y504T;E501V+Y504*;T65A+Q327F+E501V;T65A+Q327F+Y504T;T65A+E501V+Y504T;Q327F+E501V+Y504T;T65A+Q327F+Y504*;T65A+E501V+Y504*;Q327F+E501V+Y504*;T65A+Q327F+E501V+Y504T;T65A+Q327F+E501V+Y504*;E501V+Y504T;T65A+K161S;T65A+Q405T;T65A+Q327W;T65A+Q327F;T65A+Q327Y;P11F+T65A+Q327F;

[0284] R1K+D3W+K5Q+G7V+N8S+T10K+P11S+T65A+Q327F;P2N+P4S+P11F+T65A+Q327F;P11F+D26C+K33C+T65A+Q327F;P2N+P4S+P11F+T65A+Q327W+E501V+Y504T;R1E+D3N+P4G+G6R+G7A+N8A+T10D+P11D+T65A+Q327F;P11F+T65A+Q327W;P2N+P4S+P11F+T65A+Q327F+E501V+Y504T;P11F+T65A+Q327W+E501V+Y504T;T65A+Q327F+E501V+Y504T;T65A+S105P+Q327W;T65A+S105P+Q327F;T65A+Q327W+S364P;T65A+Q327F+S364P;T65A+S103N+Q327F;P2N+P4S+P11F+K34Y+T65A+Q327F;P2N+P4S+P11F+T65A+Q327F+D445N+V447S;P2N+P4S+P11F+T65A+I172V+Q327F;P2N+P4S+P11F+T65A+Q327F+N502*;P2N+P4S+P11F+T65A+Q327F+N502T+P563S+K571E;P2N+P4S+P11F+R31S+K33V+T65A+Q327F+N564D+K571S;P2N+P4S+P11F+T65A+Q327F+S377T;P2N+P4S+P11F+T65A+V325T+Q327W;P2N+P4S+P11F+T65A+Q327F+D445N+V447S+E501V+Y504T;P2N+P4S+P11F+T65A+I172V+Q327F+E501V+Y504T;P2N+P4S+P11F+T65A+Q327F+S377T+E501V+Y504T;P2N+P4S+P11F+D26N+K34Y+T65A+Q327F;P2N+P4S+P11F+T65A+Q327F+I375A+E501V+Y504T;P2N+P4S+P11F+T65A+K218A+K221D+Q327F+E501V+Y504T;P2N+P4S+P11F+T65A+S103N+Q327F+E501V+Y504T;P2N+P4S+T10D+T65A+Q327F+E501V+Y504T;P2N+P4S+F12Y+T65A+Q327F+E501V+Y504T;K5A+P11F+T65A+Q327F+E501V+Y504T;P2N+P4S+T10E+E18N+T65A+Q327F+E501V+Y504T;P2N+T10E+E18N+T65A+Q327F+E501V+Y504T;P2N+P4S+P11F+T65A+Q327F+E501V+Y504T+T568N;P2N+P4S+P11F+T65A+Q327F+E501V+Y504T+K524T+G526A;P2N+P4S+P11F+K34Y+T65A+Q327F+D445N+V447S+E501V+Y504T;P2N+P4S+P11F+R31S+K33V+T65A+Q327F+D445N+V447S+E501V+Y504T;P2N+P4S+P11F+D26N+K34Y+T65A+Q327F+E501V+Y504T;P2N+P4S+P11F+T65A+F80*+Q327F+E501V+Y504T;P2N+P4S+P11F+T65A+K112S+Q327F+E501V+Y504T;P2N+P4S+P11F+T65A+Q327F+E501V+Y504T+T516P+K524T+G526A;P2N+P4S+P11F+T65A+Q327F+E501V+N502T+Y504*;P2N+P4S+P11F+T65A+Q327F+E501V+Y504T;P2N+P4S+P11F+T65A+S103N+Q327F+E501V+Y504T;K5A+P11F+T65A+Q327F+E501V+Y504T;P2N+P4S+P11F+T65A+Q327F+E501V+Y504T+T516P+K524T+G526A;P2N+P4S+P11F+T65A+V79A+Q327F+E501V+Y504T;P2N+P4S+P11F+T65A+V79G+Q327F+E501V+Y504T;P2N+P4S+P11F+T65A+V79I+Q327F+E501V+Y504T;P2N+P4S+P11F+T65A+V79L+Q327F+E501V+Y504T;P2N+P4S+P11F+T65A+V79S+Q327F+E501V+Y504T;P2N+P4S+P11F+T65A+L72V+Q327F+E501V+Y504T;S255N+Q327F+E501V+Y504T; P2N+P4S+P11F+T65A+E74N+Q327F+E501V+Y504T; P 2N+P4S+P11F+T65A+G220N+Q327F+E501V+Y504T; P2N+P4S+P11F+T65A+Y245N+Q3 27F+E501V+Y504T; P2N+P4S+P11F+T65A+Q253N+Q327F+E501V+Y504T; P2N+P4S+P 11F+T65A+D279N+Q327F+E501V+Y504T; P2N+P4S+P11F+T65A+Q327F+S359N+E501 V+Y504T; P2N+P4S+P11F+T65A+Q327F+D370N+E501V+Y504T; P2N+P4S+P11F+T65 A+Q327F+V460S+E501V+Y504T; P2N+P4S+P11F+T65A+Q327F+V460T+P468T+E501V +Y504T; P2N+P4S+P11F+T65A+Q327F+T463N+E501V+Y504T; P2N+P4S+P11F+T65A+Q327F+S465N+E501V+Y504T; or P2N+P4S+P11F+T65A+Q327F+T477N+E501V+Y504T.

[0285] In a preferred embodiment, the Penicillium oxalate glucosyl amylase variant has a K79V substitution (PE001 variant) numbered using SEQ ID NO:12 herein, and further comprises one of the following mutations: P11F+T65A+Q327F; P2N+P4S+P11F+T65A+Q327F; P11F+D26C+K33C+T65A+Q327F; P2N+P4S+P11F+T65A+Q327W+E501V+Y504T; P2N+P4S+P11F+T65A+Q327F+E501V+Y504T; or P11F+T65A+Q327W+E501V+Y504T.

[0286] In one embodiment, the glucosylamylase variant (such as the penicillium oxalate glucosylamylase variant) has at least 60%, such as at least 70%, such as at least 75%, preferably at least 80%, more preferably at least 85%, more preferably at least 90%, more preferably at least 91%, more preferably at least 92%, even more preferably at least 93%, most preferably at least 94%, and even most preferably at least 95%, such as even at least 96%, at least 97%, at least 98%, at least 99%, but less than 100% identity with the mature polypeptide of SEQ ID NO: 12 herein.

[0287] Carbohydrate-producing enzymes (especially glucoamylase) can be added in amounts of 0.1-100 μg EP / g DS, such as 0.5-50 μg EP / g DS, such as 1-25 μg EP / g DS, such as 2-12 μg EP / g DS.

[0288] Pullulanase present and / or added during liquefaction

[0289] Optionally, pullulanase may be present and / or added during liquefaction step i) together with a xylanase resistant to metal ion inhibition (preferably having a melting point (DSC) greater than 80°C). As mentioned above, thermostable α-amylase, protease, carbohydrate-producing enzyme, preferably thermostable glucosylase may also be present and / or added during liquefaction step i).

[0290] Pullulanase may be present and / or added during liquefaction step i) and / or saccharification step ii) or during both saccharification and fermentation.

[0291] Pullulanases (EC3.2.1.41, pullulanose-6-glucan-hydrolyzeases) are debranching enzymes characterized by their ability to hydrolyze α-1,6-glycosidic bonds in, for example, amylopectin and pullulanose.

[0292] Pullulanases covered by the present invention include pullulanases from *Bacillus amyloderamificans* disclosed in U.S. Patent No. 4,560,651 (incorporated by reference), pullulanases from *Bacillus amyloderamificans* disclosed in WO 01 / 151620 (incorporated by reference) as SEQ ID NO:2, pullulanases from *Bacillus amyloderamificans* disclosed in WO 01 / 151620 (incorporated by reference) as SEQ ID NO:4, and pullulanases from *Bacillus amylopectinus* disclosed in WO 01 / 151620 (incorporated by reference) as SEQ ID NO:6, as well as pullulanases described in FEMS Mic. Let. [FEMS Microbiology Communications] (1994) 115, 97-106.

[0293] Additional pullulanases covered by the present invention include pullulanases from *Pyrococcus woesei*, specifically from *Pyrococcus woesei* DSM No. 3773 disclosed in WO 92 / 02614.

[0294] In one embodiment, the pullulanase is a GH57 pullulanase. In one embodiment, the pullulanase includes the X47 domain as disclosed in WO 2011 / 087836 (which is hereby incorporated by reference). More specifically, the pullulanase may be derived from strains of the genus *Thermococcus*, including *Thermococcus litoralis* and *Thermococcus hydrothermalis*, as shown in WO 2011 / 087836, specifically the *Thermococcus hydrothermalis* pullulanase truncated at the X4 site following the X47 domain. The pullulanase may also be a hybrid of *Thermococcus litoralis* and *Thermococcus hydrothermalis* pullulanases or a *Thermococcus hydrothermalis* / *Thermococcus litoralis* hybrid enzyme having the truncated X4 site disclosed in WO 2011 / 087836 (which is hereby incorporated by reference).

[0295] In another embodiment, the pullulanase is a pullulanase comprising the X46 domain disclosed in WO 2011 / 076123 (Novison).

[0296] According to the present invention, pullulanase can be added in an effective amount, preferably about 0.0001-10 mg enzyme protein / g DS, more preferably 0.0001-0.10 mg enzyme protein / g DS, and more preferably 0.0001-0.010 mg enzyme protein / g DS. Pullulanase activity can be determined as NPUN. The assay used to determine NPUN is described in the “Materials and Methods” section below.

[0297] Suitable commercially available pullulanase products include PROMOZYME 400L and PROMOZYME. TM D2 (Novozymes A / S, Denmark), OPTIMAX L-300 (Genencor Int., USA), and AMANO8 (Amano, Japan).

[0298] Phytase present and / or added during liquefaction

[0299] Optionally, during liquefaction, phytase may be present and / or added in combination with a metal-resistant xylanase (preferably a metal-resistant xylanase having a melting point (DSC) greater than 80°C). As described above, during liquefaction step i), a thermostable α-amylase, protease, or carbohydrate-producing enzyme may also optionally be present and / or added, preferably a thermostable glucosylase.

[0300] The phytase used according to the present invention can be any enzyme capable of releasing inorganic phosphate from phytic acid (inositol hexaphosphate) or any salt thereof (phytate). Phytases can be classified according to their specificity in the initial hydrolysis step, whereby they first hydrolyze phosphate ester groups. The phytase used in the present invention can have any specificity, for example, it can be 3-phytase (EC 3.1.3.8), or 6-phytase (EC 3.1.3.26), or 5-phytase (no EC number). In one embodiment, the phytase has an optimal temperature greater than 50°C, for example, in the range from 50°C to 90°C.

[0301] Phytase can originate from plants or microorganisms, such as bacteria or fungi, like yeast or filamentous fungi.

[0302] Plant phytases can be derived from wheat bran, corn, soybean, or lily pollen. Suitable plant phytases are described in Thomlinson et al., Biochemistry, 1 (1962), 166-171; Barrientos et al., Plant. Physiol., 106 (1994), 1489-1495; WO 98 / 05785; WO 98 / 20139.

[0303] Bacterial phytase can originate from Bacillus, Citrobacter, Hafnia, Pseudomonas, Buttiauxella, or Escherichia, especially Bacillus subtilis, Citrobacter braakii, Citrobacter freundii, Hafnia alvei, Buttiauxella gaviniae, Buttiauxella agrestis, Buttiauxella noackies, and Escherichia coli. Suitable bacterial phytases are described in Paver and Jagannathan, 1982, Journal of Bacteriology, 151:1102-1108; Cosgrove, 1970, Australian Journal of Biological Sciences, 23:1207-1220; Greiner et al., Arch. Biochem. Biophys., 303, 107-113, 1993; WO 1997 / 33976; WO 1997 / 48812, WO 1998 / 06856, WO 1998 / 028408, WO 2004 / 085638, WO 2006 / 037327, WO 2006 / 038062, WO 2006 / 063588, WO 2008 / 092901, WO 2008 / 116878, and WO 2010 / 034835.

[0304] Yeast phytases can originate from the genera *Schwanniomyces* or *Schwanniomyces*, particularly from the species *Saccharomyces occidentalis*. The enzymes described above are suitable yeast phytases described in Nayini et al., 1984, *Lebensmittel Wissenschaft und Technologie* [Food Science and Technology] 17:24-26; Wodzinski et al., *Advances in Applied Microbiology*, 42, 263-303; AU-A-24840 / 95.

[0305] Phytases from filamentous fungi can originate from the phyla Ascomycota or Basidiomycota, such as *Aspergillus*, *Thermomyces* (also known as *Pyrophytes*), *Myceliophthora*, *Manascus*, *Peniophora*, *Agrocybe*, *Paxillus*, or *Trametes*, particularly species such as *Aspergillus terreus*, *Aspergillus niger* var. *awamori*, *Aspergillus ficuum*, *Aspergillus fumigatus*, *Aspergillus oryzae*, *T. lanuginosus* (also known as *H. lanuginosa*), *Myceliophthora*, and *Peniophora*. *Lycii*, *Agrocybe pediades*, *Manascus anka*, *Paxillus involtus*, or *Trametes pubescens*. Suitable fungal phytases are described in Yamada et al., 1986, Agric. Biol. Chem. [Agricultural and Biochemical] 322:1275-1282; Piddington et al., 1993, Gene [Gene] 133:55-62; EP 684,313; EP 0 420358; EP 0 684 313; WO 1998 / 28408; WO 1998 / 28409; JP7-67635; WO 1998 / 44125; WO 1997 / 38096; WO 1998 / 13480.

[0306] In a preferred embodiment, the phytase is derived from the genus *Buttiauxella*, such as *Buttiauxella gaviniae*, *Buttiauxella agrestis*, or *Buttiauxella noackies*, as disclosed in WO 2008 / 092901 (incorporated hereby by reference) as SEQ ID NO:2, SEQ ID NO:4, and SEQ ID NO:6, respectively.

[0307] In a preferred embodiment, the phytase is derived from the genus Citrobacter, such as Citrobacter brycetes, as disclosed in WO2006 / 037328 (which is hereby incorporated by reference).

[0308] Modified phytases or phytase variants can be obtained by methods known in the art, particularly by the methods disclosed in: EP 897010; EP 897985; WO 99 / 49022; WO 99 / 48330, WO 2003 / 066847, WO 2007 / 112739, WO 2009 / 129489, and WO 2010 / 034835.

[0309] Commercially available phytases containing the product include bio-feed phytase. TM Phytase NOVO TM CT or L (both from Novozymes), LIQMAX (DuPont), or RONOZYME TM NP, HiPhos P5000(CT), NATUPHOS TM NG 5000 (from DSM).

[0310] Enzymes present and / or added during saccharification and / or fermentation that are carbohydrate-producing sources

[0311] According to the present invention, an enzyme that produces a carbohydrate source, preferably glucosylamylase, is present and / or added during saccharification and / or fermentation.

[0312] In a preferred embodiment, the carbohydrate-producing enzyme is a fungal glucosylamylase, preferably from the genus *Aspergillus*, specifically strains of *Aspergillus niger*, *Aspergillus awamori*, or *Aspergillus oryzae*; or strains of the genus *Trichoderma*, preferably *Trichoderma reesei*; or strains of the genus *Basilaria*, preferably *Basilaria emersonii*.

[0313] Glucoamylase

[0314] According to the invention, the glucosylamylase present and / or added during saccharification and / or fermentation can be derived from any suitable source, for example, from microorganisms or plants. Preferred glucosylamylases are of fungal or bacterial origin, selected from the group consisting of: Aspergillus glucosylamylases, particularly Aspergillus niger G1 or G2 glucosylamylases (Boel et al., 1984, EMBO J. [Journal of the European Society for Molecular Biology] 3(5), pp. 1097-1102), or variants thereof, such as those disclosed in WO92 / 00381, WO 00 / 04136 and WO 01 / 04273 (from Novozymes, Denmark); Aspergillus avocado glucosylamylase disclosed in WO 84 / 02921; Aspergillus oryzae glucosylamylase (Agric. Biol. Chem. [Agricultural and Biochemical] (1991), 55(4), pp. 941-949), or variants or fragments thereof. Other Aspergillus glucosyl amylase variants include those with enhanced thermostability: G137A and G139A (Chen et al. (1996), Prot. Eng. 9, 499-505); D257E and D293E / Q (Chen et al. (1995), Prot. Eng. 8, 575-582); N182 (Chen et al. (1994), Biochem. J 301, 275-281); disulfide bond, A246C (Fierobe et al., 1996, Biochemistry 35: 8698-8704); and the introduction of Pro residues at positions A435 and S436 (Li et al., 1997, Protein Engng 10, 1199-1204).

[0315] Other glucosylamylases include Athelia rolfsii (formerly known as Corticium rolfsii) glucosylamylase (see U.S. Patent No. 4,727,026 and Nagasaka et al. (1998) “Purification and properties of the raw-starch-degrading glucoamylases from Corticium rolfsii” Appl. Microbiol. Biotechnol. 50:323-330), Basilaria glucosylamylases, particularly those derived from Basilaria emersonii (WO 99 / 28448), Basilaria resèsii (U.S. Patent No. Re. 32,153), Basilaria duponti, and Basilaria thermophila (U.S. Patent No. 4,587,215). In a preferred embodiment, the glucosylamylase used during saccharification and / or fermentation is Emersonian basket bacteria glucosylamylase disclosed in WO 99 / 28448.

[0316] The bacterial glucosylases covered include those from the genus Clostridium, particularly those from *C. thermoamylolyticum* (EP 135,138) and *C. thermohydrosulfuricum* (WO86 / 01831).

[0317] The fungal glucosylases covered include *Trametescingulata*, *Pachykytospora papyracea*, and *Leucopaxillus giganteus*, all disclosed in WO 2006 / 069289; and *Peniophora rufomarginata*, disclosed in WO 2007 / 124285; or mixtures thereof. The invention also covers heterozygous glucosylases. Examples include heterozygous glucosylases disclosed in WO 2005 / 045018. Specific examples include the heterozygous glucosylases disclosed in Tables 1 and 4 of Example 1 (these heterozygotes are hereby incorporated by reference).

[0318] In one embodiment, the glucosylamylase is derived from strains of the genus *Pycnoporus*, particularly strains of the genus *Pycnoporus* as described in WO 2011 / 066576 (SEQ ID NO: 2, 4, or 6); or strains of the genus *Gloephyllum*, particularly strains of the genus *Gloephyllum* as described in WO 2011 / 068803 (SEQ ID NO: 2, 4, 6, 8, 10, 12, 14, or 16); or strains of the genus *Nigrofomes*, particularly strains of *Nigrofomes* species disclosed in WO 2012 / 064351 (SEQ ID NO: 2) (all references are hereby incorporated by way of citation). It also includes the following glucosylamylases that exhibit high identity with any of the aforementioned glucosylamylases, i.e., having at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or as many as 100% identity with any of the mature portions of the aforementioned enzyme sequences.

[0319] In one embodiment, glucosyl amylase may be added to saccharification and / or fermentation in the following amounts: 0.0001-20 AGU / g DS, preferably 0.001-10 AGU / g DS, particularly between 0.01-5 AGU / g DS, for example 0.1-2 AGU / g DS.

[0320] Commercially available compositions containing glucosyl amylase include AMG 200L; AMG 300L; SAN TM SUPER, SAN TM EXTRA L、SPIRIZYME TM PLUS, SPIRIZYME TM FUEL, SPIRIZYME TM B4U, SPIRIZYME TM ULTRA, SPIRIZYME TM EXCEL, SPIRIZYME TM ACHIEVE and AMG TM E (from Novozymes A / S); OPTIDEX TM 300, GC480, GC417 (from Genencor International); AMIGASE TM and AMIGASE TM PLUS (from DSM); G-ZYME TM G900, G-ZYME TMAnd G990 ZR (from Danisco US).

[0321] Maltose amylase production

[0322] The carbohydrate-producing enzyme present and / or added during saccharification and / or fermentation can also be a maltose-producing α-amylase. "Maltose-producing α-amylase" (glucan 1,4-α-maltose hydrolase, EC 3.2.1.133) hydrolyzes maltose in the α-conformation of both amylose and amylopectin. Maltose-producing amylase from the thermophilic Bacillus stearothermophilus strain NCIB 11837 is commercially available from Novozymes A / S. Maltose-producing α-amylase is described in U.S. Patent Nos. 4,598,048, 4,604,355, and 6,162,628, which are incorporated herein by reference. In a preferred embodiment, the maltose-producing amylase can be added at an amount of 0.05-5 mg total protein / g DS or 0.05-5 MANU / g DS.

[0323] Combinations of cellulases or cellolytic enzymes present and / or added during saccharification and / or fermentation or SSF.

[0324] In a preferred embodiment of the invention, a cellulase or cellulase composition is present and / or added during saccharification in step ii) and / or during fermentation or SSF in step iii).

[0325] The cellulase or cellulase composition may contain one or more cellulases. The cellulase or cellulase composition may be from any source. In a preferred embodiment, the cellulase or cellulase composition contains a fungal-derived cellulase. In one embodiment, the cellulase or cellulase composition is derived from a strain of the genus *Trichoderma*, such as *Trichoderma reesei*; or a strain of the genus *Pythium*, such as *Pythium spp.*; or a strain of the genus *Chrysosporium lucknowense*; or a strain of the genus *Penicillium*, such as *Penicillium decumbens*. In a preferred embodiment, the cellulase composition is derived from a strain of *Trichoderma reesei*. The cellulase may be a β-glucosidase, cellobiase, and endoglucanase, or a combination thereof. The cellulase composition may contain a β-glucosidase, a cellobiase, and an endoglucanase.

[0326] In one embodiment, the cellulase or cellulolytic enzyme composition comprises one or more polypeptides selected from the group consisting of: -β-glucosidase; -cellobiase I; -cellobiase II; or mixtures thereof.

[0327] In one embodiment, the cellulase or cellulolytic enzyme composition comprises one or more polypeptides selected from the group consisting of: β-glucosidase; cellobiase; and endoglucanase; or mixtures thereof.

[0328] In one embodiment, the cellulase or cellulolytic enzyme composition comprises one or more polypeptides selected from the group consisting of: -β-glucosidase; -cellobiase I; and -endoglucanase; or mixtures thereof.

[0329] In a preferred embodiment, the cellulase or cellulolytic enzyme composition further comprises a GH61 polypeptide having cellulolytic-enhancing activity. Cellulolytic-enhancing activity is defined and determined as described in WO 2011 / 041397 (incorporated by reference).

[0330] The term "GH61 polypeptide with enhanced cellulose-degrading activity" refers to a GH61 polypeptide that enhances the hydrolysis of cellulose materials by an enzyme with cellulose-degrading activity. For the purposes of this invention, cellulose-degrading activity can be determined by measuring the increase in reducing sugars or the total amount of cellobiose and glucose in cellulose materials hydrolyzed by cellulase under the following conditions: 1-50 mg total protein / g cellulose in PCS (pretreated corn stalks), wherein the total protein consists of 50-99.5% w / w cellulase protein and 0.5-50% w / w GH61 polypeptide protein exhibiting enhanced cellulose-degrading activity compared to control hydrolysis (with an equal total protein loading but without enhanced cellulose-degrading activity, 1-50 mg of cellulase protein / g cellulose in PCS) sustained at 50°C for 1-7 days. In a preferred aspect, CELLUCLAST is used in the presence of a cellulase protein loading of 2%-3% of the total protein weight of Aspergillus oryzae β-glucosidase (recombinantly produced in Aspergillus oryzae according to WO 02 / 095014) or 2%-3% of the total protein weight of Aspergillus fumigatus β-glucosidase (recombinantly produced in Aspergillus oryzae as described in WO 2002 / 095014). TM 1.5L (Novozymes, Bageswald) A mixture from Denmark serves as a source of cellulose-degrading activity.

[0331] The cellulase composition may contain a β-glucosidase, preferably derived from strains of the genus *Aspergillus* such as *Aspergillus oryzae*, for example, the β-glucosidase disclosed in WO 2002 / 095014 or the fusion protein with β-glucosidase activity disclosed in WO 2008 / 057637 (see SEQ ID NO:74 or 76), or a β-glucosidase such as *Aspergillus fumigatus*, for example, the β-glucosidase disclosed in SEQ ID NO:2 in WO2005 / 047499 or SEQ ID NO:16 herein; or a variant of *Aspergillus fumigatus* β-glucosidase disclosed in WO 2012 / 044915; or a strain derived from the genus *Penicillium*, such as *Penicillium brasiliensis* disclosed in WO 2007 / 019442, or a strain of the genus *Trichoderma*, such as *Trichoderma reesei*.

[0332] In one embodiment, the β-glucosidase is derived from a strain of Aspergillus, such as a strain of Aspergillus fumigatus, for example, Aspergillus fumigatus β-glucosidase (SEQ ID NO: 16 herein) or a variant thereof, the variant comprising one or more substitutions selected from the group consisting of: L89M, G91L, F100D, I140V, I186V, S283G, N456E, and F512Y; or variants having the following substitutions:

[0333] -F100D+S283G+N456E+F512Y; -L89M+G91L+I186V+I140V;

[0334] -I186V+L89M+G91L+I140V+F100D+S283G+N456E+F512Y (using SEQ ID NO:16 for numbering in this document).

[0335] The parental β-glucosidase may have at least 60% identity with the mature polypeptide of SEQ ID NO:16 herein, such as at least 70%, at least 80%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or at least 100% identity.

[0336] In the case that the β-glucosidase is a variant of the β-glucosidase, it may have at least 60% identity with the mature polypeptide of SEQ ID NO:16 herein, for example at least 70%, for example at least 80%, for example at least 90%, for example at least 95%, for example at least 96%, for example at least 97%, for example at least 98%, for example at least 99%, but less than 100% identity.

[0337] In cases where the cellulase composition may contain the GH61 polypeptide, it may be a polypeptide derived from the genus *Thermophila* (e.g., strains of *Thermophila orangeensis*), such as the polypeptide described as SEQ ID NO:6 in WO2005 / 074656 or SEQ ID NO:18 herein; or a polypeptide derived from the genus *Clostridium*, such as strains of *Clostridium terreum*, such as the polypeptide described as SEQ ID NO:7 and SEQ ID NO:8 in WO 2005 / 074647; or a polypeptide derived from the genus *Aspergillus*, such as strains of *Aspergillus fumigatus*, such as the polypeptide described as SEQ ID NO:1 and SEQ ID NO:2 in WO 2010 / 138754; or a polypeptide derived from the genus *Penicillium*, such as strains of *Penicillium emersonii*, such as the polypeptide disclosed as SEQ ID NO:6 in WO 2011 / 041397 or SEQ ID NO:19 herein.

[0338] In a preferred embodiment, the GH61 polypeptide (such as a polypeptide derived from a Penicillium strain (preferably a Penicillium emersonii strain)) is selected from the group consisting of:

[0339] (i) GH61 peptide comprising the mature peptide of SEQ ID NO:19 of this article;

[0340] (ii) A GH61 polypeptide comprising the following amino acid sequence having at least 60%, for example at least 70%, for example at least 75%, at least 80%, at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99% identity with the mature polypeptide of SEQ ID NO:19 herein.

[0341] In one embodiment, the cellulase composition comprises cellobiase I (CBH I), such as strains derived from the genus Aspergillus, such as strains of Aspergillus fumigatus, such as Cel7a CBH I disclosed in SEQ ID NO:6 of WO2011 / 057140 or SEQ ID NO:20 herein, or strains derived from the genus Trichoderma, such as strains of Trichoderma reesei.

[0342] In a preferred embodiment, cellobiase I, such as that derived from strains of the genus Aspergillus, preferably strains of Aspergillus fumigatus, is selected from the group consisting of:

[0343] (i) Cellobiase I containing the mature polypeptide of SEQ ID NO:20 of this article;

[0344] (ii) Cellobiose hydrolase I comprising the following amino acid sequence having at least 60%, for example at least 70%, for example at least 75%, at least 80%, at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99% similarity to the mature polypeptide of SEQ ID NO:20 herein.

[0345] In one embodiment, the cellulase composition comprises cellobiase II (CBH II), such as cellobiase II derived from strains of the genus Aspergillus, such as strains of Aspergillus fumigatus; such as cellobiase II disclosed herein as SEQ ID NO:21; or strains derived from the genus Trichoderma, such as Trichoderma reesei; or strains derived from the genus Clostridium, such as strains of Clostridium terrestris, such as cellobiase II CEL6A from Clostridium terrestris.

[0346] In a preferred embodiment, cellobiase II, such as that derived from strains of the genus Aspergillus, preferably strains of Aspergillus fumigatus, is selected from the group consisting of:

[0347] (i) Cellobiase II containing the mature polypeptide of SEQ ID NO:21 of this article;

[0348] (ii) Cellobiose hydrolase II comprising the following amino acid sequence having at least 60%, such as at least 70%, such as less than 75%, at least 80%, at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99% identity with the mature polypeptide of SEQ ID NO:21 herein.

[0349] In one embodiment, the cellulase composition comprises a GH61 polypeptide with cellulase-enhancing activity and a β-glucosidase.

[0350] In one embodiment, the cellulase composition comprises a GH61 polypeptide with cellulolytic-enhancing activity derived from a Penicillium strain, such as Penicillium emersonii, for example, the GH61 polypeptide disclosed as SEQ ID NO:2 in WO 2011 / 041397 or SEQ ID NO:19 herein, and a β-glucosidase.

[0351] In one embodiment, the cellulase composition comprises a GH61 polypeptide with cellulase-enhancing activity, β-glucosidase, and CBH I.

[0352] In one embodiment, the cellulase composition comprises a GH61 polypeptide with cellulolytic-enhancing activity derived from a strain of Penicillium (such as Penicillium emersonii) (e.g., the GH61 polypeptide disclosed as SEQ ID NO:2 in WO 2011 / 041397 or SEQ ID NO:19 herein), β-glucosidase, and CBHI.

[0353] In one embodiment, the cellulase composition comprises a GH61 polypeptide with cellulase-enhancing activity, β-glucosidase, CBHI, and CBHII.

[0354] In one embodiment, the cellulase composition comprises a GH61 polypeptide with cellulolytic-enhancing activity derived from a strain of Penicillium (such as a strain of Penicillium emersonii) (e.g., the GH61 polypeptide disclosed as SEQ ID NO:2 in WO 2011 / 041397 or SEQ ID NO:19 herein), β-glucosidase, CBHI, and CBHII.

[0355] In one embodiment, the cellulase composition is a Trichoderma reesei cellulase composition, which further comprises a Thermophilic Ascomycota GH61A polypeptide (SEQ ID NO:2 in WO 2005 / 074656 or SEQ ID NO:18 herein) and an Aspergillus oryzae β-glucosidase fusion protein (WO 2008 / 057637).

[0356] In one embodiment, the cellulase composition is a Trichoderma reesei cellulase composition, which further comprises a Thermophilic Ascomycota orange GH61A polypeptide (SEQ ID NO:2 in WO 2005 / 074656 or SEQ ID NO:18 herein) having cellulase-enhancing activity, and Aspergillus fumigatus β-glucosidase (SEQ ID NO:2 in WO 2005 / 047499 or SEQ ID NO:16 herein).

[0357] In one embodiment, the cellulase composition is a Trichoderma reesei cellulase composition, further comprising the Penicillium emersonii GH61A polypeptide disclosed in WO 2011 / 041397 SEQ ID NO:2 or SEQ ID NO:19 herein, and Aspergillus fumigatus β-glucosidase or a variant thereof disclosed in WO2005 / 047499 SEQ ID NO:2 or SEQ ID NO:16 herein, the variant having one of the following substitutions, preferably all of the following substitutions: F100D, S283G, N456E, F512Y.

[0358] In one embodiment, the cellulase composition comprises one or more of the following components: (i) Aspergillus fumigatus cellobiose hydrolase I; (ii) Aspergillus fumigatus cellobiose hydrolase II; and (iii) Aspergillus fumigatus β-glucosidase or a variant thereof.

[0359] In one embodiment, the cellulase composition comprises one or more of the following components: (i) Aspergillus fumigatus cellobiase I; (ii) Aspergillus fumigatus β-glucosidase or a variant thereof; and (iii) Trichoderma reesei endoglucanase I.

[0360] In one embodiment, Aspergillus fumigatus β-glucosidase (SEQ ID NO:16 herein) comprises one or more substitutions selected from the group consisting of: L89M, G91L, F100D, I140V, I186V, S283G, N456E, and F512Y; for example, variants having the following substitutions: -F100D+S283G+N456E+F512Y; -L89M+G91L+I186V+I140V; or -I186V+L89M+G91L+I140V+F100D+S283G+N456E+F512Y.

[0361] In one embodiment, the cellulase composition further comprises the Penicillium species GH61 polypeptide shown in SEQ ID NO:19 herein; or comprises the GH61 polypeptide having an amino acid sequence having at least 60%, such as at least 70%, such as at least 75%, at least 80%, at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99%, such as 100%, identity with the mature polypeptide of SEQ ID NO:19 herein.

[0362] In one embodiment, the cellulase composition further comprises the Trichoderma reesei polypeptide shown in SEQ ID NO:17 herein; or a polypeptide comprising the following amino acid sequence having at least 60%, such as at least 70%, for example at least 75%, at least 80%, at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99%, such as 100%, identity with the mature polypeptide of SEQ ID NO:17 herein.

[0363] In one embodiment, the cellulase composition comprises the following components: (i) Aspergillus fumigatus cellobiose hydrolase I as shown in SEQ ID NO:20 herein; (ii) Aspergillus fumigatus cellobiose hydrolase II as shown in SEQ ID NO:21 herein; (iii) a variant of Aspergillus fumigatus β-glucosidase as shown in SEQ ID NO:16 having the following substitutions: F100D+S283G+N456E+F512Y; and (iv) Penicillium species GH61 polypeptide as shown in SEQ ID NO:19 herein.

[0364] In one embodiment, the cellulase composition comprises the following components: (i) Aspergillus fumigatus cellobiose hydrolase I as shown in SEQ ID NO:20 herein; (ii) a variant of Aspergillus fumigatus β-glucosidase as shown in SEQ ID NO:16 having the following substitutions: F100D+S283G+N456E+F512Y; and (iii) Trichoderma reesei endoglucanase I as shown in SEQ ID NO:17 herein.

[0365] In one embodiment, the cellulase or cellulolytic enzyme composition is derived from *Trichoderma reesei* and further comprises: (i) *Aspergillus fumigatus* cellobiose hydrolase I as shown in SEQ ID NO:20 herein; (ii) a variant of *Aspergillus fumigatus* β-glucosidase shown in SEQ ID NO:16 having the following substitutions: F100D+S283G+N456E+F512Y; and (iii) *Trichoderma reesei* endoglucanase I as shown in SEQ ID NO:17 herein.

[0366] In one embodiment, the cellulase composition (i.e., during saccharification in step ii) and / or fermentation or SSF in step iii) is added in doses of 0.0001-3 mg EP / g DS, preferably 0.0005-2 mg EP / g DS, preferably 0.001-1 mg / g DS, more preferably from 0.005-0.5 mg EP / g DS, and even more preferably 0.01-0.1 mg EP / g DS.

[0367] Examples of preferred methods of the present invention

[0368] In a preferred embodiment, the present invention relates to a method for producing fermentation products from starch-containing materials, the method comprising the following steps:

[0369] i) Using the following liquefied starch-containing materials at pH values ​​ranging from greater than 4.0 to 6.5 and at temperatures ranging from 70°C to 100°C:

[0370] - α-amylase derived from Bacillus stearothermophilus;

[0371] - Xylanase, which is resistant to the inhibition of metal ions when liquefying starch-containing materials, and also has a melting point (DSC) greater than 80°C;

[0372] - Optional endoglucanase with a melting point (DSC) greater than 70°C;

[0373] ii) Saccharification using glucosyl amylase;

[0374] iii) Fermentation using fermenting organisms.

[0375] In a preferred embodiment, the method of the present invention includes the following steps:

[0376] i) Using the following methods to liquefy starch-containing materials at a pH range of greater than 4.5 to 6.2 and at a temperature greater than the initial gelatinization temperature:

[0377] -α-amylase, preferably derived from thermophilic Bacillus stearothermophilus, has a T1 / 2 (min) of at least 10 at pH 4.5, 85°C, and 0.12 mM CaCl2;

[0378] - Xylanase, which is resistant to the inhibition of metal ions when liquefying starch-containing materials, and also has a melting point (DSC) greater than 80°C;

[0379] - Optional endoglucanase with a melting point (DSC) greater than 70°C;

[0380] ii) Saccharification using glucosyl amylase;

[0381] iii) Fermentation using fermenting organisms.

[0382] In a preferred embodiment, the method of the present invention includes the following steps:

[0383] i) Liquefying starch-containing materials at a pH range of greater than 4.0 to 6.5 and at a temperature between 70°C and 100°C:

[0384] - Bacterial α-amylase, preferably derived from thermophilic Bacillus stearothermophilus, having a T1 / 2 (min) of at least 10 at pH 4.5, 85°C, and 0.12 mM CaCl2;

[0385] - Xylanase, which is resistant to inhibition by metal ions when liquefying starch-containing materials and also has a melting point (DSC) greater than 80°C; - Optional endoglucanase having a melting point (DSC) between 70°C and 95°C.

[0386] -Optionally, the protease, preferably derived from *Fireballia victoriae* or *Thermophilus cibarius*, has a thermal stability value of more than 20% with relative activity at 80°C / 70°C.

[0387] ii) Saccharification using glucosyl amylase;

[0388] iii) Fermentation using fermenting organisms.

[0389] In a preferred embodiment, the method of the present invention includes the following steps:

[0390] i) Use the following liquefaction methods for starch-containing materials at a pH range of greater than 4.0 to 6.5 and at a temperature greater than the initial gelatinization temperature:

[0391] -α-Amylase, the α-amylase shown in SEQ ID NO:5 has a double deletion at position R179+G180 or I181+G182, and optionally the substitution N193F; and optionally another from the following set of substitutions:

[0392] -E129V+K177L+R179E;

[0393] -V59A+Q89R+E129V+K177L+R179E+H208Y+K220P+N224L+Q254S;

[0394] -V59A+E129V+K177L+R179S+Q254S;

[0395] -E129V+K177L+R179E+K220P+N224L+S242Q+Q254S;

[0396] -V59A+Q89R+E129V+K177L+R179E+Q254S+M284V (numbered using SEQ ID NO:5 in this document);

[0397] - Xylanase, which is resistant to the inhibition of metal ions when liquefying starch-containing materials, has a melting point (DSC) greater than 80°C;

[0398] Xylanase having at least 60%, such as at least 70%, such as at least 75%, preferably at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, more preferably at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, more preferably at least 90%, more preferably at least 91%, more preferably at least 92%, even more preferably at least 93%, most preferably at least 94%, and even most preferably at least 95%, such as even at least 96%, at least 97%, at least 98%, at least 99%, such as 100% identity with the mature portion of the polypeptides of SEQ ID NO:2, 3 and 4 in this document;

[0399] - An optional endoglucanase having a melting point (DSC) between 70°C and 95°C; an endoglucanase having at least 60%, such as at least 70%, such as at least 75%, preferably at least 80%, more preferably at least 85%, more preferably at least 90%, more preferably at least 91%, more preferably at least 92%, even more preferably at least 93%, most preferably at least 94%, and even most preferably at least 95%, such as even at least 96%, at least 97%, at least 98%, at least 99%, such as 100% endoglucanase having a melting point (DSC) between 70°C and 95°C;

[0400] -Optionally, a protease having a thermostability value of more than 20% with relative activity at 80°C / 70°C, derived from *Firecoccus viridans* and / or *Thermophilus orangeus*.

[0401] -Optionally, the penicillium oxalate glucoamylase in SEQ ID NO:12 of this article preferably has substitutions selected from the group consisting of:

[0402] -K79V;

[0403] -K79V+P11F+T65A+Q327F; or

[0404] -K79V+P2N+P4S+P11F+T65A+Q327F; (Use SEQ ID NO:12 for numbering);

[0405] ii) Saccharification using glucosyl amylase;

[0406] iii) Fermentation using fermenting organisms.

[0407] In a preferred embodiment, the method of the present invention includes the following steps:

[0408] i) Use the following liquefied starch-containing materials at a pH range of greater than 4.0 to 6.5 and at a temperature between 70°C and 100°C:

[0409] - An α-amylase derived from Bacillus stearothermophilus, having a double deletion at position I181+G182, and optionally the substitution N193F; and optionally another from the following set of substitutions:

[0410] -I181*+G182*+N193F+E129V+K177L+R179E;

[0411] -N193F+V59A+Q89R+E129V+K177L+R179E+H208Y+K220P+N224L+Q254S;

[0412] -N193F+V59A+Q89R+E129V+K177L+R179E+Q254S+M284V;

[0413] -N193F+V59A+E129V+K177L+R179E+Q254S+M284V;

[0414] -N193F+E129V+K177L+R179E+K220P+N224L+S242Q+Q254S;

[0415] -V59A+E129V+K177L+R179E+Q254S+M284V+V212T+Y268G+N293Y+T297N;

[0416] -V59A+E129V+K177L+R179E+Q254S+M284V+V212T+Y268G+N293Y+T297N+S173N+E188P+H208Y+S242Y+K279I;

[0417] -V59A+E129V+K177L+R179S+Q254S+M284V+V212T+Y268G+N293Y+T297N+A184Q+E188P+T191N;

[0418] -V59A+E129V+K177L+R179S+Q254S+M284V+V212T+Y268G+N293Y+T297N+A184Q+E188P+T191N+S242Y+K279I;

[0419] -V59A+E129V+K177L+R179S+Q254S+M284V+V212T+Y268G+N293Y+T297N+A184Q+E188P+T191N+N193F+S242Y+K279I;

[0420] -V59A+E129V+K177L+R179E+Q254S+M284V+V212T+Y268G+N293Y+T297N+E188P+K279W;

[0421] -V59A+E129V+K177L+R179E+Q254S+M284V+V212T+Y268G+N293Y+T297N+W115D+D117Q+T133P;

[0422] -V59A+Q89R+E129V+K177L+R179E+H208Y+K220P+N224L+Q254S; or

[0423] -V59A+Q89R+E129V+K177L+R179E+Q254S+M284V (numbered using SEQ ID NO:5 in this document);

[0424] - Xylanase, which is resistant to the inhibition of metal ions when liquefying starch-containing materials, has a melting point (DSC) greater than 80°C;

[0425] Xylanase having at least 60%, such as at least 70%, such as at least 75%, preferably at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, more preferably at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, more preferably at least 90%, more preferably at least 91%, more preferably at least 92%, even more preferably at least 93%, most preferably at least 94%, and even most preferably at least 95%, such as even at least 96%, at least 97%, at least 98%, at least 99%, such as 100% identity with the mature portion of the polypeptides of SEQ ID NO:2, 3 and 4 in this document;

[0426] - An optional endoglucanase having a melting point (DSC) between 70°C and 95°C; preferably having at least 90% identity with the mature portion of the polypeptide of SEQ ID NO:7 herein;

[0427] - An optional protease having a thermostability value exceeding 20% ​​with relative activity at 80°C / 70°C, derived from *Pomacea canaliculata* and / or *Thermophilus orangeus*; and

[0428] -Optionally, the penicillium oxalate glucoamylase in SEQ ID NO:12 of this article preferably has substitutions selected from the group consisting of:

[0429] -K79V; or

[0430] -K79V+P11F+T65A+Q327F; or

[0431] -K79V+P2N+P4S+P11F+T65A+Q327F (using SEQ ID NO:12 for numbering in this document);

[0432] ii) Saccharification using glucosyl amylase;

[0433] iii) Fermentation using fermenting organisms.

[0434] In a preferred embodiment, the method of the present invention includes the following steps:

[0435] i) Use the following liquefied starch-containing materials at a pH range of greater than 4.0 to 6.5 and at a temperature between 70°C and 100°C:

[0436] - An α-amylase derived from Bacillus stearothermophilus, having a double deletion at position I181+G182, and optionally the substitution N193F; and optionally another from the following set of substitutions:

[0437] -V59A+Q89R+E129V+K177L+R179S+H208Y+K220P+N224L+Q254S; or

[0438] -V59A+Q89R+E129V+K177L+R179S+Q254S+M284V (numbered using SEQ ID NO:5 in this document);

[0439] - Xylanase, which is resistant to the inhibition of metal ions when liquefying starch-containing materials, and also has a melting point (DSC) greater than 80°C;

[0440] Xylanase having at least 60%, such as at least 70%, such as at least 75%, preferably at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, more preferably at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, more preferably at least 91%, more preferably at least 92%, even more preferably at least 93%, most preferably at least 94%, and even most preferably at least 95%, such as even at least 96%, at least 97%, at least 98%, at least 99%, such as 100% identity with the mature portion of the polypeptides of SEQ ID NO:2, 3 and 4 in this document;

[0441] - An optional endoglucanase having a melting point (DSC) between 70°C and 95°C; preferably having at least 90% identity with the mature portion of the polypeptide of SEQ ID NO:7 herein;

[0442] - An optional protease having a thermostability value exceeding 20% ​​with relative activity at 80°C / 70°C, derived from *Pomacea canaliculata* and / or *Thermophilus orangeus*; and

[0443] -Optionally, the penicillium oxalate glucoamylase in SEQ ID NO:12 of this article preferably has substitutions selected from the group consisting of:

[0444] -K79V; or

[0445] -K79V+P11F+T65A+Q327F; or

[0446] -K79V+P2N+P4S+P11F+T65A+Q327F (using SEQ ID NO:12 for numbering in this document);

[0447] ii) Saccharification using glucosyl amylase;

[0448] iii) Fermentation using fermenting organisms.

[0449] In a preferred embodiment, the method of the present invention includes the following steps:

[0450] i) Use the following liquefied starch-containing materials at a pH range of greater than 4.0 to 6.5 and at a temperature between 70°C and 100°C:

[0451] - An α-amylase derived from Bacillus stearothermophilus, having a double deletion at position I181+G182, and optionally the substitution N193F; and optionally another from the following set of substitutions:

[0452] -I181*+G182*+N193F+E129V+K177L+R179E;

[0453] -N193F+V59A+Q89R+E129V+K177L+R179E+H208Y+K220P+N224L+Q254S;

[0454] -N193F+V59A+Q89R+E129V+K177L+R179E+Q254S+M284V;

[0455] -N193F+V59A+E129V+K177L+R179E+Q254S+M284V;

[0456] -N193F+E129V+K177L+R179E+K220P+N224L+S242Q+Q254S;

[0457] -V59A+E129V+K177L+R179E+Q254S+M284V+V212T+Y268G+N293Y+T297N;

[0458] -V59A+E129V+K177L+R179E+Q254S+M284V+V212T+Y268G+N293Y+T297N+S173N+E188P+H208Y+S242Y+K279I;

[0459] -V59A+E129V+K177L+R179S+Q254S+M284V+V212T+Y268G+N293Y+T297N+A184Q+E188P+T191N;

[0460] -V59A+E129V+K177L+R179S+Q254S+M284V+V212T+Y268G+N293Y+T297N+A184Q+E188P+T191N+S242Y+K279I;

[0461] -V59A+E129V+K177L+R179S+Q254S+M284V+V212T+Y268G+N293Y+T297N+A184Q+E188P+T191N+N193F+S242Y+K279I;

[0462] -V59A+E129V+K177L+R179E+Q254S+M284V+V212T+Y268G+N293Y+T297N+E188P+K279W;

[0463] -V59A+E129V+K177L+R179E+Q254S+M284V+V212T+Y268G+N293Y+T297N+W115D+D117Q+T133P;

[0464] -E129V+K177L+R179E;

[0465] -V59A+Q89R+E129V+K177L+R179E+H208Y+K220P+N224L+Q254S;

[0466] -V59A+Q89R+E129V+K177L+R179E+Q254S+M284V;

[0467] -E129V+K177L+R179E+K220P+N224L+S242Q+Q254S (numbered using SEQ ID NO:5 in this document);

[0468] - Xylanase, which is resistant to the inhibition of metal ions when liquefying starch-containing materials, has a melting point (DSC) greater than 80°C;

[0469] - An optional endoglucanase having a melting point (DSC) between 70°C and 95°C; preferably having at least 90% identity with the mature portion of the polypeptide of SEQ ID NO:7 herein;

[0470] - A protease having a thermostability value of over 20% with relative activity at 80°C / 70°C, derived from *Fireballococcus virens*.

[0471] -The penicillium oxalate glucoamylase in SEQ ID NO:12 of this article preferably has substitutions selected from the group consisting of:

[0472] -K79V;

[0473] -K79V+P11F+T65A+Q327F; or

[0474] -K79V+P2N+P4S+P11F+T65A+Q327F; or

[0475] -K79V+P11F+D26C+K33C+T65A+Q327F; or

[0476] -K79V+P2N+P4S+P11F+T65A+Q327W+E501V+Y504T; or

[0477] -K79V+P2N+P4S+P11F+T65A+Q327F+E501V+Y504T; or

[0478] -K79V+P11F+T65A+Q327W+E501V+Y504T (using SEQ ID NO:12 for numbering in this document);

[0479] ii) Saccharification using glucosyl amylase;

[0480] iii) Fermentation using fermenting organisms.

[0481] In a preferred embodiment, the method of the present invention includes the following steps:

[0482] i) Use the following liquefied starch-containing materials at a pH range of greater than 4.0 to 6.5 and at a temperature between 80°C and 95°C:

[0483] α-Amylase, preferably a thermostable bacterial α-amylase, more preferably an α-amylase having at least 80%, at least 85%, at least 90%, or at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% identity with the amino acid sequence of amino acids 1 to 491 of SEQ ID NO:5, having the mutant I181*+G182*+N193F+V59A+Q89R+E129V+K177L+R179E+Q254S+M284V;

[0484] - Thermostable xylanase resistant to metal ion inhibition, more preferably a thermostable xylanase having at least 80%, at least 85%, at least 90%, or at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% identity with the amino acid sequence of the mature polypeptide of SEQ ID NO:2; and

[0485] - A thermostable protease having an amino acid sequence identity of at least 80%, at least 85%, at least 90%, or at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% with the mature polypeptide of SEQ ID NO:11;

[0486] ii) Saccharification using glucosyl amylase;

[0487] iii) Fermentation using fermenting organisms.

[0488] In a preferred embodiment, the method of the present invention includes the following steps:

[0489] i) Use the following liquefied starch-containing materials at a pH range of greater than 4.0 to 6.5 and at a temperature between 80°C and 95°C:

[0490] -α-amylase, preferably thermostable bacterial α-amylase, more preferably α-amylase having at least 80%, at least 85%, at least 90%, or at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% identity with the amino acid sequence of amino acids 1 to 491 of SEQ ID NO:5, having the mutant -I181*+G182*+V59A+E129V+K177L+R179S+Q254S+M284V+V212T+Y268G+N293Y+T297N+A184Q+E188P+T191N+N193F+S242Y+K279I;

[0491] - Thermostable xylanase-resistant to metal ions, more preferably having at least 80%, at least 85%, at least 90%, or at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% identity with the amino acid sequence of the mature polypeptide of SEQ ID NO:2; and

[0492] - A thermostable protease having an amino acid sequence identity of at least 80%, at least 85%, at least 90%, or at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% with the mature polypeptide of SEQ ID NO:11;

[0493] ii) Saccharification using glucosyl amylase;

[0494] iii) Fermentation using fermenting organisms.

[0495] In a preferred embodiment, the method of the present invention includes the following steps:

[0496] i) Use the following liquefied starch-containing materials at a pH range of greater than 4.0 to 6.5 and at a temperature between 80°C and 95°C:

[0497] -α-amylase, preferably thermostable bacterial α-amylase, more preferably α-amylase having at least 80%, at least 85%, at least 90%, or at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% identity with the amino acid sequence of amino acids 1 to 491 of SEQ ID NO:5, having the mutant -I181*+G182*+V59A+E129V+K177L+R179S+Q254S+M284V+V212T+Y268G+N293Y+T297N+A184Q+E188P+T191N+N193F+S242Y+K279I;

[0498] - Thermostable xylanase-resistant to metal ions, more preferably having at least 80%, at least 85%, at least 90%, or at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% identity with the amino acid sequence of the mature polypeptide of SEQ ID NO:3; and

[0499] - A thermostable protease having an amino acid sequence identity of at least 80%, at least 85%, at least 90%, or at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% with the mature polypeptide of SEQ ID NO:11;

[0500] ii) Saccharification using glucosyl amylase; and

[0501] iii) Fermentation using fermenting organisms.

[0502] In a preferred embodiment, the method of the present invention includes the following steps:

[0503] i) Use the following liquefied starch-containing materials at a pH range of greater than 4.0 to 6.5 and at a temperature between 80°C and 95°C:

[0504] -α-amylase, preferably thermostable bacterial α-amylase, more preferably α-amylase having at least 80%, at least 85%, at least 90%, or at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% identity with the amino acid sequence of amino acids 1 to 491 of SEQ ID NO:5, having the mutant -I181*+G182*+V59A+E129V+K177L+R179S+Q254S+M284V+V212T+Y268G+N293Y+T297N+A184Q+E188P+T191N+N193F+S242Y+K279I;

[0505] - Thermostable xylanase-resistant to metal ions, more preferably having at least 80%, at least 85%, at least 90%, or at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% identity with the amino acid sequence of the mature polypeptide of SEQ ID NO:3; and

[0506] A thermostable protease having an amino acid sequence that is at least 80%, at least 85%, at least 90%, or at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% identical to the mature polypeptide of SEQ ID NO:11;

[0507] ii) Saccharification using glucosyl amylase; and

[0508] iii) Fermentation using fermenting organisms.

[0509] In a preferred embodiment, the method of the present invention includes the following steps:

[0510] i) Use the following liquefied starch-containing materials at a pH range of greater than 4.0 to 6.5 and at a temperature between 80°C and 95°C:

[0511] -α-amylase, preferably thermostable bacterial α-amylase, more preferably α-amylase having at least 80%, at least 85%, at least 90%, or at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% identity with the amino acid sequence of amino acids 1 to 491 of SEQ ID NO:5, having the mutant -I181*+G182*+V59A+E129V+K177L+R179S+Q254S+M284V+V212T+Y268G+N293Y+T297N+A184Q+E188P+T191N+N193F+S242Y+K279I;

[0512] - Thermostable xylanase-resistant to metal ions, more preferably having at least 80%, at least 85%, at least 90%, or at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% identity with the amino acid sequence of the mature polypeptide of SEQ ID NO:4; and

[0513] - A thermostable protease having an amino acid sequence identity of at least 80%, at least 85%, at least 90%, or at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% with the mature polypeptide of SEQ ID NO:11;

[0514] ii) Saccharification using glucosyl amylase;

[0515] iii) Fermentation using fermenting organisms.

[0516] In a preferred embodiment, the method of the present invention includes the following steps:

[0517] i) Use the following liquefied starch-containing materials at a pH range of greater than 4.0 to 6.5 and at a temperature between 80°C and 95°C:

[0518] -α-amylase, preferably thermostable bacterial α-amylase, more preferably α-amylase having at least 80%, at least 85%, at least 90%, or at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% identity with the amino acid sequence of amino acids 1 to 491 of SEQ ID NO:5, having the mutant -I181*+G182*+V59A+E129V+K177L+R179S+Q254S+M284V+V212T+Y268G+N293Y+T297N+A184Q+E188P+T191N+N193F+S242Y+K279I;

[0519] - Thermostable xylanase-resistant to metal ions, more preferably having at least 80%, at least 85%, at least 90%, or at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% identity with the amino acid sequence of the mature polypeptide of SEQ ID NO:4; and

[0520] - A thermostable protease having an amino acid sequence identity of at least 80%, at least 85%, at least 90%, or at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% with the mature polypeptide of SEQ ID NO:11;

[0521] ii) Saccharification using glucosyl amylase; and

[0522] iii) Fermentation using fermenting organisms.

[0523] In a preferred embodiment, the method of the present invention includes the following steps:

[0524] i) Use the following liquefied starch-containing materials at a pH range of greater than 4.0 to 6.5 and at a temperature between 80°C and 95°C:

[0525] -α-amylase, preferably thermostable bacterial α-amylase, more preferably α-amylase having at least 80%, at least 85%, at least 90%, or at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% identity with the amino acid sequence of amino acids 1 to 491 of SEQ ID NO:5, having the mutant -I181*+G182*+V59A+E129V+K177L+R179S+Q254S+M284V+V212T+Y268G+N293Y+T297N+A184Q+E188P+T191N+N193F+S242Y+K279I;

[0526] - Thermostable xylanase-resistant to metal ions, more preferably having at least 80%, at least 85%, at least 90%, or at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% identity with the amino acid sequence of the mature polypeptide of SEQ ID NO:2; and

[0527] - A thermostable protease having an amino acid sequence that is at least 80%, at least 85%, at least 90%, or at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% identical to the mature polypeptides of SEQ ID NO:26, SEQ ID NO:27, SEQ ID NO:28, and SEQ ID NO:29.

[0528] ii) Saccharification using glucosyl amylase; and

[0529] iii) Fermentation using fermenting organisms.

[0530] In a preferred embodiment, the method of the present invention includes the following steps:

[0531] i) Use the following liquefied starch-containing materials at a pH range of greater than 4.0 to 6.5 and at a temperature between 80°C and 95°C:

[0532] -α-amylase, preferably thermostable bacterial α-amylase, more preferably α-amylase having at least 80%, at least 85%, at least 90%, or at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% identity with the amino acid sequence of amino acids 1 to 491 of SEQ ID NO:5, having the mutant -I181*+G182*+V59A+E129V+K177L+R179S+Q254S+M284V+V212T+Y268G+N293Y+T297N+A184Q+E188P+T191N+N193F+S242Y+K279I;

[0533] - Thermostable xylanase-resistant to metal ions, more preferably having at least 80%, at least 85%, at least 90%, or at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% identity with the amino acid sequence of the mature polypeptide of SEQ ID NO:2; and

[0534] - A thermostable protease having an amino acid sequence that is at least 80%, at least 85%, at least 90%, or at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% identical to the mature polypeptides of SEQ ID NO:26, SEQ ID NO:27, SEQ ID NO:28, and SEQ ID NO:29.

[0535] ii) Saccharification using glucosyl amylase; and

[0536] iii) Fermentation using fermenting organisms.

[0537] In a preferred embodiment, the method of the present invention includes the following steps:

[0538] i) Use the following liquefied starch-containing materials at a pH range of greater than 4.0 to 6.5 and at a temperature between 80°C and 95°C:

[0539] -α-amylase, preferably thermostable bacterial α-amylase, more preferably α-amylase having at least 80%, at least 85%, at least 90%, or at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% identity with the amino acid sequence of amino acids 1 to 491 of SEQ ID NO:5, having the mutant -I181*+G182*+V59A+E129V+K177L+R179S+Q254S+M284V+V212T+Y268G+N293Y+T297N+A184Q+E188P+T191N+N193F+S242Y+K279I;

[0540] - Thermostable xylanase-resistant to metal ions, more preferably having at least 80%, at least 85%, at least 90%, or at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% identity with the amino acid sequence of the mature polypeptide of SEQ ID NO:3; and

[0541] - A thermostable protease having an amino acid sequence that is at least 80%, at least 85%, at least 90%, or at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% identical to the mature polypeptides of SEQ ID NO:26, SEQ ID NO:27, SEQ ID NO:28, and SEQ ID NO:29.

[0542] ii) Saccharification using glucosyl amylase; and

[0543] iii) Fermentation using fermenting organisms.

[0544] In a preferred embodiment, the method of the present invention includes the following steps:

[0545] i) Use the following liquefied starch-containing materials at a pH range of greater than 4.0 to 6.5 and at a temperature between 80°C and 95°C:

[0546] -α-amylase, preferably thermostable bacterial α-amylase, more preferably α-amylase having at least 80%, at least 85%, at least 90%, or at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% identity with the amino acid sequence of amino acids 1 to 491 of SEQ ID NO:5, having the mutant -I181*+G182*+V59A+E129V+K177L+R179S+Q254S+M284V+V212T+Y268G+N293Y+T297N+A184Q+E188P+T191N+N193F+S242Y+K279I;

[0547] - Thermostable xylanase-resistant to metal ions, more preferably having at least 80%, at least 85%, at least 90%, or at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% identity with the amino acid sequence of the mature polypeptide of SEQ ID NO:3; and

[0548] Thermostable protease having an amino acid sequence that is at least 80%, at least 85%, at least 90%, or at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% identical to the mature polypeptides of SEQ ID NO:26, SEQ ID NO:27, SEQ ID NO:28, and SEQ ID NO:29.

[0549] ii) Saccharification using glucosyl amylase; and

[0550] iii) Fermentation using fermenting organisms.

[0551] In a preferred embodiment, the method of the present invention includes the following steps:

[0552] i) Use the following liquefied starch-containing materials at a pH range of greater than 4.0 to 6.5 and at a temperature between 80°C and 95°C:

[0553] -α-amylase, preferably thermostable bacterial α-amylase, more preferably α-amylase having at least 80%, at least 85%, at least 90%, or at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% identity with the amino acid sequence of amino acids 1 to 491 of SEQ ID NO:5, having the mutant -I181*+G182*+V59A+E129V+K177L+R179S+Q254S+M284V+V212T+Y268G+N293Y+T297N+A184Q+E188P+T191N+N193F+S242Y+K279I;

[0554] - Thermostable xylanase-resistant to metal ions, more preferably having at least 80%, at least 85%, at least 90%, or at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% identity with the amino acid sequence of the mature polypeptide of SEQ ID NO:4; and

[0555] - A thermostable protease having an amino acid sequence that is at least 80%, at least 85%, at least 90%, or at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% identical to the mature polypeptides of SEQ ID NO:26, SEQ ID NO:27, SEQ ID NO:28, and SEQ ID NO:29.

[0556] ii) Saccharification using glucosyl amylase; and

[0557] iii) Fermentation using fermenting organisms.

[0558] In a preferred embodiment, the method of the present invention includes the following steps:

[0559] i) Use the following liquefied starch-containing materials at a pH range of greater than 4.0 to 6.5 and at a temperature between 80°C and 95°C:

[0560] -α-amylase, preferably thermostable bacterial α-amylase, more preferably α-amylase having at least 80%, at least 85%, at least 90%, or at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% identity with the amino acid sequence of amino acids 1 to 491 of SEQ ID NO:5, having the mutant -I181*+G182*+V59A+E129V+K177L+R179S+Q254S+M284V+V212T+Y268G+N293Y+T297N+A184Q+E188P+T191N+N193F+S242Y+K279I;

[0561] - Thermostable xylanase-resistant to metal ions, more preferably having at least 80%, at least 85%, at least 90%, or at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% identity with the amino acid sequence of the mature polypeptide of SEQ ID NO:4; and

[0562] - A thermostable protease having an amino acid sequence that is at least 80%, at least 85%, at least 90%, or at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% identical to the mature polypeptides of SEQ ID NO:26, SEQ ID NO:27, SEQ ID NO:28, and SEQ ID NO:29.

[0563] ii) Saccharification using glucosyl amylase; and

[0564] iii) Fermentation using fermenting organisms.

[0565] In a preferred embodiment, a combination of cellulase or cellulolytic enzyme is present and / or added during fermentation or simultaneous saccharification and fermentation.

[0566] In a preferred embodiment, a combination of cellulase or cellulolytic enzymes derived from Trichoderma reesei is present and / or added during fermentation or simultaneous saccharification and fermentation (SSF).

[0567] In a preferred embodiment, cellulase or a combination of cellulase and glucosylamylase are present and / or added during fermentation or simultaneous saccharification and fermentation.

[0568] In one embodiment, the cellulase or cellulolytic enzyme composition is derived from Trichoderma reesei, Pyroderma spp., Lukenowens spp., or Penicillium spp.

[0569] The composition of the present invention

[0570] The compositions of the present invention comprise α-amylase, such as thermostable α-amylase, and xylanase, which is resistant to metal ion inhibition during liquefaction of starch-containing materials and has a melting point (DSC) greater than 80°C; optional endoglucanase having a melting point (DSC) greater than 70°C; and optional protease (such as thermostable protease). The compositions further comprise carbohydrate-producing enzymes, particularly glucosylamylase, optionally pullulanase, and optionally phytase.

[0571] Therefore, in this respect, the present invention relates to compositions comprising:

[0572] -α-amylase;

[0573] - Xylanase, which is resistant to the inhibition of metal ions when liquefying starch-containing materials, and further has a melting point (DSC) greater than 80°C;

[0574] - Optional endoglucanase with a melting point (DSC) greater than 70°C;

[0575] -Optionally, protease;

[0576] -Optionally, enzymes that produce carbohydrate sources.

[0577] α-Amylase: The α-amylase can be any α-amylase. In a preferred embodiment, the α-amylase is a bacterial α-amylase, such as an α-amylase derived from the genus Bacillus (e.g., Bacillus stearothermophilus), preferably the α-amylase shown in SEQ ID NO:5 herein.

[0578] The α-amylase can be a thermostable α-amylase. This thermostable α-amylase can have a T1 / 2 (min) of at least 10 at pH 4.5, 85°C, and 0.12 mM CaCl2, such as at least 15, at least 20, at least 25, at least 30, at least 40, at least 50, at least 60, between 10 and 70, between 15 and 70, between 20 and 70, between 25 and 70, between 30 and 70, between 40 and 70, between 50 and 70, or between 60 and 70.

[0579] In one embodiment, the α-amylase is selected from the group consisting of variants of Bacillus stearothermophilus α-amylase, particularly those with mutations selected from the group truncated to a length of 491 amino acids (e.g., from 480 to 495 amino acids):

[0580] -I181*+G182*;

[0581] -I181*+G182*+N193F;

[0582] Preferably

[0583] -I181*+G182*+E129V+K177L+R179E;

[0584] -I181*+G182*+N193F+E129V+K177L+R179E;

[0585] -I181*+G182*+N193F+V59A+Q89R+E129V+K177L+R179E+H208Y+K220P+N224L+Q254S;

[0586] -I181*+G182*+N193F+E129V+K177L+R179E;

[0587] -N193F+V59A+Q89R+E129V+K177L+R179E+H208Y+K220P+N224L+Q254S;

[0588] -N193F+V59A+Q89R+E129V+K177L+R179E+Q254S+M284V;

[0589] -N193F+V59A+E129V+K177L+R179E+Q254S+M284V;

[0590] -N193F+E129V+K177L+R179E+K220P+N224L+S242Q+Q254S;

[0591] -V59A+E129V+K177L+R179E+Q254S+M284V+V212T+Y268G+N293Y+T297N;

[0592] -V59A+E129V+K177L+R179E+Q254S+M284V+V212T+Y268G+N293Y+T297N+S173N+E188P+H208Y+S242Y+K279I;

[0593] -V59A+E129V+K177L+R179S+Q254S+M284V+V212T+Y268G+N293Y+T297N+A184Q+E188P+T191N;

[0594] -V59A+E129V+K177L+R179S+Q254S+M284V+V212T+Y268G+N293Y+T297N+A184Q+E188P+T191N+S242Y+K279I;

[0595] -V59A+E129V+K177L+R179S+Q254S+M284V+V212T+Y268G+N293Y+T297N+A184Q+E188P+T191N+N193F+S242Y+K279I;

[0596] -V59A+E129V+K177L+R179E+Q254S+M284V+V212T+Y268G+N293Y+T297N+E188P+K279W;

[0597] -V59A+E129V+K177L+R179E+Q254S+M284V+V212T+Y268G+N293Y+T297N+W115D+D117Q+T133P;

[0598] -I181*+G182*+N193F+V59A Q89R+E129V+K177L+R179E+Q254S+M284V; and

[0599] -I181*+G182*+N193F+E129V+K177L+R179E+K220P+N224L+S242Q+Q254S (numbered using SEQ ID NO:5 in this document).

[0600] It should be understood that these α-amylases are merely specific examples. Any α-amylase disclosed in the "α-amylases present and / or added during liquefaction" section above may be used as the α-amylase component in the compositions of the present invention.

[0601] Endoglucanase: According to the invention, an optional endoglucanase component may be included in the composition. This may be any endoglucanase having a melting point (DSC) greater than 70°C, such as greater than 75°C, particularly greater than 80°C, such as between 70°C and 95°C, as determined by differential scanning calorimetry (DSC) as described in the “Materials and Methods” section below.

[0602] In one embodiment, the endoglucanase has a melting point (DSC) greater than 72°C, such as greater than 74°C, such as greater than 76°C, such as greater than 78°C, such as greater than 80°C, such as greater than 82°C, such as greater than 84°C, such as greater than 86°C, such as greater than 88°C, such as between 70°C and 95°C, such as between 76°C and 94°C, such as between 78°C and 93°C, such as between 80°C and 92°C, such as between 82°C and 91°C, such as between 84°C and 90°C.

[0603] In a preferred embodiment, the endoglucanase included in the composition of the invention and used in the method of the invention is a glycoside hydrolase family 5 endoglucanase or GH5 endoglucanase (see in "..."). www.cazy.org (CAZy database of the website). In one embodiment, the GH5 endoglucanase is derived from family EG II, such as the *Basilella raseseri* endoglucanase shown in SEQ ID NO:7 herein; the *Penicillium capsulee* endoglucanase shown in SEQ ID NO:22 herein; and the *Plasmodium chrysospora* endoglucanase shown in SEQ ID NO:23 herein.

[0604] In one embodiment, the endoglucanase is a GH45 endoglucanase. In one embodiment, the GH45 endoglucanase is derived from the EG V family, such as *Cladosporium foetida* as shown in SEQ ID NO:25 herein or *Cladosporium terrestrialum* as shown in SEQ ID NO:24 herein.

[0605] In one embodiment, the endoglucanase has at least 60%, such as at least 70%, such as at least 75%, preferably at least 80%, more preferably at least 85%, more preferably at least 90%, more preferably at least 91%, more preferably at least 92%, even more preferably at least 93%, most preferably at least 94%, and even most preferably at least 95%, such as even at least 96%, at least 97%, at least 98%, at least 99%, such as 100%, identity with the mature portion of the polypeptide of SEQ ID NO:7 herein. In one embodiment, the endoglucanase is derived from a strain of the genus *Basilella*, such as *Basilella repens*.

[0606] In one embodiment, the endoglucanase has at least 60%, such as at least 70%, such as at least 75%, preferably at least 80%, more preferably at least 85%, more preferably at least 90%, more preferably at least 91%, more preferably at least 92%, even more preferably at least 93%, most preferably at least 94%, and even most preferably at least 95%, such as even at least 96%, at least 97%, at least 98%, at least 99%, such as 100%, identity with the mature portion of the polypeptide of SEQ ID NO:22 herein, preferably derived from a strain of Penicillium, such as a strain of Penicillium capsuleum.

[0607] In one embodiment, the endoglucanase has at least 60%, such as at least 70%, such as at least 75%, preferably at least 80%, more preferably at least 85%, more preferably at least 90%, more preferably at least 91%, more preferably at least 92%, even more preferably at least 93%, most preferably at least 94%, and even most preferably at least 95%, such as even at least 96%, at least 97%, at least 98%, at least 99%, such as 100%, identity with the mature portion of the polypeptide of SEQ ID NO:23 herein, preferably derived from a strain of the genus Trichophaea, such as a strain of Trichophaea brownis.

[0608] In one embodiment, the endoglucanase has at least 60%, such as at least 70%, such as at least 75%, preferably at least 80%, more preferably at least 85%, more preferably at least 90%, more preferably at least 91%, more preferably at least 92%, even more preferably at least 93%, most preferably at least 94%, and even most preferably at least 95%, such as even at least 96%, at least 97%, at least 98%, at least 99%, such as 100%, identity with the mature portion of the polypeptide of SEQ ID NO:24 herein, preferably derived from a strain of the genus *Clostridium*, such as a strain of *Clostridium terreum*.

[0609] In one embodiment, the endoglucanase has at least 60%, such as at least 70%, such as at least 75%, preferably at least 80%, more preferably at least 85%, more preferably at least 90%, more preferably at least 91%, more preferably at least 92%, even more preferably at least 93%, most preferably at least 94%, and even most preferably at least 95%, such as even at least 96%, at least 97%, at least 98%, at least 99%, such as 100%, identity with the mature portion of the polypeptide of SEQ ID NO:25 herein, preferably derived from a strain of the genus *Ceratophyllum*, such as a strain of *Ceratophyllum commune*.

[0610] It should be understood that these endoglucanases are merely specific examples. Any endoglucanase disclosed in the "Thermostable Endoglucanases Present and / or Added During Liquefaction" section above may be used as an optional endoglucanase component in the compositions of the present invention.

[0611] In a particularly preferred embodiment, the endoglucanase (EG) has at least 90% identity with the mature portion of the polypeptide of SEQ ID NO:7 herein, is derived from a strain of *Basilella repens*, and has a melting point (DSC) greater than 80°C.

[0612] Protease: The compositions of the present invention may optionally contain a protease, such as a thermostable protease. There are no limitations on the origin of the protease component, provided that it meets the thermostable properties defined herein.

[0613] In one embodiment, the protease is of fungal origin. In one embodiment, the protease is a metalloproteinase. In one embodiment, the protease is derived from the orange thermophilic ascomycete shown in SEQ ID NO:6 herein.

[0614] In a preferred embodiment, the protease is a variant of the thermophilic ascomycete protease mentioned above, having a thermal stability value of more than 20% of the relative activity at 80°C / 70°C, as determined in Example 2 of US-2018-0371505 (which describes the determination of the determination of thermal stability, particularly as described in Example 2, and is hereby incorporated by reference).

[0615] In a particular preferred embodiment, the protease is a variant of a metalloproteinase derived from *Thermophilus orangeus*, disclosed as the mature portion of SEQ ID NO:2 disclosed in WO 2003 / 048353 or the mature portion of SEQ ID NO:1 in WO 2010 / 008841 or SEQ ID NO:6 herein, having a mutation selected from the group consisting of:

[0616] -D79L+S87P+A112P+D142L;

[0617] -D79L+S87P+D142L; and

[0618] -A27K+D79L+Y82F+S87G+D104P+A112P+A126V+D142L.

[0619] In another embodiment, the protease is a bacterial protease. In another embodiment, the protease is a serine protease. In a preferred embodiment, the serine protease is derived from a strain of *Porcine contaminant*, such as the serine protease shown in SEQ ID NO:1 of US 6,358,726 or SEQ ID NO:11 herein, or related to SEQ ID NO. The amino acid sequence of NO:1 has at least 60%, such as at least 70%, such as at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, preferably at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, more preferably at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, more preferably at least 90%, more preferably at least 91%, more preferably at least 92%, at least 93%, at least 94%, or at least 95%, such as at least 96%, at least 97%, at least 98%, at least 99%, as a serine protease. In one embodiment, the serine protease is derived from a strain of the genus *Schizophyllum*, such as the serine protease shown in SEQ ID NO:26 herein, or a serine protease having at least 60%, such as at least 70%, such as at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, preferably at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, more preferably at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, more preferably at least 90%, more preferably at least 91%, more preferably at least 92%, at least 93%, at least 94%, or at least 95%, such as at least 96%, at least 97%, at least 98%, at least 99%.In one embodiment, the protease is derived from a strain of the genus *Thermolyticus*, such as the *Thermolyticus brownii* protease shown in SEQ ID NO:27 herein (referred to as SEQ ID NO:8 in WO 2018 / 118815 A1, the entire contents of which are incorporated herein by reference) or related to SEQ ID NO:27. The amino acid sequence of NO:27 has at least 60%, such as at least 70%, such as at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, preferably at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, more preferably at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, more preferably at least 90%, more preferably at least 91%, more preferably at least 92%, at least 93%, at least 94%, or at least 95%, such as at least 96%, at least 97%, at least 98%, at least 99%, as a protease. In one embodiment, the protease is derived from a strain of the genus *Thermobifida*, such as the halophilic thermophilic protease *Thermobifida halotolerans* shown in SEQ ID NO:28 herein (referred to as SEQ ID NO:10 in WO 2018 / 118815A1, the entire contents of which are incorporated herein by reference) or related to SEQ ID NO:28. The amino acid sequence of NO:28 has at least 60%, such as at least 70%, such as at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, preferably at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, more preferably at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, more preferably at least 90%, more preferably at least 91%, more preferably at least 92%, at least 93%, at least 94%, or at least 95%, such as at least 96%, at least 97%, at least 98%, at least 99%, as a protease.In one embodiment, the protease is derived from a strain of the genus *Thermococcus*, such as the *Thermococcus nautili* protease shown in SEQ ID NO:29 herein (referred to as SEQ ID NO:3 in WO2018 / 169780A1, the entire contents of which are incorporated herein by reference) or related to SEQ ID NO:29. The amino acid sequence of NO:29 has at least 60%, such as at least 70%, such as at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, preferably at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, more preferably at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, more preferably at least 90%, more preferably at least 91%, more preferably at least 92%, at least 93%, at least 94%, or at least 95%, such as at least 96%, at least 97%, at least 98%, at least 99%, as a protease.

[0620] It should be understood that these proteases are merely examples. Any proteases disclosed in the "Proteases Present and / or Added During Liquefaction" section above may be used as a protease component in the compositions of the present invention.

[0621] Enzymes that produce carbohydrates: The compositions of the present invention may optionally further comprise a carbohydrate-producing enzyme, particularly a glucosylamylase (such as a thermostable glucosylamylase), which has a thermostability of at least 30% (preferably at least 35%) at 85°C and pH 5.3.

[0622] The carbohydrate-producing enzyme may be a thermostable glucosylamylase having a relative activity thermostability of at least 20%, at least 30%, preferably at least 35% at 85°C, as determined as described in Example 4 (Thermal Stability).

[0623] In one embodiment, the carbohydrate-producing enzyme is glucosylamylase, which has a relative activity of at least 90%, preferably at least 95%, preferably at least 97%, such as 100%, at a pH optimum of pH 5.0, as determined as described in Example 4 (pH optimum).

[0624] In one embodiment, the carbohydrate-producing enzyme is glucosylamylase, which has a pH stability of at least 80%, at least 85%, and at least 90% at pH 5.0, as determined as described in Example 4 (pH stability).

[0625] In a preferred embodiment, the carbohydrate-producing enzyme is a thermostable glucoamylase, preferably of fungal origin, preferably filamentous fungi, such as strains from the genus Penicillium, especially strains of Penicillium oxalate or variants thereof disclosed in WO 2011 / 127802 (which is hereby incorporated by reference) as SEQ ID NO:2 and SEQ ID NO:12 herein.

[0626] In one embodiment, the glucosylamylase or a variant thereof may have at least 80%, more preferably at least 85%, more preferably at least 90%, more preferably at least 91%, more preferably at least 92%, even more preferably at least 93%, most preferably at least 94%, and even most preferably at least 95%, such as even at least 96%, at least 97%, at least 98%, at least 99%, such as 100% identity with the mature polypeptide shown in SEQ ID NO:2 of WO 2011 / 127802 or SEQ ID NO:12 herein.

[0627] In a specific and preferred embodiment, the carbohydrate-producing enzyme is a variant of Penicillium oxalate glucosyl amylase disclosed in WO 2011 / 127802 as shown in SEQ ID NO:2 and herein as shown in SEQ ID NO:12, which has a K79V substitution (the mature sequence shown herein as shown in SEQ ID NO:12 is used for numbering). As disclosed in WO 2013 / 036526 (which is hereby incorporated by reference), this K79V glucosyl amylase variant has reduced sensitivity to protease degradation relative to its parent.

[0628] Examples of suitable thermostable Penicillium oxalate glucoamylase variants are listed above.

[0629] In one embodiment, the carbohydrate-producing enzyme, such as glucosylamylase or penicillium oxalate glucosylamylase, has pullulanase paraactivity.

[0630] It should be understood that these carbohydrate-producing enzymes, particularly glucosylamylase, are merely examples. Any carbohydrate-producing enzyme disclosed in the "Carbohydrate-producing enzymes present and / or added during liquefaction" section above may be used as a component in the compositions of the present invention.

[0631] In a preferred embodiment, the carbohydrate-producing enzyme is the penicillin oxalate glucoamylase shown in SEQ ID NO:12 herein, or a sequence having at least 90% identity with a further K79V-substituted enzyme.

[0632] pullulanase: The compositions of the present invention may optionally further comprise pullulanase. The pullulanase may be from any source.

[0633] In one embodiment, the pullulanase is bacterial in origin. In another embodiment, the pullulanase is derived from a strain of a Bacillus species.

[0634] In one embodiment, the pullulanase is a GH57 pullulanase. In a preferred embodiment, the pullulanase includes the X47 domain as disclosed in WO 2011 / 087836 (which is hereby incorporated by reference).

[0635] Specifically, the pullulanase can be derived from strains of the genus *Thermococcus*, including *Thermococcus scutellatus* and *Thermococcus hydrophilus*, or hybrids thereof.

[0636] Pullulanase may be the thermococcal pullulanase truncated at site X4 as shown in SEQ ID NO:9 herein, or the thermococcal / seaside thermococcal hybrid enzyme with truncated site X4 as disclosed in WO 2011 / 087836 (SEQ ID NO:10 herein).

[0637] In another embodiment, the pullulanase is a pullulanase that includes the X46 domain disclosed in WO 2011 / 076123 (Novozymes).

[0638] It should be understood that these pullulanases are merely specific examples. Any pullulanase disclosed in the "Pullulanases Present or Added During Liquefaction" section above may be used as an optional pullulanase component in the compositions of the present invention.

[0639] Phytase: The compositions of the present invention may optionally further comprise phytase. The phytase may be from any source.

[0640] In one embodiment, the phytase is bacterial in origin. In one embodiment, the phytase is derived from a strain of the genus *Buchuria*, such as *Buchuria bugavani* strain disclosed in WO2008 / 092901 (amino acids 1-33 are expected to be the signal peptide); or *Buchuria sylvatica* strain shown in WO2008 / 092901 (SEQ ID NO:4, amino acids -9 to -1 are expected to be the signal peptide portion); or *Buchuria noaculosa* strain shown in WO2008 / 092901 (SEQ ID NO:6).

[0641] In another embodiment, the phytase is derived from a strain of the genus Citrobacter, such as a strain of Citrobacter brycetes, such as the strain disclosed in WO 2006 / 037328 (which is hereby incorporated by reference) with SEQ ID NO:2 or 4.

[0642] It should be understood that these phytases are merely specific examples. Any phytase disclosed in the "Phytases Present and / or Added During Liquefaction" section above may be used as an optional phytase component in the compositions of the present invention.

[0643] In a preferred embodiment, the phytase is derived from strains of the genus *Buchuria*.

[0644] Examples of preferred embodiments of the compositions of the present invention

[0645] In a preferred embodiment, the composition of the present invention comprises

[0646] - α-amylase derived from Bacillus stearothermophilus;

[0647] - Xylanase, which is resistant to the inhibition of metal ions when liquefying starch-containing materials, and further has a melting point (DSC) greater than 80°C;

[0648] - Optional endoglucanase with a melting point (DSC) greater than 70°C (e.g., between 70°C and 95°C);

[0649] - Optionally, a protease having a thermostability value exceeding 20% ​​with relative activity at 80°C / 70°C, derived from *Pomacea canaliculata* or *Thermophilus orangeus*; and

[0650] -Optionally, glucosylamylase, such as glucosylamylase derived from Penicillium oxalate.

[0651] In another embodiment, the composition of the present invention comprises

[0652] -α-amylase, preferably derived from thermophilic Bacillus stearothermophilus, has a T1 / 2 (min) of at least 10 at pH 4.5, 85°C, and 0.12 mM CaCl2;

[0653] - Xylanase, which is resistant to the inhibition of metal ions when liquefying starch-containing materials, and further has a melting point (DSC) greater than 80°C;

[0654] - Optional endoglucanase with a melting point (DSC) between 70°C and 95°C;

[0655] - Optional protease, preferably derived from *Porciniella fibrillariae* or *Thermophilus orangeus*, having a thermostability value exceeding 20% ​​with relative activity at 80°C / 70°C; and

[0656] -Optionally, glucosyl amylase, for example, derived from Penicillium oxalate.

[0657] In another embodiment, the composition of the present invention comprises

[0658] - An α-amylase derived from Bacillus stearothermophilus, having a double deletion at position I181+G182, and optionally the substitution N193F; and optionally another from the following set of substitutions:

[0659] -I181*+G182*+E129V+K177L+R179E;;

[0660] -I181*+G182*+N193F+E129V+K177L+R179E;

[0661] -I181*+G182*+N193F+V59A+Q89R+E129V+K177L+R179E+H208Y+K220P+N224L+Q254S;

[0662] -I181*+G182*+N193F+E129V+K177L+R179E;

[0663] -N193F+V59A+Q89R+E129V+K177L+R179E+H208Y+K220P+N224L+Q254S;

[0664] -N193F+V59A+Q89R+E129V+K177L+R179E+Q254S+M284V;

[0665] -N193F+V59A+E129V+K177L+R179E+Q254S+M284V;

[0666] -N193F+E129V+K177L+R179E+K220P+N224L+S242Q+Q254S;

[0667] -V59A+E129V+K177L+R179E+Q254S+M284V+V212T+Y268G+N293Y+T297N;

[0668] -V59A+E129V+K177L+R179E+Q254S+M284V+V212T+Y268G+N293Y+T297N+S173N+E188P+H208Y+S242Y+K279I;

[0669] -V59A+E129V+K177L+R179S+Q254S+M284V+V212T+Y268G+N293Y+T297N+A184Q+E188P+T191N;

[0670] -V59A+E129V+K177L+R179S+Q254S+M284V+V212T+Y268G+N293Y+T297N+A184Q+E188P+T191N+S242Y+K279I;

[0671] -V59A+E129V+K177L+R179S+Q254S+M284V+V212T+Y268G+N293Y+T297N+A184Q+E188P+T191N+N193F+S242Y+K279I;

[0672] -V59A+E129V+K177L+R179E+Q254S+M284V+V212T+Y268G+N293Y+T297N+E188P+K279W;

[0673] -V59A+E129V+K177L+R179E+Q254S+M284V+V212T+Y268G+N293Y+T297N+W115D+D117Q+T133P;

[0674] -I181*+G182*+N193F+V59A Q89R+E129V+K177L+R179E+Q254S+M284V; and

[0675] -I181*+G182*+N193F+E129V+K177L+R179E+K220P+N224L+S242Q+Q254S (numbered using SEQ ID NO:5 in this document);

[0676] - Xylanase, which is resistant to the inhibition of metal ions when liquefying starch-containing materials, and further has a melting point (DSC) greater than 80°C;

[0677] - Optional endoglucanase with a melting point (DSC) greater than 70°C;

[0678] - Optionally, the protease, preferably derived from *Porciniella fibrillariae* and / or *Thermophilus orangeus*, has a thermostability value exceeding 20% ​​with relative activity at 80°C / 70°C; and

[0679] -Optionally, the SEQ ID NO:12 penicillium oxalate glucoamylase has substitutions selected from the group consisting of:

[0680] -K79V;

[0681] -K79V+P11F+T65A+Q327F; or

[0682] -K79V+P2N+P4S+P11F+T65A+Q327F; or

[0683] -K79V+P11F+D26C+K33C+T65A+Q327F; or

[0684] -K79V+P2N+P4S+P11F+T65A+Q327W+E501V+Y504T; or

[0685] -K79V+P2N+P4S+P11F+T65A+Q327F+E501V+Y504T; or

[0686] -K79V+P11F+T65A+Q327W+E501V+Y504T (using SEQ ID NO:12 for numbering).

[0687] In one embodiment, the thermophilic Bacillus stearothermophilus α-amylase (SEQ ID NO:5 herein) or a variant thereof is a mature α-amylase or a corresponding mature α-amylase having at least 80% identity, at least 90% identity, at least 95% identity, at least 96% identity, at least 97% identity, or at least 99% identity with SEQ ID NO:5 herein.

[0688] In one embodiment, the xylanase (such as xylanase from the genus Thermophyton) has a melting point (DSC) greater than 82°C, such as greater than 84°C, such as greater than 86°C, such as greater than 88°C, such as greater than 88°C, such as greater than 90°C, such as greater than 92°C, such as greater than 94°C, such as greater than 96°C, such as greater than 98°C, such as greater than 100°C, such as between 80°C and 110°C, such as between 82°C and 110°C, such as between 84°C and 110°C.

[0689] Examples of suitable thermostable xylanases, particularly xylanases from the genus *Thermophyton*, include the xylanase shown in SEQ ID NO:2, for example, from strains of *Thermophyton nautiloides*; the xylanase shown in SEQ ID NO:3, for example, from strains of *Thermophyton nautiloides*; the xylanase shown in SEQ ID NO:5, for example, from strains of *Thermophyton nautiloides*; or those respectively associated with SEQ ID... The mature portion of any polypeptide of NO:2, 3 and 4 has at least 60%, such as at least 70%, such as at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, preferably at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, more preferably at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, more preferably at least 90%, more preferably at least 91%, more preferably at least 92%, at least 93%, at least 94%, or at least 95%, such as at least 96%, at least 97%, at least 98%, at least 99%, or as 100% identity.

[0690] In a preferred embodiment, the composition of the present invention comprises: - α-amylase, preferably a thermostable bacterial α-amylase, more preferably an α-amylase having at least 80%, at least 85%, at least 90%, or at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% identity with the amino acid sequence of amino acids 1 to 491 of SEQ ID NO:5, having the mutant I181*+G182*+N193F+V59A+Q89R+E129V+K177L+R179E+Q254S+M284V; - a thermostable xylanase resistant to metal ions, more preferably a thermostable xylanase having at least 80%, at least 85%, at least 90%, or at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% identity with the amino acid sequence of the mature polypeptide of SEQ ID NO:2; and a thermostable protease, having the same amino acid sequence as SEQ ID NO:5. The mature polypeptide of NO:11 has an amino acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% identical.

[0691] In a preferred embodiment, the composition of the present invention comprises - α-amylase, preferably a thermostable bacterial α-amylase, more preferably an α-amylase having at least 80%, at least 85%, at least 90%, or at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% identity with the amino acid sequence of amino acids 1 to 491 of SEQ ID NO:5, having the mutant -I181*+G182*+V59A+E129V+K177L+R179S+Q254S+M284V+V212T+Y268G+N293Y+T297N+A184Q+E188P+T191N+N193F+S242Y+K279I; - thermostable xylanase resistant to metal ions, more preferably with SEQ ID NO:5 The mature polypeptide of NO:2 has an amino acid sequence that is at least 80%, at least 85%, at least 90%, or at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% identical to a thermostable metal ion-resistant xylanase; and a thermostable protease that has an amino acid sequence that is at least 80%, at least 85%, at least 90%, or at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% identical to the mature polypeptide of SEQ ID NO:11.

[0692] In a preferred embodiment, the composition of the present invention comprises - α-amylase, preferably a thermostable bacterial α-amylase, more preferably an α-amylase having at least 80%, at least 85%, at least 90%, or at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% identity with the amino acid sequence of amino acids 1 to 491 of SEQ ID NO:5, having the mutant -I181*+G182*+V59A+E129V+K177L+R179S+Q254S+M284V+V212T+Y268G+N293Y+T297N+A184Q+E188P+T191N+N193F+S242Y+K279I; - thermostable xylanase resistant to metal ions, more preferably with SEQ ID NO:5 The mature polypeptide of NO:2 has an amino acid sequence that is at least 80%, at least 85%, at least 90%, or at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% identical to a thermostable metal ion-resistant xylanase; and a thermostable protease that has an amino acid sequence that is at least 80%, at least 85%, at least 90%, or at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% identical to the mature polypeptide of SEQ ID NO:11.

[0693] In a preferred embodiment, the composition of the present invention comprises - α-amylase, preferably a thermostable bacterial α-amylase, more preferably an α-amylase having at least 80%, at least 85%, at least 90%, or at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% identity with the amino acid sequence of amino acids 1 to 491 of SEQ ID NO:5, having the mutant -I181*+G182*+V59A+E129V+K177L+R179S+Q254S+M284V+V212T+Y268G+N293Y+T297N+A184Q+E188P+T191N+N193F+S242Y+K279I; - thermostable xylanase resistant to metal ions, more preferably with SEQ ID NO:5 The mature polypeptide of NO:3 has an amino acid sequence that is at least 80%, at least 85%, at least 90%, or at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% identical to a thermostable metal ion-resistant xylanase; and a thermostable protease that has an amino acid sequence that is at least 80%, at least 85%, at least 90%, or at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% identical to the mature polypeptide of SEQ ID NO:11.

[0694] In a preferred embodiment, the composition of the present invention comprises - α-amylase, preferably a thermostable bacterial α-amylase, more preferably an α-amylase having at least 80%, at least 85%, at least 90%, or at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% identity with the amino acid sequence of amino acids 1 to 491 of SEQ ID NO:5, having the mutant -I181*+G182*+V59A+E129V+K177L+R179S+Q254S+M284V+V212T+Y268G+N293Y+T297N+A184Q+E188P+T191N+N193F+S242Y+K279I; - thermostable xylanase resistant to metal ions, more preferably with SEQ ID NO:5 The mature polypeptide of NO:3 has an amino acid sequence that is at least 80%, at least 85%, at least 90%, or at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% identical to a thermostable metal ion-resistant xylanase; and a thermostable protease that has an amino acid sequence that is at least 80%, at least 85%, at least 90%, or at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% identical to the mature polypeptide of SEQ ID NO:11.

[0695] In a preferred embodiment, the composition of the present invention comprises - α-amylase, preferably a thermostable bacterial α-amylase, more preferably an α-amylase having at least 80%, at least 85%, at least 90%, or at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% identity with the amino acid sequence of amino acids 1 to 491 of SEQ ID NO:5, having the mutant -I181*+G182*+V59A+E129V+K177L+R179S+Q254S+M284V+V212T+Y268G+N293Y+T297N+A184Q+E188P+T191N+N193F+S242Y+K279I; - thermostable xylanase resistant to metal ions, more preferably with SEQ ID NO:5 The mature polypeptide of NO:4 has an amino acid sequence that is at least 80%, at least 85%, at least 90%, or at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% identical to a thermostable metal ion-resistant xylanase; and a thermostable protease that has an amino acid sequence that is at least 80%, at least 85%, at least 90%, or at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% identical to the mature polypeptide of SEQ ID NO:11.

[0696] In a preferred embodiment, the composition of the present invention comprises - α-amylase, preferably a thermostable bacterial α-amylase, more preferably an α-amylase having at least 80%, at least 85%, at least 90%, or at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% identity with the amino acid sequence of amino acids 1 to 491 of SEQ ID NO:5, having the mutant -I181*+G182*+V59A+E129V+K177L+R179S+Q254S+M284V+V212T+Y268G+N293Y+T297N+A184Q+E188P+T191N+N193F+S242Y+K279I; - thermostable xylanase resistant to metal ions, more preferably with SEQ ID NO:5 The mature polypeptide of NO:4 has an amino acid sequence that is at least 80%, at least 85%, at least 90%, or at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% identical to a thermostable metal ion-resistant xylanase; and a thermostable protease that has an amino acid sequence that is at least 80%, at least 85%, at least 90%, or at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% identical to the mature polypeptide of SEQ ID NO:11.

[0697] In a preferred embodiment, the composition of the present invention comprises - α-amylase, preferably a thermostable bacterial α-amylase, more preferably an α-amylase having at least 80%, at least 85%, at least 90%, or at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% identity with the amino acid sequence of amino acids 1 to 491 of SEQ ID NO:5, having the mutant -I181*+G182*+V59A+E129V+K177L+R179S+Q254S+M284V+V212T+Y268G+N293Y+T297N+A184Q+E188P+T191N+N193F+S242Y+K279I; - thermostable xylanase resistant to metal ions, more preferably with SEQ ID NO:5 The mature polypeptide of NO:2 has an amino acid sequence that is at least 80%, at least 85%, at least 90%, or at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% identical to a thermostable metal ion-resistant xylanase; and a thermostable protease that has an amino acid sequence that is at least 80%, at least 85%, at least 90%, or at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% identical to the mature polypeptide of SEQ ID NO:26, SEQ ID NO:27, SEQ ID NO:28, or SEQ ID NO:29.

[0698] In a preferred embodiment, the composition of the present invention comprises - α-amylase, preferably a thermostable bacterial α-amylase, more preferably an α-amylase having at least 80%, at least 85%, at least 90%, or at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% identity with the amino acid sequence of amino acids 1 to 491 of SEQ ID NO:5, having the mutant -I181*+G182*+V59A+E129V+K177L+R179S+Q254S+M284V+V212T+Y268G+N293Y+T297N+A184Q+E188P+T191N+N193F+S242Y+K279I; - thermostable xylanase resistant to metal ions, more preferably with SEQ ID NO:5 The mature polypeptide of NO:2 has an amino acid sequence that is at least 80%, at least 85%, at least 90%, or at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% identical to a thermostable metal ion-resistant xylanase; and a thermostable protease that has an amino acid sequence that is at least 80%, at least 85%, at least 90%, or at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% identical to the mature polypeptide of SEQ ID NO:26, SEQ ID NO:27, SEQ ID NO:28, or SEQ ID NO:29.

[0699] In a preferred embodiment, the composition of the present invention comprises - α-amylase, preferably a thermostable bacterial α-amylase, more preferably an α-amylase having at least 80%, at least 85%, at least 90%, or at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% identity with the amino acid sequence of amino acids 1 to 491 of SEQ ID NO:5, having the mutant -I181*+G182*+V59A+E129V+K177L+R179S+Q254S+M284V+V212T+Y268G+N293Y+T297N+A184Q+E188P+T191N+N193F+S242Y+K279I; - thermostable xylanase resistant to metal ions, more preferably with SEQ ID NO:5 The mature polypeptide of NO:3 has an amino acid sequence that is at least 80%, at least 85%, at least 90%, or at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% identical to a thermostable metal ion-resistant xylanase; and a thermostable protease that has an amino acid sequence that is at least 80%, at least 85%, at least 90%, or at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% identical to the mature polypeptide of SEQ ID NO:26, SEQ ID NO:27, SEQ ID NO:28, or SEQ ID NO:29.

[0700] In a preferred embodiment, the composition of the present invention comprises - α-amylase, preferably a thermostable bacterial α-amylase, more preferably an α-amylase having at least 80%, at least 85%, at least 90%, or at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% identity with the amino acid sequence of amino acids 1 to 491 of SEQ ID NO:5, having the mutant -I181*+G182*+V59A+E129V+K177L+R179S+Q254S+M284V+V212T+Y268G+N293Y+T297N+A184Q+E188P+T191N+N193F+S242Y+K279I; - thermostable xylanase resistant to metal ions, more preferably with SEQ ID NO:5 The mature polypeptide of NO:3 has an amino acid sequence that is at least 80%, at least 85%, at least 90%, or at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% identical to a thermostable metal ion-resistant xylanase; and a thermostable protease that has an amino acid sequence that is at least 80%, at least 85%, at least 90%, or at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% identical to the mature polypeptide of SEQ ID NO:26, SEQ ID NO:27, SEQ ID NO:28, or SEQ ID NO:29.

[0701] In a preferred embodiment, the composition of the present invention comprises - α-amylase, preferably a thermostable bacterial α-amylase, more preferably an α-amylase having at least 80%, at least 85%, at least 90%, or at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% identity with the amino acid sequence of amino acids 1 to 491 of SEQ ID NO:5, having the mutant -I181*+G182*+V59A+E129V+K177L+R179S+Q254S+M284V+V212T+Y268G+N293Y+T297N+A184Q+E188P+T191N+N193F+S242Y+K279I; - thermostable xylanase resistant to metal ions, more preferably with SEQ ID NO:5 The mature polypeptide of NO:4 has an amino acid sequence that is at least 80%, at least 85%, at least 90%, or at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% identical to a thermostable metal ion-resistant xylanase; and a thermostable protease that has an amino acid sequence that is at least 80%, at least 85%, at least 90%, or at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% identical to the mature polypeptide of SEQ ID NO:26, SEQ ID NO:27, SEQ ID NO:28, or SEQ ID NO:29.

[0702] In a preferred embodiment, the composition of the present invention comprises - α-amylase, preferably a thermostable bacterial α-amylase, more preferably an α-amylase having at least 80%, at least 85%, at least 90%, or at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% identity with the amino acid sequence of amino acids 1 to 491 of SEQ ID NO:5, having the mutant -I181*+G182*+V59A+E129V+K177L+R179S+Q254S+M284V+V212T+Y268G+N293Y+T297N+A184Q+E188P+T191N+N193F+S242Y+K279I; - thermostable xylanase resistant to metal ions, more preferably with SEQ ID NO:5 The mature polypeptide of NO:4 has an amino acid sequence that is at least 80%, at least 85%, at least 90%, or at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% identical to a thermostable metal ion-resistant xylanase; and a thermostable protease that has an amino acid sequence that is at least 80%, at least 85%, at least 90%, or at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% identical to the mature polypeptide of SEQ ID NO:26, SEQ ID NO:27, SEQ ID NO:28, or SEQ ID NO:29.

[0703] In one embodiment, the optional endoglucanase has a melting point (DSC) greater than 74°C, such as greater than 76°C, such as greater than 78°C, such as greater than 80°C, such as greater than 82°C, such as greater than 84°C, such as greater than 86°C, such as greater than 88°C, such as between 70°C and 95°C, such as between 76°C and 94°C, such as between 78°C and 93°C, such as between 80°C and 92°C, such as between 82°C and 91°C, such as between 84°C and 90°C.

[0704] In one embodiment, the optional endoglucanase has at least 60%, such as at least 70%, such as at least 75%, preferably at least 80%, more preferably at least 85%, more preferably at least 90%, more preferably at least 91%, more preferably at least 92%, even more preferably at least 93%, most preferably at least 94%, and even most preferably at least 95%, such as even at least 96%, at least 97%, at least 98%, at least 99%, such as 100%, identity with the mature portion of the polypeptide of SEQ ID NO: 7, 22, 23, 24 or 25 herein.

[0705] In one embodiment, the endoglucanase has at least 80% identity with the mature portion of the polypeptide of SEQ ID NO:7 herein.

[0706] In one embodiment, the endoglucanase has at least 90% identity with the mature portion of the polypeptide of SEQ ID NO:7 herein, and the endoglucanase has a melting point (DSC) greater than 70°C.

[0707] In one embodiment, *Porciniella fibrinolytica* protease (SEQ ID NO:11 herein) and / or *Thermophilic Ascomycota* protease (SEQ ID NO:6 herein) or variants thereof are mature proteases, or corresponding mature proteases having at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, or at least 99% identity with SEQ ID NO:6 or SEQ ID NO:11 herein, respectively.

[0708] In one embodiment, Penicillium oxalate glucosylamylase (SEQ ID NO:12 herein) or a variant thereof is a mature glucosylamylase, or a corresponding mature glucosylamylase having at least 80% identity, at least 85% identity, at least 90% identity, at least 95% identity, at least 96% identity, at least 97% identity, or at least 99% identity with SEQ ID NO:12 herein.

[0709] Other aspects of the invention

[0710] In another aspect of the invention, it relates to the use of the compositions of the invention for liquefying starch-containing materials.

[0711] In another aspect of the invention, therein lies a method for producing liquefied starch, the method comprising liquefying a starch-containing material with the composition of the invention.

[0712] In another aspect of the invention, it relates to the use of xylanase resistant to metal ion inhibition for liquefying starch-containing materials.

[0713] In another aspect of the invention, therein lies a method for producing liquefied starch, the method comprising liquefying a starch-containing material with a xylanase resistant to metal ion inhibition.

[0714] In another aspect of the invention, it relates to the use of the compositions of the invention for reducing residual starch in liquefaction products.

[0715] In another aspect of the invention, it relates to the use of xylanase resistant to metal ion inhibition for reducing residual starch in liquefaction.

[0716] In another aspect of the invention, it relates to the use of the compositions of the invention for increasing short-chain oligosaccharides in liquefaction products.

[0717] In another aspect of the invention, it relates to the use of xylanases resistant to metal ion inhibition for increasing short-chain oligosaccharides in liquefaction.

[0718] The invention is further summarized in the following paragraphs:

[0719] 1. A method for producing fermentation products from starch-containing materials, the method comprising the following steps:

[0720] i) In the presence of a thermostable xylanase, starch-containing materials are liquefied at a temperature above the initial gelatinization temperature, and the thermostable xylanase is resistant to inhibition by metal ions when liquefying starch-containing materials.

[0721] ii) Saccharification using enzymes that produce carbohydrates; and

[0722] iii) Fermentation is carried out using fermenting organisms to produce the fermentation product.

[0723] 2. The method as described in paragraph 1, wherein the amount of residual starch present at the end of liquefaction step i) is reduced compared to the amount of residual starch present at the end of liquefaction step i) in the absence of xylanase, or compared to the amount of residual starch present at the end of liquefaction step i) when a thermostable xylanase (such as, for example, the xylanase of SEQ ID NO: 1) with little or no resistance to inhibition of metal ions is used in liquefying starch-containing materials.

[0724] 3. The method as described in paragraph 1, wherein the amount of short-chain oligosaccharides present at the end of liquefaction step i) is increased compared to the amount of short-chain oligosaccharides present at the end of liquefaction step i) when using a thermostable xylanase (such as xylanase of SEQ ID NO: 1, for example) that has little or no resistance to the inhibition of metal ions when liquefying starch-containing materials.

[0725] 4. A method for reducing the amount of residual starch present in a liquefied substance, the method comprising:

[0726] i) Using a thermostable xylanase to liquefy starch-containing materials to produce a liquefied product, wherein the thermostable xylanase is resistant to inhibition by metal ions when liquefying starch-containing materials, and wherein the liquefied product has a reduced amount of residual starch compared to a liquefied product produced without the thermostable xylanase or compared to a liquefied product produced using a thermostable xylanase that is not resistant to inhibition by metal ions or has less resistance when liquefying starch-containing materials;

[0727] Optionally, ii) saccharification is performed using an enzyme that produces carbohydrates; and optionally iii) fermentation is performed using a fermenting organism to produce the fermentation product.

[0728] 5. A method for increasing the amount of short-chain oligosaccharides present in a liquefaction, the method comprising:

[0729] i) Using a thermostable xylanase to liquefy starch-containing materials to produce a liquefied product, wherein the thermostable xylanase is resistant to inhibition by metal ions when liquefying starch-containing materials, and wherein the liquefied product has an increased amount of short-chain oligosaccharides compared with liquefied products produced without the thermostable xylanase or compared with liquefied products produced by using a thermostable xylanase that is not resistant to inhibition by metal ions or has less resistance when liquefying starch-containing materials;

[0730] Optionally, ii) saccharification is performed using an enzyme that produces carbohydrates; and optionally iii) fermentation is performed using a fermenting organism to produce the fermentation product.

[0731] 6. The method as described in paragraph 4 or 5, further comprising ii) saccharification using an enzyme that produces a carbohydrate source; and optionally iii) fermentation using a fermenting organism to produce the fermentation product.

[0732] 7. The method of any one of paragraphs 1 to 6, wherein the thermostable xylanase is derived from a strain of the genus Thermomyces.

[0733] 8. The method as described in any one of paragraphs 1 to 7, wherein the thermostable xylanase is the same as described in SEQ ID NO. The mature portion of the polypeptide of NO:2 has at least 60%, such as at least 70%, such as at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, preferably at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, more preferably at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, more preferably at least 90%, more preferably at least 91%, more preferably at least 92%, at least 93%, at least 94%, or at least 95%, such as at least 96%, at least 97%, at least 98%, at least 99%, or at least 100%, preferably derived from strains of the genus Thermophyton, such as strains of Thermophyton spp.

[0734] 9. The method as described in any one of paragraphs 1 to 8, wherein the thermostable xylanase is the same as described in SEQ ID NO. The mature portion of the polypeptide of NO:3 has at least 60%, such as at least 70%, such as at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, preferably at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, more preferably at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, more preferably at least 90%, more preferably at least 91%, more preferably at least 92%, at least 93%, at least 94%, or at least 95%, such as at least 96%, at least 97%, at least 98%, at least 99%, or at least 100%, preferably derived from strains of the genus Thermophyton, such as strains of Thermophyton naples.

[0735] 10. The method as described in any one of paragraphs 1 to 9, wherein the thermostable xylanase is the same as described in SEQ ID NO. The mature portion of the polypeptide of NO:4 has at least 60%, such as at least 70%, such as at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, preferably at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, more preferably at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, more preferably at least 90%, more preferably at least 91%, more preferably at least 92%, at least 93%, at least 94%, or at least 95%, such as at least 96%, at least 97%, at least 98%, at least 99%, or 100%, preferably derived from strains of the genus Thermophyton, such as strains of Thermophyton naphthaleneophilus.

[0736] 11. The method of any one of paragraphs 1 to 10, wherein the heat-stable xylanase has a melting point (DSC) greater than 82°C, such as greater than 84°C, such as greater than 86°C, such as greater than 88°C, such as greater than 90°C, such as greater than 92°C, such as greater than 94°C, such as greater than 96°C, such as greater than 98°C, such as greater than 100°C, such as between 80°C and 110°C, such as between 82°C and 110°C, such as between 84°C and 110°C.

[0737] 12. The method as described in any one of paragraphs 1 to 11, wherein the starch-containing material is corn, and the metal ions are copper ions, iron ions, and zinc ions when the starch-containing material is liquefied.

[0738] 13. The method as described in any one of paragraphs 1 to 12, wherein the resistance to metal ion inhibition during liquefaction of the starch-containing material is at least 60%, at least 65%, at least 70%, at least 71%, at least 72%, at least 73%, at least 74%, at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, or at least 98%.

[0739] 14. The method of any one of paragraphs 1 to 13, wherein the thermostable xylanase retains at least 80% of its relative activity in the presence of copper ions when liquefying starch-containing materials.

[0740] 15. The method of any one of paragraphs 1 to 14, wherein the thermostable xylanase retains at least 70% of its relative activity in the presence of iron ions when liquefying starch-containing materials.

[0741] 16. The method of any one of paragraphs 1 to 15, wherein the thermostable xylanase retains at least 95% of its relative activity in the presence of zinc ions when liquefying starch-containing materials.

[0742] 17. The method of any one of paragraphs 1 to 16, wherein the average concentration of metal ions present during liquefaction of the starch-containing material ranges from 0.012 mM to 0.15 mM.

[0743] 18. The method as described in any one of paragraphs 1 to 17, wherein the average concentration of copper ions present in the corn is 0.012 mM.

[0744] 19. The method as described in any one of paragraphs 1 to 18, wherein the average concentration of iron ions present in the corn is 0.15 mM.

[0745] 20. The method as described in any one of paragraphs 1 to 19, wherein the average concentration of zinc ions present in the corn is 0.12 mM.

[0746] 21. The method as described in any one of paragraphs 1 to 20, wherein a thermostable α-amylase and / or a thermostable protease are present in liquefaction step i).

[0747] 22. The method as described in any one of paragraphs 1 to 21, wherein the thermostable α-amylase is the same as described in the SEQ document. The mature portion of the peptide of IDNO:5 has at least 60%, such as at least 70%, such as at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, preferably at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, more preferably at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, more preferably at least 90%, more preferably at least 91%, more preferably at least 92%, at least 93%, at least 94%, or at least 95%, such as at least 96%, at least 97%, at least 98%, at least 99%, or at least 100%, preferably derived from a strain of the genus Bacillus, such as Bacillus stearothermophilus.

[0748] 23. The method of any one of paragraphs 1 to 22, wherein the thermostable protease is selected from the group consisting of:

[0749] (i) a protease derived from strains of the genus *Vorticella*, such as the potent *Vorticella* protease shown in SEQ ID NO:11, or a protease having at least 60%, such as at least 70%, such as at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, preferably at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, more preferably at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, more preferably at least 90%, more preferably at least 91%, more preferably at least 92%, at least 93%, at least 94%, or at least 95%, such as at least 96%, at least 97%, at least 98%, at least 99%.

[0750] (ii) A protease derived from strains of the genus *Thermolyticus*, such as the cellulolytic *Thermolyticus* protease shown in SEQ ID NO:26 herein, or a protease having at least 60%, such as at least 70%, such as at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, preferably at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, more preferably at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, more preferably at least 90%, more preferably at least 91%, more preferably at least 92%, at least 93%, at least 94%, or at least 95%, such as at least 96%, at least 97%, at least 98%, at least 99%, or the amino acid sequence of SEQ ID NO:26 herein. The brown thermophilic protease shown in NO:27 or the protease having at least 60%, such as at least 70%, such as at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, preferably at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, more preferably at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, more preferably at least 90%, more preferably at least 91%, more preferably at least 92%, at least 93%, at least 94%, or at least 95%, such as at least 96%, at least 97%, at least 98%, at least 99%, or the salt-tolerant thermophilic protease shown in SEQ ID NO:28 or the protease having at least 60%, such as at least 70%, such as at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, preferably at least 80%, at least 81%, at least 82%, at least 83%, at least 94%, or at least 95%, such as at least 96%, at least 97%, at least 98%, at least 99%, or the protease having at least 60%, such as at least 70%, at least 75%, at least 77%, at least 98%, at least 99%, similar to the amino acid sequence of SEQ ID NO:27, preferably ...5%, at least 96%, at least 97%, at least 98%, at least 99%, similar to the amino acid sequence of SEQ ID NO:2 The amino acid sequence of NO:28 has at least 60%, such as at least 70%, such as at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, preferably at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, more preferably at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, more preferably at least 90%, more preferably at least 91%, more preferably at least 92%, at least 93%, at least 94%, or at least 95%, such as at least 96%, at least 97%, at least 98%, at least 99%, as in a protease; and

[0751] (iii) A protease derived from a strain of Thermococcus, such as the Notilly Thermococcus protease shown in SEQ ID NO:29 herein, or a protease having at least 60%, such as at least 70%, such as at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, preferably at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, more preferably at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, more preferably at least 90%, more preferably at least 91%, more preferably at least 92%, at least 93%, at least 94%, or at least 95%, such as at least 96%, at least 97%, at least 98%, at least 99%.

[0752] 24. The method as described in any one of paragraphs 1 to 23, wherein the pH during liquefaction step i) is between 4.0 and 6.5, such as 4.5 to 6.2, such as greater than 4.8 to 6.0, such as between 5.0 and 5.8.

[0753] 25. The method as described in any one of paragraphs 1 to 24, wherein the temperature during liquefaction is in the range of 70°C to 100°C, such as between 70°C and 95°C, such as between 75°C and 90°C, preferably between 80°C and 90°C, such as about 85°C.

[0754] 26. The method as described in any one of paragraphs 1 to 25, wherein saccharification and fermentation are carried out sequentially or simultaneously.

[0755] 27. The method as described in any one of paragraphs 1 to 27, wherein the fermentation product is an alcohol, preferably ethanol, especially fuel ethanol, drinking ethanol and / or industrial ethanol.

[0756] 28. The method as described in any one of paragraphs 1 to 28, wherein the starch-containing starting material is a whole grain.

[0757] 29. The method of any one of paragraphs 1 to 28, wherein the starch-containing material is derived from corn, wheat, barley, rye, sorghum, sago, cassava, tapioca, tapioca starch, sorghum, rice, or potato.

[0758] 30. The method as described in any one of paragraphs 1 to 29, wherein the fermenting organism is yeast, preferably a strain of the genus *Saccharomyces*, especially a strain of *Saccharomyces cerevisiae*.

[0759] 31. The method of any one of paragraphs 1 to 30, wherein the thermostable xylanase is a GH10 family xylanase containing the motif YITEMD (SEQ ID NO:30).

[0760] The invention described and claimed herein is not limited to the specific embodiments disclosed herein, as these embodiments are intended to serve as illustrative examples of several aspects of the invention. Any equivalent embodiments are intended to be within the scope of the invention. In fact, various modifications to the invention, in addition to those shown and described herein, will become apparent to those skilled in the art from the foregoing description. Such modifications are also intended to fall within the scope of the appended claims. In case of conflict, the disclosure including the definition shall prevail. Several references are cited herein, the disclosures of which are incorporated herein by reference in their entirety. The invention is further described by the following examples, which should not be construed as limiting the scope of the invention.

[0761] Materials and Methods

[0762] Material:

[0763] α-Amylase 369 (AA369): A thermophilic Bacillus α-amylase with the following mutation: I181*+G182*+N193F+V59A+Q89R+E129V+K177L+R179E+Q254S+M284V truncated to 491 amino acids (SEQ ID NO:5 of this article).

[0764] α-Amylase 2330 (AA2330): A thermophilic Bacillus α-amylase with the following mutation: -I181*+G182*+V59A+E129V+K177L+R179S+Q254S+M284V+V212T+Y268G+N293Y+T297N+A184Q+E188P+T191N+N193F+S242Y+K279I truncated to 491 amino acids (SEQ ID NO:5 of this article).

[0765] Endoglucanase TL (EG TL): Endoglucanase GH5 from *Basilella repens* (disclosed as SEQ ID NO:2 in WO2013 / 019780 and SEQ ID NO:7 in this article). (P23YSQ).

[0766] Protease Pfu: A protease derived from *Vorococcus viridans*, purchased from Takara Bio (Japan), is designated as Pfu protease S (activity 10.5 mg / mL) and is also shown in SEQ ID NO:11 herein.

[0767] Glucoamylase Po: The mature portion of Penicillium oxalate glucosylase is disclosed in WO2011 / 127802 as SEQ ID NO:2 and is shown in SEQ ID NO:12 herein.

[0768] Glucoamylase PE001: Variants of Penicillium oxalate glucoamylase with K79V substitution are numbered using the mature sequence shown in SEQ ID NO:12.

[0769] Glucoamylase Po 498 (GA498): A variant of Penicillium oxalate glucosylase with the following mutation: K79V+P2N+P4S+P11F+T65A+Q327F (numbered using SEQ ID NO:12).

[0770] Glucoamylase SA (GSA): comprising the following blends: *Emersonia spp.* glucosylase disclosed in WO 99 / 28448 as SEQ ID NO:34 or disclosed herein as SEQ ID NO:15; *Cyclocarya paliurus* glucosylase disclosed in WO 06 / 69289 as SEQ ID NO:2 or disclosed herein as SEQ ID NO:13; and *Rhizomucorpusillus* α-amylase disclosed herein as SEQ ID NO:14, having an *Aspergillus niger* glucosylase linker and a starch-binding domain (SBD), the *Rhizomucorpusillus* α-amylase having the following substitution: G128D+D143N (the activity ratio of AGU:AGU:FAU-F is approximately 20:5:1).

[0771] Glucoamylase BL (GBL): comprises the following blends: *Strombus vulgaris* glucosylase disclosed in WO 06 / 69289 as SEQ ID NO:2 or disclosed herein as SEQ ID NO:13, and *Rhizopus microsporus* α-amylase disclosed herein as SEQ ID NO:14, having an *Aspergillus niger* glucosylase linker and a starch-binding domain (SBD), the *Rhizopus microsporus* α-amylase having the following substitution: G128D+D143N (the activity ratio of AGU:AGU:FAU-F is approximately 20:5:1).

[0772] Protease X: A metalloproteinase derived from Ascomycota orangeensis CGMCC No. 0670, containing amino acids 1-177 in SEQ ID NO: 6 disclosed herein, and amino acids 1-177 in SEQ ID NO: 2 of WO 2003 / 048353.

[0773] Yeast: ETHANOL RED TMPurchased from Red Star / Lesaffre, USA.

[0774] method

[0775] The Td of xylanase was determined by differential scanning calorimetry.

[0776] The thermal stability of the enzyme was determined by differential scanning calorimetry (DSC) using a VP-capillary differential scanning calorimeter (MicroCal Inc., Piscatave, NJ, USA). The thermal analysis chromatogram (Cp vs. T) obtained after heating the enzyme solution (approximately 0.5 mg / ml) in buffer (50 mM acetate, pH 5.0) at a constant programmed heating rate of 200 K / h was used, with the denaturation temperature Td (°C) considered as the apex of the denaturation peak (the predominant endothermic peak).

[0777] Sample solution and reference solution (approximately 0.2 ml) were loaded into the calorimeter from storage conditions at 10°C (reference solution: enzyme-free buffer) and pre-equilibrated at 20°C for 20 minutes, followed by DSC scanning from 20°C to 120°C. Denaturation temperature was determined with an accuracy of approximately + / -1°C.

[0778] Identity: The parameter “identity” describes the correlation between two amino acid sequences or two nucleotide sequences.

[0779] For the purposes of this invention, the degree of identity between two amino acid sequences and between two nucleotide sequences can be determined by a procedure called Needleman-Wunsch alignment (i.e., overall alignment). This procedure is used for aligning peptide and nucleotide sequences. Peptide alignment is performed using the default scoring matrix BLOSUM50, and nucleotide alignment is performed using the default identity matrix. For peptides, the penalty for the first residue of the cleavage is -12, and for nucleotides, the penalty is -16. For peptides, the penalty for the remaining residues of the cleavage is -2, and for nucleotides, the penalty is -4.

[0780] "Alignment" is part of FASTA package version v20u6 (see WRPearson and DJ Lipman (1988), "Improved Tools for Biological Sequence Analysis", PNAS 85:2444-2448, and WRPearson (1990), "Rapid and Sensitive Sequence Comparison with FASTP and FASTA", Methods in Enzymology 183:63-98). FASTA protein alignment is performed using the Smith-Waterman algorithm, which has no limitation on gap size (see "Smith-Waterman algorithm", TFSmith and MS Waterman (1981), J. Mol. Biol. 147:195-197).

[0781] Zeatin-BCA assay:

[0782] The zeatin-BCA assay can be performed at different temperatures using variant proteases to quantify the soluble protein released from zeatin.

[0783] plan:

[0784] 1) Mix 10 μL of 10 μg / ml enzyme solution and 100 μL of 0.025% zeatin solution in a microtiter plate (MTP).

[0785] 2) Incubate at different temperatures for 60 minutes.

[0786] 3) Add 10 μL of 100% trichloroacetic acid (TCA) solution.

[0787] 4) Centrifuge the MTP at 3500 rpm for 5 min.

[0788] 5) Transfer 15 μL to a new MTP containing 100 μL of BCA assay solution (Pierce catalog number: 23225, BCA protein assay kit).

[0789] 6) Incubate at 60℃ for 30 minutes.

[0790] 7) Measure A562.

[0791] The results of this assay can be used to identify proteases that have improved thermal stability compared to a reference protease.

[0792] Determination of pullulanase activity (NPUN)

[0793] Endoplasmin-pullulanase activity in NPUN was measured relative to Novozymes pullulanase standards. One pullulanase unit (NPUN) is defined as the amount of enzyme that releases 1 micromole of glucose per minute under standard conditions (0.7% red pullulan (Megazyme), pH 5, 40°C, 20 min). This activity was measured in NPUN / ml using red pullulan.

[0794] Incubate 1 mL of diluted sample or standard at 40°C for 2 minutes. Add 0.5 mL of 2% red pullulan, 0.5 M KCl, and 50 mM citric acid (pH 5) and mix. Incubate these tubes at 40°C for 20 minutes and terminate by adding 2.5 mL of 80% ethanol. Let the tubes stand at room temperature for 10–60 minutes, then centrifuge at 4000 rpm for 10 minutes. Measure the OD of the supernatant at 510 nm and calculate the activity using a standard curve.

[0795] AZCL-Casein Assay

[0796] While stirring, a 0.2% solution of the blue substrate AZCL-casein was suspended in Borax / NaH2PO4 buffer at pH 9. This solution was dispersed onto microtiter plates (100 μL per well) while stirring, 30 μL of enzyme sample was added, and the plates were incubated in an Eppendorf Thermomixer at 45 °C and 600 rpm for 30 min. A denatured enzyme sample (boiled at 100 °C for 20 min) was used as a blank control. The reaction was terminated by transferring the microtiter plates to ice, and the stained solution was separated from the solid by centrifugation at 3000 rpm for 5 min at 4 °C. 60 μL of the supernatant was transferred to a microtiter plate, and the absorbance was measured at 595 nm using a BioRad Microplate Reader.

[0797] Protease assay

[0798] AZCL-Casein Assay

[0799] While stirring, a 0.2% solution of the blue substrate AZCL-casein was suspended in Borax / NaH2PO4 buffer at pH 9. This solution was dispersed onto microtiter plates (100 μL per well) while stirring, 30 μL of enzyme sample was added, and the plates were incubated in an Eppendorf Thermomixer at 45 °C and 600 rpm for 30 min. A denatured enzyme sample (boiled at 100 °C for 20 min) was used as a blank control. The reaction was terminated by transferring the microtiter plates to ice, and the stained solution was separated from the solid by centrifugation at 3000 rpm for 5 min at 4 °C. 60 μL of the supernatant was transferred to a microtiter plate, and the absorbance was measured at 595 nm using a BioRad Microplate Reader.

[0800] pNA assay

[0801] Add 50 μL of protease-containing sample to a microtiter plate and begin the assay by adding 100 μL of 1 mM pNA substrate (5 mg dissolved in 100 μL DMSO and further diluted to 10 mL with Borax / NaH2PO4 buffer at pH 9.0). Monitor OD. 405 The increase at room temperature is used as a measure of protease activity.

[0802] Glucoamylase activity (AGU)

[0803] Glucoamylase activity can be measured in glucosylamylase units (AGU).

[0804] Novozymes glucosyl amylase unit (AGU) is defined as the amount of enzyme that hydrolyzes 1 micromole of maltose per minute under the following standard conditions: 37°C, pH 4.3, substrate: 23.2 mM maltose, buffer: 0.1 M acetate, and reaction time: 5 minutes.

[0805] An automated analyzer system can be used. Mulliganase is added to the glucose dehydrogenase reagent, causing any α-D-glucose present to be converted to β-D-glucose. Glucose dehydrogenase specifically reacts with β-D-glucose in the above-mentioned reaction to form NADH, which is measured at 340 nm using a photometer as a measure of the original glucose concentration.

[0806] <![CDATA[ AMG incubation: ]]> Substrate: Maltose 23.2mM Buffer solution: Acetate 0.1M pH: 4.30±0.05 Incubation temperature: 37℃±1℃ Reaction time: 5 minutes Enzyme working range: 0.5-4.0 AGU / mL

[0807] <![CDATA[ Color reaction: ]]> GlucDH: 430U / L Mulligans: 9U / L NAD: 0.21mM Buffer solution: 0.12M phosphate; 0.15M NaCl pH: 7.60±0.05 Incubation temperature: 37℃±1℃ Reaction time: 5 minutes wavelength: 340nm

[0808] A document that describes this analysis method in more detail ( EB-SM-0131.02 / 01 The document is available from Novozymes in Denmark and is incorporated herein by reference.

[0809] Acid α-amylase activity (AFAU)

[0810] Acid α-amylase activity can be measured in AFAU (acidic fungal α-amylase units), which is determined relative to enzyme standards. 1 AFAU is defined as the amount of enzyme that degrades 5.260 mg of dry starch per hour under the following standard conditions.

[0811] Acidic α-amylase, an endo-α-amylase (1,4-α-D-glucan-glucan hydrolase, EC 3.2.1.1), hydrolyzes α-1,4-glycosidic bonds in the internal regions of starch molecules to form dextrins and oligosaccharides with varying chain lengths. The intensity of the color formed by iodine is directly proportional to the starch concentration. Amylase activity is determined by a decrease in starch concentration under specified analytical conditions using a reverse colorimetric method.

[0812]

[0813] λ = 590nm

[0814] Blue / purple: t = 23 seconds. Decolorization.

[0815] Standard conditions / reaction conditions:

[0816]

[0817] A folder containing a more detailed description of this analysis method EB-SM-0259.02 / 01 It can be obtained from Novozymes in Denmark, and this folder is hereby included by reference.

[0818] α-Amylase activity (KNU)

[0819] Potato starch can be used as a substrate to determine α-amylase activity. This method is based on potato starch modified by enzyme degradation, and the reaction is tracked by mixing a sample of starch / enzyme solution with iodine solution. Initially, a dark blue color is formed, but the blue color weakens and gradually turns reddish-brown during starch degradation, compared with colored glass standards.

[0820] One thousand Novozymes α-amylase units (KNU) are defined as 0.0003 MCa under standard conditions (i.e., 37°C + / - 0.05°C; 0.0003 MCa). 2+ The amount of enzyme used to dextrinize 5260 mg of soluble starch dry matter Merck Amylum at pH 5.6.

[0821] A folder containing a more detailed description of this analysis method ( EB-SM-0009.02 / 01 This can be obtained from Novozymes in Denmark, and the folder is hereby included by reference.

[0822] Determination of FAU(F)

[0823] Measure FAU(F) fungal α-amylase units relative to enzyme standards of known strength. F ungal Alpha- A mylase U nits ( F ungamyl)).

[0824]

[0825] A folder (EB-SM-0216.02) describing this standard method in more detail is available from Novozymes in Denmark and is hereby included by reference.

[0826] Determination of pullulanase activity (NPUN)

[0827] Endoplasmic pullulanase activity in NPUN was measured relative to Novozymes pullulanase standards. One pullulanase unit (NPUN) is defined as the amount of enzyme that releases 1 micromole of glucose per minute under standard conditions (0.7% red pullulan (McGen), pH 5, 40°C, 20 min). This activity was measured in NPUN / ml using red pullulan.

[0828] Incubate 1 mL of diluted sample or standard at 40°C for 2 minutes. Add 0.5 mL of 2% red pullulan, 0.5 M KCl, and 50 mM citric acid (pH 5) and mix. Incubate the tube at 40°C for 20 minutes and terminate by adding 2.5 mL of 80% ethanol. Let the tube stand at room temperature for 10–60 minutes, then centrifuge at 4000 rpm for 10 minutes. Measure the OD of the supernatant at 510 nm and calculate the activity using a standard curve.

[0829] The invention will be described in more detail in the following examples, which are provided to illustrate the invention and are in no way intended to limit the scope of the invention. All references cited herein are specifically incorporated by reference to the description herein.

[0830] Example

[0831] Example 1 - Stability of α-amylase variants

[0832] By incubating the reference α-amylase (a truncated 491 amino acid strain of Bacillus stearothermophilus with the mutant I181*+G182*+N193F (numbered SEQ ID NO:1 herein)) and its α-amylase variants with 0.12 mM CaCl2 at pH 4.5 and 5.5 and at temperatures of 75 °C and 85 °C, followed by using Substrate The stability of the reference α-amylase and its variants was determined by residual activity assay using the Ultra Amylase assay kit (E33651, Molecular Probes).

[0833] Dilute the purified enzyme sample to a working concentration of 0.5 and 1 or 5 and 10 ppm (µg / mL) in enzyme dilution buffer (10 mM acetate, 0.01% Triton X100, 0.12 mM CaCl2, pH 5.0). Transfer 20 µL of enzyme sample to a 48-well PCR MTP well and add 180 µL of stability buffer (150 mM acetate, 150 mM MES, 0.01% Triton X100, 0.12 mM CaCl2, pH 4.5 or 5.5) to each well and mix. Perform the assay twice using both enzyme concentrations. Before incubation at 75°C or 85°C, remove 20 µL and store on ice as a control sample. Incubate in a PCR instrument (at 75°C and 85°C). Following incubation, the sample was diluted to 15 ng / mL in residual activity buffer (100 mM acetate, 0.01% Triton X100, 0.12 mM CaCl2, pH 5.5), and 25 μL of the diluted enzyme was transferred to a black 384-MTP. Residual activity was measured using EnzChek substrate by adding 25 μL of substrate solution (100 μg / mL) to each well. Fluorescence was measured per minute for 15 minutes using a 485-P nm excitation filter and a 555 nm emission filter (fluorescence reader: Polarstar, BMG). For each setting, residual activity was normalized relative to a control sample.

[0834] Assuming logarithmic decay, the half-life time (T1 / 2(min)) is calculated using the following equation: T1 / 2(min) = T(min) * LN(0.5) / LN(%RA / 100), where T is the measured incubation time in minutes, and %RA is the percentage of residual activity determined in the assay.

[0835] Using this assay setup, half-life times were determined for reference α-amylase and its variants, as shown in Table 1.

[0836] Table 1

[0837]

[0838]

[0839]

[0840]

[0841]

[0842] ND not detected

[0843] These results demonstrate that the α-amylase variant has a significantly longer half-life and greater stability than the reference α-amylase.

[0844] Example 2 - Preparation and thermal stability testing of protease variants

[0845] Strains and plasmids

[0846] Escherichia coli DH12S (available from Gibco BRL) was used for yeast plasmid rescue. pJTP000 is a Saccharomyces cerevisiae and Escherichia coli shuttle vector under the control of the TPI promoter, constructed from pJC039 described in WO 01 / 92502, in which the Ascomycota orangeensis M35 protease gene (WO 03048353) has been inserted.

[0847] Saccharomyces cerevisiae YNG318 competent cells: MATa Dpep4[cir+]ura3-52,leu2-D2,his 4-539 were used for protease variant expression. This was described in J. Biol. Chem. 272(15), pp. 9720-9727, 1997.

[0848] Culture medium and substrate

[0849] 10X base solution: 66.8 g / L yeast nitrogen group (DIFCO) without amino acids, 100 g / L succinate, 60 g / L NaOH.

[0850] SC-Glucose: 100 ml / L of 20% glucose (i.e., final concentration 2% = 2 g / 100 ml), 4 ml / L of 5% threonine, 10 ml / L of 1% tryptophan, 25 ml / L of 20% casein amino acids, and 100 ml / L of 10X basal solution. Sterilize the solution using a filter with a pore size of 0.20 microns. Autoclave agar (2%) and H2O (approximately 761 ml) together, and add the separately sterilized SC-glucose solution to the agar solution.

[0851] YPD: Bacterial peptone 20g / l, yeast extract 10g / l, 20% glucose 100ml / l.

[0852] YPD+Zn: YPD+0.25mM ZnSO4.

[0853] PEG / LiAc solution: 40% PEG4000 50ml, 5M lithium acetate 1ml.

[0854] 96-well zeatin microtiter plate:

[0855] Each well contains 200 μL of 0.05%–0.1% zeatin (Sigma), 0.25 mM ZnSO4, and 1% agar in 20 mM sodium acetate buffer, pH 4.5.

[0856] DNA manipulation

[0857] Unless otherwise stated, DNA manipulation and transformation were performed using standard molecular biology methods as described in Sambrook et al. (1989), *Molecular Cloning: A Laboratory Manual*, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY; Ausubel, FM et al. (eds.), “Current Protocols in Molecular Biology”, John Wiley and Sons, 1995; and Harwood, CR and Cutting, SM (eds.).

[0858] yeast conversion

[0859] Yeast transformation was performed using the lithium acetate method. 0.5 μL of vector (digested with restriction endonuclease) and 1 μL of PCR fragment were mixed. The DNA mixture, 100 μL of YNG318 competent cells, and 10 μL of yeast marker carrier DNA (Clontech) were added to a 12 mL polypropylene tube (Falcon 2059). 0.6 mL of PEG / LiAc solution was added and gently mixed. The mixture was incubated at 30 °C and 200 rpm for 30 min, followed by incubation at 42 °C for 30 min (heat shock). The mixture was transferred to a microcentrifuge tube and centrifuged for 5 seconds. The supernatant was removed and dissolved in 3 mL of YPD. The cell suspension was incubated at 30 °C and 200 rpm for 45 min. The suspension was poured onto SC-glucose plates and incubated at 30 °C for 3 days to allow colony growth. Total yeast DNA was extracted using the Zymoprep yeast plasmid miniaturization kit (ZYMO Research).

[0860] DNA sequencing

[0861] E. coli transformation for DNA sequencing was performed via electroporation (BIO-RAD Gene Pulser). Transformation was performed using the alkaline method (Molecular Cloning, Cold Spring Harbor) or... DNA plasmids were prepared using a plasmid kit. DNA fragments were recovered from agarose gels using a Qiager gel extraction kit. PCR was performed using a PTC-200 DNA Engine. All DNA sequences were determined using an ABI PRISM™ 310 gene analyzer.

[0862] Construction of protease expression vector

[0863] The M35 protease gene of Ascomycetes genus was amplified using primer pairs Prot F (SEQ ID NO:4) and Prot R (SEQ ID NO:5). The resulting PCR fragment, along with the pJC039 vector, was introduced into Saccharomyces cerevisiae YNG318 (described in WO 2001 / 92502), and digested with restriction endonucleases to remove the specific saprophytic cutinase gene.

[0864] The plasmid in the yeast clone was recovered from the SC-glucose plate to confirm the internal sequence and was named pJTP001.

[0865] Construction of yeast libraries and site-directed variants

[0866] Yeast libraries and site-directed variants were constructed using SOE PCR (Splicing by Overlap Extension, see “PCR: A Practical Approach”, pp. 207-209, Oxford University Press, edited by McPherson, Quirke, Taylor) followed by in vivo recombination.

[0867] Universal primers for amplification and sequencing

[0868] Using primers AM34 (SEQ ID NO:5) and AM35 (SEQ ID NO:6), DNA fragments containing any mutations or simply the entire protease gene can be prepared via SOE with degenerate primers (AM34 + reverse primer and AM35 + forward primer).

[0869]

[0870] DNA fragments were recovered from agarose gels using a Qiager gel extraction kit. The purified fragments were mixed with vector digest. The mixture was introduced into Saccharomyces cerevisiae to construct libraries or site-directed variants via in vivo recombination.

[0871] Relative activity assay

[0872] Yeast clones on SC-glucose were inoculated into the wells of 96-well microtiter plates containing YPD+Zn medium and cultured at 28°C for 3 days. The culture supernatant was applied to the 96-well zeatin microtiter plates and incubated at at least two temperatures (e.g., 60°C and 65°C, 70°C and 75°C, 70°C and 80°C) for more than 4 hours or overnight. The turbidity of zeatin in the plates was measured as A630, and relative activity (higher / lower temperature) was determined as an indicator of improved thermostability. Clones exhibiting higher relative activity than the parental variants were selected, and these sequences were identified.

[0873] Residual activity assay

[0874] Yeast clones on SC-glucose were inoculated into the wells of 96-well microtiter plates and cultured at 28°C for 3 days. The culture supernatant was incubated for 10 min in 20 mM sodium acetate buffer (pH 4.5) at a specific temperature (80°C or 84°C, with 4°C as a reference), and the residual activity was determined by measuring protease activity using azo-casein (McGenzyme) at 65°C. Clones exhibiting higher residual activity than the parental variants were selected, and these sequences were determined.

[0875] Azo-casein assay

[0876] Mix 20 μL of sample with 150 μL of substrate solution (4 mL of 12.5% ​​azo-casein in ethanol, in 96 mL of 20 mM sodium acetate (pH 4.5) containing 0.01% triton-100 and 0.25 mM ZnSO4) and incubate for 4 hours or longer.

[0877] After adding 20 μL / well of 100% trichloroacetic acid (TCA) solution, the plate was centrifuged and 100 μL of the supernatant was aspirated to measure A440.

[0878] Expression of protease variants in Aspergillus oryzae

[0879] Expression vectors for *Aspergillus* were constructed using constructs containing protease variant genes. The *Aspergillus* expression vectors consisted of an expression cassette based on a *Aspergillus niger* neutral amylase II promoter (Pna2 / tpi) fused with a non-translational leader sequence of *Aspergillus niger* triose phosphate isomerase, and a *Aspergillus niger* amylase terminator (Tamg). The plasmid also contained the *Aspergillus*-selective marker amdS, derived from *Aspergillus niger* capable of growth on acetamide as the sole nitrogen source. As described in Lassen et al. (2001), *Applied and Environmental Microbiology*, 67, 4701-4707, the protease variant expression plasmids were transformed into *Aspergillus*. For each construct, 10–20 strains were isolated, purified, and cultured in shake flasks.

[0880] Purification of the expressed variant

[0881] 1. Adjust the pH of the 0.22μm filtered fermentation sample to 4.0.

[0882] 2. Place the sample in an ice bath with magnetic stirring. Add (NH4)2SO4 in small aliquots (corresponding to approximately 2.0-2.2 M (NH4)2SO4, volume increase not considered when adding this compound).

[0883] 3. After the final addition of (NH4)2SO4, the sample was incubated in an ice bath with gentle magnetic stirring for 45 min.

[0884] 4. Centrifugation: Hitachi Himac CR20G high-speed refrigerated centrifuge, equipped with R20A2 rotor, 5℃, 20,000rpm, 30min.

[0885] 5. Dissolve the precipitate in 200 ml of 50 mM sodium acetate (pH 4.0).

[0886] 6. Filter the sample using a 0.22 μm PES PLUS membrane (IWAKI) via a vacuum aspirator.

[0887] 7. In a cold chamber, desalting / buffering of the sample was performed using ultrafiltration (Vivacell 250 from Sartorius, equipped with a 5kDa MWCO PES membrane) to replace the buffer solution with 50mM sodium acetate (pH 4.0). The osmotic sample was then diluted to 200 ml using 50mM sodium acetate (pH 4.0). The conductivity of the sample is preferably less than 5 mS / cm.

[0888] 8. Load the sample onto a cation exchange column equilibrated with 50 mM sodium acetate (pH 4.0). Elute the unbound sample from the column using 3 column volumes of binding buffer (50 mM sodium acetate, pH 4.0) and elute the sample at 10 column volumes using a linear gradient (0–100% elution buffer (50 mM sodium acetate + 1 M NaCl, pH 4.0)).

[0889] 9. The collected fractions were determined by endopeptidase assay (see below), followed by standard SDS-PAGE (reducing conditions) of the selected fractions. Multiple fractions were pooled based on the endopeptidase assay and SDS-PAGE.

[0890] Endopeptide-protease assay

[0891] 1. Dissolve Protazyme OL tablets / 5ml 250mM sodium acetate (pH 5.0) by magnetic stirring (substrate: Protazyme AK tablets, catalog number PRAK 11 / 08, from MagMed).

[0892] 2. While stirring, transfer 250 μL of substrate solution to a 1.5 mL Ependorf tube.

[0893] 3. Add 25 μL of sample to each tube (the blank control is sample buffer).

[0894] 4. Incubate these tubes at 50°C in a heat mixer (1000 rpm) for 15 minutes.

[0895] 5. Add 250 μL of 1M NaOH to each tube and then vortex.

[0896] 6. Centrifuge at 16,100×G at 25°C for 3 min.

[0897] 7. Transfer 200 μL of the supernatant to MTP and record the absorbance at 590 nm.

[0898] result

[0899]

[0900]

[0901]

[0902]

[0903]

[0904]

[0905]

[0906]

[0907] Example 3

[0908] Temperature characteristic curves of the selected variant using purified enzymes.

[0909] The selected variant exhibiting good thermostability was purified, and the purified enzyme was used in the zeatin-BCA assay as described below. After incubating the enzyme at the elevated temperature as indicated for 60 min, the residual protease activity was determined at 60 °C.

[0910] Zeatin-BCA assay:

[0911] The zeatin-BCA assay was performed at different temperatures using a variant protease to quantify the soluble protein released from zeatin.

[0912] plan:

[0913] 8) Mix 10 μL of 10 μg / ml enzyme solution and 100 μL of 0.025% zeatin solution in a microtiter plate (MTP).

[0914] 9) Incubate at different temperatures for 60 minutes.

[0915] 10) Add 10 μL of 100% trichloroacetic acid (TCA) solution.

[0916] 11) Centrifuge MTP at 3500 rpm for 5 min.

[0917] 12) Take 15 μL into a new MTP (Pierce, catalog number: 23225, BCA protein assay kit) containing 100 μL of BCA assay solution.

[0918] 13) Incubate at 60℃ for 30 minutes.

[0919] 14) Measure A562.

[0920] The results are shown in Table 6. Compared with wild-type proteases, all tested variants showed improved thermal stability.

[0921] Table 6. Zeaxanthin-BCA Determination

[0922]

[0923] Example 4

[0924] Thermal stability of proteinase Pfu

[0925] The thermostability of the potent volcanic protease (Pfu S), purchased from Takara Bio Inc. (Japan), was tested using the same method as in Example 2. The thermostability (relative activity) at pH 4.5 was found to be 110% (80°C / 70°C) and 103% (90°C / 70°C).

[0926] Example 5: Determining the concentration of metal ions in liquefied corn mash

[0927] Metal ion analysis was performed using ion-coupled plasma optical emission spectrometry (ICP-OES). Various liquefied corn mash samples were collected from industrial ethanol plants in the Midwestern United States. The liquefied mash was degraded with nitric acid (3%, v / v), and the concentrations of individual elements such as aluminum (Al), boron (B), calcium (Ca), copper (Cu), iron / ferrous (Fe), potassium (K), magnesium (Mg), manganese (Mn), sodium (Na), nickel (Ni), and zinc (Zn) were quantified using ICP-OES. The concentrations of each element were calculated using a commercially available standard mixture from SPEX CertiPrep (Fisher P / N CL-CAL-2).

[0928] Weigh 1 g of the liquefied sample into a 125 ml graduated Nalgene bottle, fill to the 100 ml mark with 3% nitric acid, and mix well. Loosen the cap and allow it to degrade overnight in a fume hood at room temperature. After overnight degradation, filter 10 ml of the treated mash through a 0.45 μm syringe filter into a 15 ml centrifuge tube. Place the filtered sample onto an ICP-OES autosampler (PerkinElmer Avio 500). Blank readings were taken with 3% nitric acid, and the analysis of each sample was averaged from three individual readings.

[0929] result

[0930] The metal ion concentrations (mM) of various industrial liquefied mashes determined by ICP-OES are shown in Table 7. Metal ions such as Ca, Cu, Fe, Mg, Mn, Ni, and Zn were selected to characterize their effects on the activity of thermostable xylanases from *Thermophila thermophila* (SEQ ID NO:1) and *Thermophila marinea* (SEQ ID NO:2).

[0931] Table 7.

[0932]

[0933]

[0934] Example 6 - Effects of metal ions on the activity of thermostable xylanases from *Thermophilus fasciatus* and *Thermophilus spp.*

[0935] The activity of purified thermostable xylanases from *Thermoplasticella thermophila* (SEQ ID NO:1) and *Thermoplasticella natans* (SEQ ID NO:2) was determined using 10 g / L wheat viscosyl xylan (P-WAXYM, Magmilco) as a substrate. The substrate solution was prepared by weighing 0.5 g of wheat viscosyl xylan into a beaker and adding approximately 40 mL of ultrapure water. The solution was vigorously stirred and heated to 80 °C in a microwave oven, and the stirring / heating steps were repeated until the matrix was completely dissolved. The beaker was cooled in a water bath while stirring. After the solution cooled to room temperature, it was transferred to a volumetric flask and brought to a final volume of 50 mL with ultrapure water.

[0936] The substrate, buffer, and metal ion mixture was prepared by mixing 250 μl of substrate solution, 200 μl of 250 mM sodium acetate buffer (pH 5.0), and 50 μl of metal ion solution containing or without final concentrations of 0, 0.0625, 0.125, 0.25, and 0.5 mM Ca, Cu, Fe, Mg, Mn, and Zn into a 1.5 ml tube and vortexing. Enzyme activity was measured using a PCR thermal cycler. In a PCR plate, 80 μl of the substrate / buffer / metal ion mixture was dispensed into each well, and the reaction was initiated by adding 20 μl of appropriately diluted purified xylanase. The plate was capped and incubated at 85 °C for 30 min on a Veriti thermal cycler (Thermo Fisher Scientific). After 30 min of reaction, the plate was immediately cooled on ice for 3 min.

[0937] The xylo-oligosaccharide product generated by xylanase was determined using p-hydroxybenzoic acid hydrazide solution (PAHBAH) (which detects the amount of reducing sugar released). 40 μl of PAHBAH solution was added to each well and incubated at 55 °C for 20 min. After 20 min, 100 μl of the corresponding PAHBAH reaction supernatant was transferred to a 96-well plate, and color development was measured at 405 nm using a spectrophotometer. Enzyme activity was defined as the absorbance intensity at 405 nm. The control was the reaction of the enzyme with substrate / buffer in the absence of metal ions. The blank was the substrate, buffer, and corresponding concentration of metal ions without the addition of enzyme.

[0938] result

[0939] Table 8 shows that concentrations of Cu, Fe, and Zn as low as 0.0625 mM reduced the activity of *Thermophilus tenella* xylanase (SEQ ID NO:1) by 20%–40%, while the activity of *Thermophilus spp.* xylanase (SEQ ID NO:2) was unaffected (Table 9). As shown in Table 7, at higher concentrations of Fe and Zn corresponding to the amounts detected in liquefied corn mash (0.125 mM to 0.25 mM), the activity of *Thermophilus tenella* xylanase (SEQ ID NO:1) was significantly reduced by 50%–60% compared to *Thermophilus spp.* xylanase (SEQ ID NO:2) (Table 8), which was not significantly affected by Cu or Zn and was less affected by Fe (Table 9).

[0940] Surprisingly, the results described in this paper suggest that thermostable xylanases with greater tolerance to inhibition of Cu, Fe, or Zn present in maize, such as Thermophyton floccosum xylanase (SEQ ID NO:2), will provide more robust and consistent performance in liquefaction for yield benefits.

[0941] Table 8: Effects of metal ions on xylanase in *Tentacula thermophila*

[0942]

[0943] Table 9: Effects of metal ions on xylanase in *Thermophyton floccosum*

[0944]

[0945]

[0946] Example 7 - Determination of residual starch in liquefied corn mash treated with thermostable xylanases from *Thermophilus fasciatus* (Dt) and *Thermophilus tumefaciens* (Tm).

[0947] Liquefaction was carried out in a metal tank using Labomat BFA-24 (Mathis, Concord, NC). 37.9 g of industrially produced ground corn was added to 62.0 g of tap water and thoroughly mixed. The target dry solids (DS) was approximately 33% DS. The pH was adjusted to 5.0 with 40% v / v sulfuric acid and the DS was measured using a moisture balance (Mettler-Toledo). A mixture of α-amylase and protease, consisting of 2.4 μg α-amylase AA2330 and 2.7 μg Pfu protease, with or without thermostable xylanase from *Thermophila thermophila* (SEQ ID NO:1) and *Thermophila marinea* (SEQ ID NO:2), was added to the corn steep liquor in doses. Each treatment was performed in triplicate. As a control, only α-amylase and protease were added without xylanase. The xylanase dosage was 5 μg / g dry solids. Liquefaction was performed in a Labomat chamber at 91°C for 2 hours. Once liquefaction was complete, all containers were cooled to room temperature in an ice bath before probes were taken for residual starch determination. 4–5 g of the liquefied mash sample was transferred to pre-weighed 15 mL tubes. To determine residual starch, soluble substances in the mash were removed by washing with ultrapure water. The washing step was performed by adding approximately 6 mL of ultrapure water, followed by vigorous vortexing and centrifugation at 3500 rpm for 5 minutes. The supernatant was carefully discarded, and the precipitate was washed twice more with 6 mL of ultrapure water as described above. After the washing step, the insoluble solids were resuspended in 6 mL of 100 mM sodium acetate buffer (pH 5.0). Residual starch in the insoluble solids was determined by adding 50 μL of a concentrated raw starch hydrolase consisting of a mixture of α-amylase and glucosylamylase (glucosylamylase BL (GBL)). The enzyme reaction was carried out overnight at 50°C. After incubation, the tubes were thoroughly vortexed and centrifuged at 3500 rpm for 5 minutes. Collect the supernatant and then filter it using a syringe filter with a 0.2 μM filter. Dilute the filtrate appropriately into HPLC vials. Quantify the glucose concentration by HPLC and convert the calculated value into the amount of starch.

[0948] result

[0949] Compared with the control or Dt xylanase-treated liquefaction (SEQ ID NO:1), the liquefied sample treated with Tm xylanase (SEQ ID NO:2) showed lower residual starch (Table 10). The lower residual starch indicates that Tm xylanase releases more starch from milled corn compared to Dt xylanase, suggesting that Tm xylanase hydrolyzes corn fiber more actively and releases more fiber-bound starch.

[0950] Table 10: Average residual starch in liquefied samples with or without heat-stabilizing xylanase treatment

[0951] deal with Xylanase dosage (ug / gDS) Residual starch after liquefaction (% starch / gDS) Comparison 0 9.2% Dt xylanase 5 8.6% Tm xylanase 5 7.6%

[0952] Example 8 - Determining the oligosaccharide concentration in liquefied corn mash treated with thermostable xylanases from *Thermophilus fasciatus* (Dt) and *Thermophilus tumefaciens* (Tm).

[0953] Liquefaction was carried out in a metal tank using Labomat BFA-24 (Mathis, Concord, NC). 38.4 g of industrially produced ground corn was added to 61.4 g of tap water and thoroughly mixed. The target dry solids (DS) was approximately 33% DS. The pH was adjusted to 5.0 with 40% v / v sulfuric acid, and the DS was measured using a moisture balance (Mettler-Toledo). A mixture of α-amylase and protease, consisting of 1.5 μg α-amylase AA2330 and 3.0 μg Pfu protease, with or without thermostable xylanase from *Thermophila thermophila* (SEQ ID NO:1) and *Thermophila marinea* (SEQ ID NO:2), was added to the corn steep liquor in doses. Each treatment was performed in triplicate. As a control, only α-amylase and protease were added without xylanase. Xylanase doses were 2.5, 5, and 10 μg / g dry solids. Liquefaction was carried out in a Labomat chamber at 91°C for 2 hours. Once liquefaction was complete, all flasks were cooled to room temperature in an ice bath before high-performance liquid chromatography (HPLC) analysis. To prepare samples for HPLC analysis, approximately 5 g of liquefied mash was transferred to a 15 mL centrifuge tube and centrifuged at 3500 rpm for 10 min. After centrifugation, the supernatant was harvested and filtered through a 0.2 μM filter into HPLC vials using a syringe. The HPLC was equipped with an Aminex HPX-42A column (Bio-rad), using ultrapure water as the mobile phase at a flow rate of 0.5 mL / min and a temperature set at 85°C, and was equipped with a refractive index detector. Oligosaccharide standards for glucose (DP1), maltose (DP2), maltotriose (DP3), maltotetraose (DP4), maltopentose (DP5), and maltohexaose (DP6) were commercially available and used as references for quantifying short-chain oligosaccharides produced by the enzymatic reaction after liquefaction.

[0954] result

[0955] Compared to the control or liquefied samples treated with Dt xylanase (SEQ ID NO:1), the liquefied samples treated with Tm xylanase (SEQ ID NO:2) showed higher concentrations of DP2, DP3, DP4, DP5, and DP6 (Table 11). The total amount of oligosaccharides (DP1 to DP6) increased proportionally with the amount of Tm xylanase. Compared to Dt xylanase, Tm xylanase exhibited higher activity after liquefaction, resulting in the production of a greater amount of short-chain oligosaccharides. Due to the release of more cellulose-bound starch by Tm xylanase, this facilitated the synergistic hydrolysis of more starch by α-amylase, enabling higher fermentation yields.

[0956] Table 11. Average concentrations of oligosaccharides (DP1 to DP6) in liquefied samples with and without treatment with thermostable xylanase.

[0957]

[0958] Example 9 - Determining the optimal temperature and temperature stability of a thermostable xylanase resistant to metal ions from *Thermophyton floccosum* (Tm).

[0959] This example illustrates how to determine the optimal temperature and DSC melting point of an enzyme (e.g., the metal-resistant xylanase, α-amylase, protease, etc. disclosed herein) to determine whether the enzyme is thermally stable (e.g., suitable for use in liquefaction step i). The optimal temperature and stability of a metal-resistant xylanase from *Thermocystis aeruginosa* (SEQ ID NO:2) were determined using 10 g / L wheat arachidonic acid xylan (P-WAXYM, Magexec) as a substrate. The substrate solution was prepared by weighing 0.5 g of wheat arachidonic acid xylan into a beaker and then adding approximately 40 mL of ultrapure water. The solution was vigorously stirred and heated in a microwave at 80 °C until the substrate was completely dissolved. The solution was cooled by placing the beaker in a water bath while stirring. After the solution cooled to room temperature, it was transferred to a volumetric flask and brought to a final volume of 50 mL with ultrapure water. The substrate and buffer mixture was prepared by mixing 250 μl of substrate solution and 200 μl of 250 mM sodium acetate buffer (pH 5.0) in a 1.5 ml test tube and vortexing.

[0960] Optimal temperatures were determined using a PCR thermal cycler preset to 80°C, 83°C, 86°C, 89°C, 92°C, and 95°C. In the PCR plate, 80 μl of substrate / buffer was dispensed into each well to mix, and the reaction was initiated by adding 20 μl of appropriately diluted purified Tm xylanase. The plate was capped and incubated for 30 minutes at the appropriate temperature using a Veriti thermal cycler (Thermo Fisher Scientific). After 30 minutes of reaction, the plate was immediately cooled on ice for 3 minutes, and then the PAHBAH assay was performed as described below.

[0961] Temperature stability was determined using a PCR thermal cycler preset to 4°C, 86°C, 89°C, 92°C, 95°C, and 98°C. 20 μl of appropriately diluted purified Tm xylanase was dispensed into each PCR plate, capped, and pre-incubated for 30 minutes. After 30 minutes of incubation, xylanase activity was measured by adding 80 μl of substrate / buffer mixture to each well, capping, and incubating for 30 minutes on a Veriti thermal cycler (Thermo Fisher Scientific). Immediately after 30 minutes of reaction, the plate was cooled on ice for 3 minutes, followed by the PAHBAH assay as described below. Furthermore, the melting temperature (Td) of Tm xylanase (SEQ ID NO:2) was determined using differential scanning calorimetry (DSC).

[0962] The xylo-oligosaccharide product generated by xylanase was determined using p-hydroxybenzoic acid hydrazide solution (PAHBAH) (which detects the amount of reducing sugar released). 40 μL of PAHBAH solution was added to each well and incubated at 55 °C for 20 min. After 20 min, 100 μL of the corresponding PAHBAH reaction supernatant was transferred to a 96-well plate, and color development was measured at 405 nm using a spectrophotometer. Enzyme activity was defined as the absorbance intensity at 405 nm. The control was the enzyme reaction with substrate / buffer in the absence of metal ions. The blank was the substrate and buffer without enzyme.

[0963] result

[0964] The optimal temperature for Tm xylanase (SEQ ID NO:2) is shown in Figure 1 The relative activity of xylanase was calculated using the temperature at which the highest activity (100%) was observed, as shown in the figure. Tm xylanase exhibited the highest activity at 95°C.

[0965] The temperature stability of Tm xylanase is shown in Figure 2 The figure shows the residual xylanase activity calculated with reference to 100% xylanase activity after pre-incubation at 4°C. Tm xylanase is very thermostable and exhibits almost no loss of activity at temperatures up to 98°C.

[0966] The melting temperature (Td) of Tm xylanase, measured by differential scanning calorimetry (DSC), has a Td value of 110 °C.

Claims

1. A method for producing a fermentation product from corn, the method comprising the following steps: i) Liquefying corn at 80-100°C in the presence of α-amylase and a thermostable xylanase, wherein the thermostable xylanase is resistant to inhibition by metal ions during corn liquefaction; the thermostable xylanase is derived from Thermoplastis marinum. ii) Saccharification using enzymes that produce carbohydrates; as well as iii) Using fermenting organisms to produce the fermentation product. The thermostable xylanase is SEQ ID NO: 2, the carbohydrate-producing enzyme is glucoamylase, the fermenting organism is yeast, and the metal ions are copper, iron, and zinc ions.

2. The method of claim 1, wherein the thermostable xylanase has a melting point (DSC) greater than 82°C.

3. The method of claim 1, wherein the average concentration of metal ions present during corn liquefaction is from 0.012 mM to 0.15 mM.

4. The method of claim 3, wherein the resistance to metal ion inhibition during corn liquefaction is the retention of at least 60% of the relative activity of the xylanase in the presence of an average concentration of the metal ion during corn liquefaction.

5. The method of claim 1, wherein, The amount of residual starch present at the end of step i) is reduced compared to the amount of residual starch present at the end of step i) in the absence of this xylanase.

6. The method of claim 1, wherein the amount of short-chain oligosaccharides present at the end of step i) is increased compared to the amount of short-chain oligosaccharides present at the end of step i) in the absence of the xylanase.

Citation Information

Patent Citations

  • A novel thermostable glucoamylase and method for its production

    EP0135138A2

  • Cloning and expression of microbial phytase

    EP0420358A1

  • Polypeptides with phytase activity

    EP0684313A2

  • Modified phytases

    EP0897010A2

  • Consensus phytases

    EP0897985A2